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Front cover, top:  HSP90, a regulator of cell survival. Inhibition of HSP90 activity 
by drugs like geldanamycin (GA) destabilizes client proteins which ultimately lead 
to the onset of apoptosis.  Dana Haley-Vicente, Assay Designs (an Enzo Life 
Sciences company). 
 
Front cover, bottom:  C. elegans expressing a proteotoxic polyglutamine-
expansion protein.  Richard Morimoto, Northwestern University. 
 
Back cover, clockwise from top left: 
Maltose binding protein (translucent), shown suspended in its molten globule 
state with chaperone protein SecB (yellow), destined for transport across the 
cellular membrane.  Philipp Bechtluft, Arnold Driessen, Sander Tans and Graham 
Johnson. 
 
Nuclear localization of Hsp10 in cultured human lung fibroblasts. The image 
shows Hsp10 in the cytoplasm and in the nucleus of most cells in a culture of the 
human lung fibroblast cell line, HLF-1. The chaperonin is considered a 
mitochondrial protein but here we demonstrate by immunohistochemistry that it 
also occurs in the cytoplasm and in the nucleus. Bar = 50 microns.  Simona 
Corrao. University of Palermo.  
 
Structure of the oligomeric small heat shock protein, alphaB-Crystallin, 
determined by solid-state NMR.  The structure reveals that the C-terminus IXI 
motif from one unit in the oligomer binds in the substrate-binding groove of a 
neighboring until, suggesting an auto-inhibitory mechanism for chaperone 
activity.  Rachel Klevit, University of Washington.  Artwork prepared by S. Jehle. 
 
Structure of the protein alpha-crystallin determined by electron microscopy.  
Johannes Buchner, Technische Universität München. 
 
Several ribosomes (brown) are shown translating a messenger RNA (gray). As 
the elongating nascent protein (orange) emerges from the ribosome, it undergoes 
limited folding, but interactions with the exit tunnel and the surrounding area 
(shaded red) prevent the acquisition of stable tertiary structure. The ribosome 
effectively acts as a chaperone to prevent premature folding and misfolding of the 
nascent chain. After release from the ribosome, the free protein folds into its 
native structure (large orange structure). These conclusions are based on our 
single molecule force spectroscopy data probing the folding state of ribosome-
associated nascent chains.  Christian Kaiser, University California, Berkeley. 
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TUESDAY, May 4—7:30 PM 
 
 
SESSION 1 CHAPERONE BIOCHEMISTRY AND PROTEIN 
FOLDING 
 
Chairperson: J. Bardwell, Howard Hughes Medical Institute,  
University of Michigan, Ann Arbor 
 
 
Protein stabilization by selection 
James Bardwell. 
Presenter affiliation: University of Michigan, Ann Arbor, Michigan. 
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Trajectory of ATP-induced domain movements in GroEL 
Dan Clare, Daven Vasishtan, Maya Topf, Joel Quispe, George Farr, 
Art Horwich, Helen Saibil. 
Presenter affiliation: Birkbeck College of London, United Kingdom. 
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Role of molecular chaperones in SOD1-linked ALS 
Arthur Horwich, Wayne Fenton, Krystyna Furtak, Maria Nagy, Urmi 
Bandyopadhyay, Navneet Tyagi. 
Presenter affiliation: Yale School of Medicine, New Haven, 
Connecticut. 
 
 
 
 
3 
  
Chaperonin-catalyzed rescue of entropically trapped states in 
protein folding 
Kausik Chakraborty, Jyoti Sinha, Manal Chatila, Qiaoyun Shi, Bernhard 
C. Poschner, Martin Sikor, Guoxin Jiang, Don  C. Lamb, F-Ulrich Hartl, 
Manajit Hayer-Hartl. 
Presenter affiliation: Max Planck Institute of Biochemistry (MPIB), 
Martinsried, Germany; Institute of Genomics and Integrative Biology 
(CSIR), Delhi, India. 
 
 
 
 
 
 
 
4 
  
Single molecule analysis of nascent protein folding 
Christian M. Kaiser, Daniel H. Goldman, Susan Marqusee, Carlos 
Bustamante. 
Presenter affiliation: University of California, Berkeley, Berkeley, 
California. 
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 vi 
Taming the beast—Structural biology of a small heat shock 
protein 
Rachel E. Klevit, Stefan Jehle, Benjamin Bardiaux, Katja Dove, Barth 
von Rossum, Hartmut Oschkinat, Ponni Rajagopal. 
Presenter affiliation: University of Washington, Seattle, Washington. 
 
 
 
 
6 
  
Three-dimensional structure of the Hsp104 AAA+ ATPase 
Francis T. Tsai, Sukyeong Lee, Bernhard Sielaff, Jungsoon Lee. 
Presenter affiliation: Baylor College of Medicine, Houston, Texas. 
 
 
7 
  
Rapid folding completion in the cage or escaping out of the 
cage—Alternative fates of substrate polypeptide interacting with 
GroEL/GroES interface region in the critical intermediate of 
chaperonin-assisted folding 
Fumihiro Motojima, Masasuke Yoshida. 
Presenter affiliation: Kyoto Sangyou University, Kyoto, Japan. 
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WEDNESDAY, May 5—9:00 AM 
 
 
SESSION 2 CHAPERONE FUNCTION IN DISEASE AND 
DEVELOPMENT 
 
Chairperson: E. Deuerling, University of Konstanz, Germany 
 
  
Functions and mechanisms of cytosolic chaperones in protein 
homeostasis 
Elke Deuerling, Ansgar Koplin, Steffen Preissler, Yulia Ilina, Miriam 
Koch, Annika Scior. 
Presenter affiliation: University of Konstanz, Konstanz, Germany. 
 
 
 
 
9 
  
The heat shock response— Integrated neuronal networks for 
metabolic control, stress, and aging 
Richard I. Morimoto, Anat Ben-Zvi, Veena Prahlad, Laetitia Chauve. 
Presenter affiliation: Northwestern University, Evanston, Illinois. 
 
 
 
10 
  
Insights into Hsp90-client protein interactions from NMR 
H. Jane Dyson, Sung Jean Park, Maria A. Martinez-Yamout. 
Presenter affiliation: The Scripps Research Institute, La Jolla, 
California. 
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 vii 
The Hsp110 molecular chaperone modulates dynein activity 
Taras Makhnevych, Philip Wong, Oxana Pogoutse, Franco J. 
Vizeacoumar, Yolanda Chong, Charles Boone, Andrew Emili, Walid A. 
Houry. 
Presenter affiliation: University of Toronto, Toronto, Canada. 
 
 
 
 
12 
  
The role of small Heat Shock Proteins in protein folding diseases 
Serena Carra, Alessandra Boncoraglio, Melania Minoia, Bart Kanon, 
Jeanette F. Brunsting, Marianne P. Zijlstra, Michel J. Vos, Ody C. 
Sibon, Harm H. Kampinga. 
Presenter affiliation: UMCG & RuG, Groningen, Netherlands. 
 
 
 
 
13 
  
How do intrinsically unfolded chaperones work? 
Dana Reichmann, Marianne Ilbert, Ying Xu, Claudia M. Cremers, 
Michael C. Fitzgerald, Ursula Jacob. 
Presenter affiliation: University of Michigan, Ann Arbor, Michigan. 
 
 
 
14 
  
The interplay between chaperones, prion protein dynamics and 
their cellular context Is crucial for protein-only inheritance 
Tricia Serio, Aaron Derdowski, Susanne DiSalvo, Courtney Klaips, 
Suzanne Sindi. 
Presenter affiliation: Brown University, Providence, Rhode Island. 
 
 
 
 
15 
  
Conserved conformational states and cochaperone interactions 
define the Hsp90 molecular chaperone cycle 
Daniel R. Southworth, David A. Agard. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California. 
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WEDNESDAY, May 5—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
SRR—A novel type of Hsp90-related supra-domain associated 
with neurodegeneration 
John F. Anderson, Efrain Siller, Jose M. Barral. 
Presenter affiliation: The University of Texas Medical Branch, 
Galveston, Texas. 
 
 
 
 
17 
  
Mechanism of Hsp40-family co-chaperones DnaJA1 and DnaJA2 
with Hsc70 
Imad Baaklini, Michael J. Wong, Jason C. Young. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
 
18 
 viii 
ATF4 potentiates cell death upon endoplasmic reticulum stress 
by decreasing and reducing the duration of eIF2a 
phosphorylation 
Sung Hoon Back, Robert Gildersleeve, Ja Young Moon, Jaeseok Han, 
Randal J. Kaufman. 
Presenter affiliation: Howard Hughes Medical Institute, University of 
Michigan, Ann Arbor, Michigan. 
 
 
 
 
 
 
19 
  
Direct observation of chaperone-induced changes in a protein 
folding pathway 
Philipp Bechtluft, Alireza Mashaghi, Sander Tans. 
Presenter affiliation: AMOLF Institute, Amsterdam, Netherlands. 
 
 
 
20 
  
The function of the chaperone Trigger Factor in co-translational 
folding of proteins 
Annemarie Becker, Anja Hoffmann, Günter Kramer, Bernd Bukau. 
Presenter affiliation: University of Heidelberg, Heidelberg, Germany. 
 
 
 
21 
  
Determining oligomeric structures of the heterogeneous small 
heat shock protein aB-crystallin 
Justin L. Benesch. 
Presenter affiliation: University of Oxford, Oxford, United Kingdom. 
 
 
 
22 
  
eIF2a phosphorylation controls the balance between adaptation 
and apoptosis in response to hypertonic conditions 
Elena Bevilacqua, Mithu Majumder, Randal J. Kaufman, Martin Holcik, 
Maria Hatzoglou. 
Presenter affiliation: Case Western University School of Medicine, 
Cleveland, Ohio. 
 
 
 
 
 
23 
  
Systematic fitness analysis of point mutants of Hsp90 
Dan Bolon. 
Presenter affiliation: UMass Medical School, Worcester, 
Massachusetts. 
 
 
 
24 
  
Mapping heat shock factor 1 activity in the landscape of 
Saccharomyces cerevisiae gene deletion mutants 
Onn Brandman, Jonathan S. Weissman. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California. 
 
 
 
 
25 
  
Hsp104 processing of prion variants 
Donell Carey, Heather True. 
Presenter affiliation: Washington University, Saint Louis, Missouri. 
 
 
26 
  
 ix 
Hsp70 activity is reduced by Ca2+/calmodulin 
Joon-Yung Cha, Min Hee Jung, Sang Yeol Lee, Woe Yeon Kim, 
Daeyoung Son. 
Presenter affiliation: Gyeongsang National University, Jinju, South 
Korea. 
 
 
 
 
27 
  
Celastrol inhibits Hsp90 chaperoning of steroid receptors by 
inducing fibrilization of the co-chaperone p23 
Ahmed Chadli, Sara Felts, Qin Wang, Marina Ramirez-Alvarado, Abul 
Fauq, Georges Mer. 
Presenter affiliation: Medical College of Georgia, Augusta, Georgia. 
 
 
 
 
28 
  
Systematic analysis of factors underlying the refolding activity of 
DnaK 
Lyra Chang, Andrea D. Thompson, Peter Ung, Heather Carlson, Jason 
E. Gestwicki. 
Presenter affiliation: University of Michigan-Ann Arbor, Ann Arbor, 
Michigan. 
 
 
 
 
 
29 
  
Genetic interactions between ribosome-bound factors and 
components of mRNA decay pathways 
Marco Chiabudini, Charlotte Conz, Sabine Rospert. 
Presenter affiliation: University of Freiburg, Freiburg, Germany. 
 
 
 
30 
  
A high-throughput fluorescence-based assay for screening 
inhibitors of protein disulfide isomerase activity 
Lijun Dai, Jack Coleman, Eric Chan, Dee Shen, Praveen Pande, 
Wayne F. Patton. 
Presenter affiliation: ENZO Life Sciences, Farmingdale, New York. 
 
 
 
 
31 
  
The yeast Not4 E3 ligase contributes to proteasome assembly 
through regulation of RP chaperones 
Olesya O. Panasenko, Martine A. Collart. 
Presenter affiliation: University of Geneva, Faculty of Medicine, 
Geneva, Switzerland. 
 
 
 
 
32 
  
PI3K-mTOR reduces stress resistance by attenuating HSP70 
translation 
Crystal S. Conn, Jun Sun, Yan Han, Vincent Yeung, Shu-Bing Qian. 
Presenter affiliation: Cornell University, Ithaca, New York. 
 
 
 
33 
  
 x 
Diversity of Hsp-chaperones in the early eukaryote Perkinsus 
marinus 
Everly Conway de Macario, Elisabet V. Caler, Jose A. Fernadez-
Robledo, Gerardo R. Vasta, Alberto JL Macario. 
Presenter affiliation: University of Maryland Biotechnology Institute, 
Baltimore, Maryland; J. Craig Venter Institute, Rockville, Maryland. 
 
 
 
 
 
34 
  
Chaperones in disease—Quantitative changes in chronic 
obstructive pulmonary disease (COPD) 
Francesco Cappello, Simona Corrao, Marco Carbone, Isabella 
Gnemmi, Chiara Vicari, Gaetano Caramori, Mauro Carone, Giampiero 
La Rocca, Bruno Balbi, Everly Conway De Macario, Alberto J. Macario, 
Antonino Di Stefano. 
Presenter affiliation: University of Palermo, Palermo, Italy. 
 
 
 
 
 
 
35 
  
Hsp10 beyond mitochondria—Novel locations predict as yet 
undescribed roles 
Simona Corrao, Rita Anzalone, Francesca Magno, Tiziana Loria, 
Melania Lo Iacono, Felicia Farina, Giovanni Zummo, Francesco 
Cappello, Everly Conway de Macario, Alberto J. Macario, Giampiero 
La Rocca. 
Presenter affiliation: University of Palermo, Palermo, Italy. 
 
 
 
 
 
 
36 
  
A distinct class of nuclear receptor alternate site modulators 
(NRAMs) that target a novel androgen receptor regulatory 
mechanism involving FKBP52 and ß-catenin 
Johanny Meneses De Leon, Cheryl Storer, Aki Iwai, Jane Trepel, 
Clementine Feau, R. Kip Guy, Robert Fletterick, Leonard M. Neckers, 
Marc B. Cox. 
Presenter affiliation: University of Texas at El Paso, El Paso, Texas. 
 
 
 
 
 
 
37 
  
Unfolding of the metastable linker region at the core of Hsp33’s 
activation as a chaperone 
Claudia M. Cremers, Dana Reichmann, Jens Hausmann, Marianne 
Ilbert, Ursula Jakob. 
Presenter affiliation: University of Michigan, Ann Arbor, Michigan. 
 
 
 
 
38 
  
Regulation of the heat shock response by tissue-specific 
networks in Caenorhabditis elegans 
Daniel M. Czyz, Eric Guisbert, Klaus Richter, Patrick McMullen, 
Richard I. Morimoto. 
Presenter affiliation: Northwestern University, Evanston, Illinois. 
 
 
 
 
39 
  
 xi 
Mimicking chaperone function—Protein folding in isolation 
Tetyana Dashivets, Martin Haslbeck, Johannes Buchner. 
Presenter affiliation: Technische Universität München, Garching, 
Germany. 
 
 
 
40 
  
Folding and aggregation of the intrinsically disordered tau 
protein are selectively regulated by chaperones 
Chad A. Dickey, Jason E. Gestwicki, Shannon E. Hill, Martin M. 
Mushcol, John Koren, John C. O'Leary, Jose F. Abisambra, Laura 
Blair, Jeffrey R. Jones, Umesh K. Jinwal. 
Presenter affiliation: University of South Florida, Tampa, Florida. 
 
 
 
 
 
41 
  
Modulating amyloids by chemical disaggregases 
Martin L. Duennwald. 
Presenter affiliation: BBRI, Watertown, Massachusetts. 
 
 
42 
  
A novel HSP104 mutant propagates cryptic [PSI+] 
Jennifer E. Dulle, Rachel Bouttenot, Heather L. True. 
Presenter affiliation: Washington University School of Medicine, Saint 
Louis, Missouri. 
 
 
 
43 
  
Chaperone assisted degradation of misfolded cytoplasmic 
protein requires the ubiquitin ligase Ubr1 
Frederik Eisele, Ingo Amm, Dieter H. Wolf. 
Presenter affiliation: Universität Stuttgart, Stuttgart, Germany. 
 
 
 
44 
  
A protein's folding state can be derived from its primary 
sequence using a simple method for computing optimal 
backbone burial 
Jeremy L. England. 
Presenter affiliation: Princeton University, Princeton, New Jersey. 
 
 
 
 
45 
  
The molecular mechanism of IgG antibody quality control 
Matthias J. Feige, Sandra Groscurth, Moritz Marcinowski, Yuichiro 
Shimizu, Linda M. Hendershot, Johannes Buchner. 
Presenter affiliation: Center for Integrated Protein Science Munich, 
Technische Universität München, Garching, Germany; St. Jude 
Children's Research Hospital, Memphis, Tennessee. 
 
 
 
 
 
46 
  
Self-association of unfolded outer membrane proteins and its 
prevention by chaperones 
Alexandra Ebie Tan, Nancy K. Burgess, Diana S. DeAndrade, Jacob 
D. Marold, Karen G. Fleming. 
Presenter affiliation: Johns Hopkins University, Baltimore, Maryland. 
 
 
 
 
47 
  
 xii 
The interplay between degradation and repair machinery in 
nuclear protein quality control 
Eric K. Fredrickson, Jennifer L. Whiting, Grace E. Woodruff, Richard G. 
Gardner. 
Presenter affiliation: University of Washington, Seattle, Washington. 
 
 
 
 
48 
  
Denatured proteins facilitate the formation of the football-shaped 
GroEL-GroES complex 
Tomoya Sameshima, Ryo Iizuka, Taro Ueno, Takashi Funatsu. 
Presenter affiliation: The University of Tokyo, Tokyo, Japan. 
 
 
 
49 
  
Analysis of ternary Hsp90•cofactor complexes by analytical 
ultracentrifugation 
Andreas M. Gaiser, Klaus Richter. 
Presenter affiliation: TU München, Garching, Germany. 
 
 
 
50 
  
Characterization of a novel transcription factor involved in 
oxidative stress resistance of Escherichia coli 
Katharina M. Gebendorfer, Jeannette Winter. 
Presenter affiliation: Technische Universitaet Muenchen, Garching, 
Germany. 
 
 
 
 
51 
  
Functional analysis of HtpG, the E. coli homolog OF Hsp90 
Olivier Genest, Sue Wickner. 
Presenter affiliation: National Cancer Institute, National Institutes of 
Health, Bethesda, Maryland. 
 
 
 
52 
  
Unraveling the role of the Lon protease and the SecB chaperone 
in presecretory protein quality-control 
Samer Sakr, Anne-Marie Cirinesi, Ronald Ullers, Francoise Schwager, 
Costa P. Georgopoulos, Pierre Genevaux. 
Presenter affiliation: CNRS/University of Toulouse, Toulouse, France. 
 
 
 
 
53 
  
Contribution of environment and genetic background to 
aggregation toxicity 
Tali Gidalevitz, Richard I. Morimoto. 
Presenter affiliation: Northweswtern University, Evanston, Illinois. 
 
 
 
54 
  
Hsp12 is an intrinsically unfolded stress protein which folds upon 
membrane association and modulates membrane function 
Birgit Rudolph, Sylvia Welker, Franz Hagn, Johannes Scheuring, 
Martin Haslbeck, Johannes Buchner. 
Presenter affiliation: Munich Center for Integrated Protein Science, 
Technische Universität München, Garching, Germany. 
 
 
 
 
 
55 
  
 xiii 
Coupled chaperone action in the biogenesis of form I 
hexadecameric Rubisco 
Manajit Hayer-Hartl, Cuimin Liu, Anna L. Young, Amanda S.-Windhof, 
Andreas Bracher, Sandra Saschenbrecker, Bharathi V. Rao, Karnam 
V. Rao, Otto Berninghausen, Thorsten Mielke, Roland Beckmann, F. 
Ulrich Hartl. 
Presenter affiliation: Max Planck Institute of Biochemistry, Martinsried, 
Germany. 
 
 
 
 
 
 
 
56 
  
Role of the unfolded protein response in inflammation 
Yin He, Haibo Sha, Ling Qi. 
Presenter affiliation: Cornell University, Ithaca, New York. 
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ATPase domain and interdomain linker play a key role in 
aggregation of mitochondrial Hsp70 chaperone Ssc1 
Marta Blamowska, Martin Sichting, Koyeli Mapa, Dejana Mokranjac, 
Walter Neupert, Kai Hell. 
Presenter affiliation: LMU München, Munich, Germany. 
 
 
 
 
58 
  
Disulfide bond formation in LptD (Imp) is essential for LPS 
assembly on the cell surface of Escherichia coli 
Annie Hiniker, Natacha Ruiz, Shusin Chng, Daniel Kahne, Thomas J. 
Silhavy. 
Presenter affiliation: UCSF, San Francisco, California; Princeton 
University, Princeton, New Jersey. 
 
 
 
 
 
59 
  
Structure-based virtual screening of Hsp90 inhibitors and 
polypyrrole nanotube FET platform as a novel tool for sensing 
Hsp90 inhibitor 17-AAG 
Tae-Joon Hong, Hwangseo Park, Yun-Jung Kim, Oh Seok Kwon, Sang 
Kyu Kim, Ji-Sook Hahn, Jyongsik Jang. 
Presenter affiliation: Seoul National University, Seoul, South Korea. 
 
 
 
 
 
60 
  
Single-molecule characterization of the football-shaped GroEL-
GroES complex using zero-mode waveguides 
Ryo Iizuka, Tomoya Sameshima, Taro Ueno, Junichi Wada, Mutsuko 
Aoki, Naonobu Shimamoto, Iwao Ohdomari, Takashi Tanii, Takashi 
Funatsu. 
Presenter affiliation: The University of Tokyo, Tokyo, Japan. 
 
 
 
 
 
61 
  
Hsp90 mutation results in activation of multiple genes that 
regulate developmental pathways in Saccharomyces cerevisiae 
Gary A. Flom, Jill L. Johnson. 
Presenter affiliation: University of Idaho, Moscow, Idaho. 
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WEDNESDAY, May 5—4:30 PM 
 
Wine and Cheese Party 
 
 
 
WEDNESDAY, May 5—7:30 PM 
 
 
SESSION 4 EVOLUTION AND REGULATION OF PROTEIN 
FOLDING MACHINES 
 
Chairperson: J. Frydman, Stanford University, California 
 
 
A ribosome-anchored chaperone network that facilitates 
eukaryotic ribosome biogenesis 
Judith Frydman. 
Presenter affiliation: Stanford University, Stanford, California. 
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A chaperone protein modulates the homeostatic regulation of the 
unfolded protein response 
Hanna El-Samad. 
Presenter affiliation: University of California, San Francisco, California. 
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Is chaperonin function mediated by water? 
Vijay Pande. 
Presenter affiliation: Stanford University, Stanford, California. 
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Phospho-regulation of the Hsp90 chaperone machinery 
Johannes Buchner, Sebastian Wandinger, Klaus Richter, Thiemo 
Schreiber, Henrik Daub, Joanna Soroka. 
Presenter affiliation: Technische Universität München, Garching, 
Germany. 
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Global functional map of the yeast p23 cochaperone Sba1 reveals 
extensive nuclear molecular chaperone activities 
Elena Zelin, Frank J. Echtenkamp, Ellinor Oxelmark, Joyce I. Woo, 
Michael J. Garabedian, Brenda J. Andrews, Brian C. Freeman. 
Presenter affiliation: University of Illinois, Urbana-Champaign, Illinois. 
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Hsp90 transforms the phenotypic manifestation of genetic 
variation in S. cerevisiae 
Daniel F. Jarosz, Susan Lindquist. 
Presenter affiliation: Whitehead Institute/Howard Hughes Medical 
Institute, Cambridge, Massachusetts. 
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 xv 
Avoiding stress—Uncovering an essential behavioral circuit 
Justine A. Melo, Gary Ruvkun. 
Presenter affiliation: Massachusetts General Hospital, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts. 
 
 
 
69 
  
Hsp110 chaperones control client fate determination in the 
Hsp70/Hsp90 chaperone system 
Kevin A. Morano, Atin K. Mandal, Patrick A. Gibney, Nadinath B. 
Nillegoda, Maria A. Theodoraki, Avrom J. Caplan. 
Presenter affiliation: University of Texas Medical School, Houston, 
Texas. 
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THURSDAY, May 6—9:00 AM 
 
 
SESSION 5 MANIPULATING CHAPERONE NETWORKS AND 
PROTEIN FOLDING PATHWAYS 
 
Chairperson: W. Balch, The Scripps Research Institute,  
La Jolla, California 
 
 
Managing proteomic folding platforms through proteostasis 
William E. Balch, Darren M. Hutt, David Herman, Sandra Pankow, Joel 
M. Gottesfeld, John R. Yates. 
Presenter affiliation: The Scripps Research Institute, La Jolla, 
California. 
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BiP binding to the ER-stress sensor Ire1 modulates the 
homeostatic regulation of the Unfolded Protein Response 
Peter Walter, David Pincus, Michael W. Chevalier, Tomas Aragón, 
Eelco van Anken, Simon E. Vidal, Hana El-Samad. 
Presenter affiliation: University of California, San Francisco, California. 
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Exploring the regulation of protein homeostasis using genetic 
interaction maps 
Michael C. Bassik, Martin Jonikas, Robert J. Lebbink, Stirling 
Churchman, Michael T. McManus, Jonathan S. Weissman. 
Presenter affiliation: University of California-San Francisco and 
Howard Hughes Medical Institute, San Francisco, California. 
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 xvi 
Targeted disruption of androgen receptor regulation by the 
immunophilin FKBP52 
Johanny Meneses De Leon, Aki Iwai, Clementine Feau, Jane Trepel, 
Sunmin Lee, Kristopher Kuchenbecker, Heather Balsiger, Robert 
Fletterick, Leonard Neckers, Marc Cox. 
Presenter affiliation: University of Texas at El Paso, El Paso, Texas. 
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The conformational dynamics of the mitochondrial Hsp70 
chaperone 
Koyeli Mapa, Martin Sikor, Walter Neupert, Don Lamb, Dejana 
Mokranjac. 
Presenter affiliation: University of Munich, Munich, Germany. 
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Using yeast to understand the mechanisms that regulate human 
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Daniel W. Neef, Liliana Batista-Nascimento, Dennis J. Thiele. 
Presenter affiliation: Duke University Medical Center, Durham, North 
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Activation of the IRE1 endoribonuclease through a novel ligand 
binding pocket 
Luke Wiseman, Yuhong Zhang, Kenneth P. Lee, Heather P. Harding, 
Frank Sicheri, David Ron. 
Presenter affiliation: The Scripps Research Institute, La Jolla, 
California; Skirball Institute of Biomedical Sciences, New York, New 
York. 
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THURSDAY, May 6—2:00 PM 
 
 
SESSION 6 POSTER SESSION II 
 
  
Genetic modulation of protein aggregation toxicity 
Christoph J. Kaiser, Klaus Richter. 
Presenter affiliation: Technische Universitaet Muenchen, Garching, 
Germany. 
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The role of Mekk1/JNK pathway in Endoplasmic Reticulum (ER) 
stress induced apoptosis 
Min Ji Kang, Jaehoon Chung, Hyung Don Ryoo. 
Presenter affiliation: NYU School of Medicine, New York, New York. 
 
 
 
79 
  
 xvii 
Manipulating the folding and fate of misfolded rhodopsin-
associated retinal degeneration with HDAC inhibitors—From 
bench to bedside 
Shalesh Kaushal. 
Presenter affiliation: University of Massachusetts School of Medicine, 
Worcester, Massachusetts. 
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Sequences flanking polyQ tracts in disease-associated proteins 
modulate their ability to form aggregates in C. elegans 
Elise A. Kikis, Anamika Dwivedi, Andreia Castro, Richard I. Morimoto. 
Presenter affiliation: Northwestern University, Evanston, Illinois. 
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Modulation of the effects of a chaperone protein on a yeast prion 
by the GET pathway and the ubiquitin system 
Denis A. Kiktev, Yuri Nishida, Susanne Müller, Jesse Patterson, 
Bhawana Bariar, He Gong, Tao Pan, Andrey V. Romanyuk, Yury O. 
Chernoff. 
Presenter affiliation: Georgia Institute of Technology, Atlanta, Georgia. 
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PROTEIN STABILIZATION BY SELECTION 
 
James Bardwell  
 
University of Michigan, Dept. of Molecular Cellular and Developmental 
Biology, Howard Hughes Medical Institute, 830 N University Drive, Ann 
Arbor, MI, 48109 
 
We have developed a powerful genetic method that allows selection for 
protein variants with enhanced stability by directly linking protein stability 
to antibiotic resistance. This has allowed us to better understand the 
relationship between protein stability and function to better understand 
protein folding in vivo and to address practical problems associated with 
protein instability.  
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TRAJECTORY OF ATP-INDUCED DOMAIN MOVEMENTS IN 
GROEL 
 
Dan Clare1, Daven Vasishtan1, Maya Topf1, Joel Quispe2, George Farr3, Art 
Horwich3, Helen Saibil1  
 
1Birkbeck College, Dept. of Crystallography, London, WC1 EHX, United 
Kingdom, 2Scripps Research Institute, Dept. of Molecular Biology, La Jolla, 
CA, 92037, 3Yale University School of Medicine, Dept. of Genetics and 
HHMI, New Haven, CT, 06520 
 
ATP binding to chaperonins triggers a series of dramatic conformational 
changes that determine the sequence of events in substrate binding, 
encapsulation and eventual release from these double-ring complexes. Upon 
ATP binding to the central, equatorial domains of GroEL, the substrate-
binding apical domains become extremely mobile, until they are captured 
by binding of the co-chaperonin GroES. We have used cryo electron 
microscopy, statistical analysis of single particle images and flexible 
domain fitting to resolve the structures in an ensemble of dynamic GroEL-
ATP states. Complexes with ATP bound to one or both rings are observed. 
The results trace out a trajectory of domain movements that ultimately lead 
to GroES binding and formation of the folding chamber. These movements 
are very different from those predicted by molecular dynamics simulation 
of trajectories based on the two conformations observed by crystallography, 
and provide new insights into the process of substrate encapsulation. 
 3 
ROLE OF MOLECULAR CHAPERONES IN SOD1-LINKED ALS 
 
Arthur Horwich, Wayne Fenton, Krystyna Furtak, Maria Nagy, Urmi 
Bandyopadhyay, Navneet Tyagi  
 
Yale School of Medicine, Genetics/HHMI, 295 Congress Ave, New Haven, 
CT, 06510 
 
Mutations in the abundant cytosolic superoxide scavenging enzyme SOD1 
account for ~2% of cases of ALS (Lou Gehrig’s Disease), associated with 
misfolding and a toxic gain of function, resulting in motor neuron 
dysfunction and cell death. We have been modeling this system using a 
folding-defective form of human SOD1, G85R, that behaves as a misfolded 
monomer, unable to form the normal disulfide bond or to produce the 
normal homodimer. Mice transgenic for G85R SOD1-YFP develop soluble 
oligomers and aggregates of the fusion protein in spinal cord and succumb 
to motor paralysis. Hsc70 and, at later times, Hsp110, associate with the 
soluble misfolded G85R SOD1-YFP species in mutant spinal cord but not 
with SOD1-YFP in the cord of wild-type transgenics. Similarly, C.elegans 
transgenic for the mutant fusion are locomotor paralyzed compared with 
normal movement of a wild-type transgenic, associated with soluble 
oligomer formation and aggregation of the mutant fusion protein. We report 
on new studies profiling chaperone content in laser- dissected motor 
neurons, measuring turnover of mutant and wild-type SOD1-YFP in the 
transgenic mice, and reconstituting chaperone interactions in vitro.  
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CHAPERONIN-CATALYZED RESCUE OF ENTROPICALLY 
TRAPPED STATES IN PROTEIN FOLDING 
 
Kausik Chakraborty1,4, Jyoti Sinha1, Manal Chatila1, Qiaoyun Shi1, 
Bernhard C Poschner1, Martin Sikor2, Guoxin Jiang1, Don C Lamb2,3, F-
Ulrich Hartl1, Manajit Hayer-Hartl1  
 
1Max Planck Institute of Biochemistry (MPIB), Department of Cellular 
Biochemistry, Am Klopferspitz 18, Martinsried, 82152, Germany, 2Center 
for Nanoscience, and Munich Center for Integrated Protein Science 
(CiPSM), Ludwig-Maximilians-Universität, Physical Chemistry, 
Department of Chemistry and Biochemistry, Butenandtstrasse 11, Munich, 
81377, Germany, 3University of Illinois at Urbana-Champaign, Department 
of Physics, 1110 W. Green St, Urbana, IL, 61801, 4 Institute of Genomics 
and Integrative Biology (CSIR), Proteomics and Structural Biology, Mall 
Road, Delhi, 110007, India 
 
GroEL and GroES form a chaperonin nano-cage for single protein 
molecules to fold in isolation. Whether the isolation of folding-substrates is 
the sole determinant of efficient folding inside the cavity or the chaperonin 
nano-cage edits the folding-information encoded by the amino acid 
sequence is not understood. Here, we addressed this question using a 
double-mutant of the maltose binding protein, DM-MBP, as a substrate. We 
show that DM-MBP refolding is not limited by the formation of reversible 
aggregates and populates a kinetically-trapped state that is collapsed but 
structurally disordered. Introducing two long-range disulfide bonds into the 
DM-MBP sequence reduces the entropic barrier of folding and accelerates 
native state formation ~10-fold. Strikingly, steric confinement of the 
unfolded DM-MBP in the chaperonin cage closely mimics the effect of 
constraining disulfides on folding kinetics, in a manner mediated by 
negative charge clusters of the cage wall. These findings suggest that 
chaperonin dependence correlates with the tendency of proteins to populate 
entropically stabilized folding intermediates. The capacity to rescue proteins 
from such folding traps may explain the uniquely essential role of the 
chaperonin-cages within the chaperone network. 
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SINGLE MOLECULE ANALYSIS OF NASCENT PROTEIN FOLDING 
 
Christian M Kaiser1,4, Daniel H Goldman2, Susan Marqusee3,4, Carlos 
Bustamante1,2,3,4  
 
1University of California, Berkeley, Department of Physics, 366 LeConte, 
Berkeley, CA, 94720, 2University of California, Berkeley, Department of 
Chemistry, 420 Latimer Hall, Berkley, CA, 94720, 3University of 
California, Berkeley, Department of Molecular and Cell Biology, 142 LSA 
#3200, Berkeley, CA, 94720, 4 University of California, Berkeley, QB3 
Institute–Berkeley, Stanley Hall, Berkeley, CA, 94720 
 
Most proteins in the cell must fold into specific three-dimensional structures 
to become biologically active. Insights into the mechanisms underlying 
protein folding have been gained largely from in vitro refolding 
experiments employing isolated full-length proteins. In the cell, however, 
proteins are synthesized by the ribosome in a vectorial manner. Hence, 
amino-terminal portions of the protein can participate in folding events 
while more carboxyl-terminal segments are still being synthesized. As 
translation proceeds, the elongating nascent protein traverses the 
polypeptide exit tunnel before emerging from the exit site located at the 
surface of the large ribosomal subunit. Interactions with components of the 
tunnel and the area around the exit site have been shown to influence the 
conformation of the emerging protein. Thus, it is likely that both the 
vectorial process of translation itself and the ribosomal environment affect 
the folding pathway of translating polypeptides. As soon as nascent proteins 
emerge from the ribosome, their folding transitions are guided by 
interactions with molecular chaperones, such as Trigger factor. How the 
concerted interplay between translating ribosomes and molecular 
chaperones affects the folding of newly synthesized proteins, thereby 
contributing to efficient folding in the crowded environment of the cell, has 
remained poorly understood. We have developed an experimental 
methodology to directly probe folding transitions of ribosome-associated 
nascent polypeptides by single molecule force spectroscopy. Using optical 
tweezers, we are able to mechanically “pull” on the nascent protein 
emerging from the ribosomal exit tunnel. In combination with a 
reconstituted in vitro translation system, we are capable of interrogating the 
conformational state of defined, incrementally longer nascent polypeptides 
in their natural context on the ribosome. This experimental system allows us 
to recapitulate the folding transitions during the earliest stages of protein 
biogenesis and to dissect how the ribosome and molecular chaperones 
contribute to the efficient folding of newly synthesized proteins.  
 
This work was supported by grants from the National Institutes of Health 
(Career Development Award, Grant No. 5K99GM086516-02) and the 
California Institute for Quantitative Biosciences (QB3 Distinguished 
Postdoctoral Fellowship) to C.M.K. 
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TAMING THE BEAST: STRUCTURAL BIOLOGY OF A SMALL HEAT 
SHOCK PROTEIN 
 
Rachel E Klevit1, Stefan Jehle1, Benjamin Bardiaux2, Katja Dove1, Barth 
von Rossum2, Hartmut Oschkinat2,3, Ponni Rajagopal1  
 
1University of Washington, Biochemistry, Box 357742, Seattle, WA, 
98195, 2Leibniz-Institut für Molekulare Pharmakologie, Structural Biology, 
Robert-Rössle-Strasse 10, Berlin, 13125, Germany, 3Freie Universität 
Berlin, Chemistry and Biochemistry, Takustraße 3, Berlin, 14195, Germany 
 
The polydisperse, oligomeric structures of small heat shock proteins (sHSPs) 
have eluded investigation by standard structural biology approaches. A 
paradigm example is αB-Crystallin (αB), a ~ 580 kDa oligomer composed of 
~28 subunits. We have used solution-state and solid-state NMR, chaperone-like 
activity assays, and SAXS (Small Angle X-ray Scattering) to determine a 
structure of αB and gain insight into its function. Similar to most sHSPs, αB has 
a conserved α-crystallin domain flanked by variable N- and C- terminal regions. 
Solid-state NMR of oligomeric αB reveals a highly curved α-crystallin domain 
dimer as the building block of the oligomer. A hybrid approach using SAXS 
and solid-state NMR was used to determine a structural model of αB: αB forms 
an oligomer with tetrahedral symmetry comprised of four units of three dimers 
organized in a triangular array. Solid state NMR data also show that residues 
from the C-terminal region, including the conserved IXI-motif, bind in the 
putative substrate-binding groove, suggesting an auto-inhibitory mechanism. 
NMR spectra reveal a modulation of this interaction by pH changes, providing a 
structural basis for the known pH-dependent activation of αB. Cardiac ischemia 
is associated with a drop in cellular pH from 7.5 to 6.9 and αB binds cardiac 
muscle proteins more strongly at the lower pH presumably to confer protection 
from stress denaturation. SAXS data collected at pH 7.5 and 6.5 reveal a large 
increase in the radius of gyration at the lower pH, consistent with dissociation 
of the C-terminal region from the substrate-binding groove.  
To more fully understand the structural basis of αB function, we are using 
isolated α-crystallin domains as biochemical and structural models for sHSPs. 
Solution-state NMR studies on the α-crystallin domain dimer from αB (αB10.1) 
show that 1) the structure of the isolated domain is similar to its structure in the 
context of the oligomer and 2) similar to the oligomer, αB10.1 undergoes 
significant conformational changes over the narrow pH range from 7.5 to 6.9. In 
contrast, pH-induced conformational changes are not detected in a disease-
associated mutant, R120G-αB, in either the α-crystallin domain or in the 
oligomer. To identify the basis of the pH-dependent behavior, we have designed 
and compared numerous mutant forms of αB. We will present structural and 
biochemical data on an engineered mutant that, like R120G-αB, does not 
display a pH-induced conformational change and has low activity in chaperone-
like activity assays. Together, our observations suggest that conformational 
plasticity providing for adaptability to changes in environment is essential for 
αB function.  
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THREE-DIMENSIONAL STRUCTURE OF THE HSP104 AAA+ 
ATPASE 
 
Francis T Tsai, Sukyeong Lee, Bernhard Sielaff, Jungsoon Lee  
 
Baylor College of Medicine, Department of Biochemistry & Molecular 
Biology, One Baylor Plaza, Houston, TX, 77030 
 
Yeast Hsp104 and bacterial ClpB belong to the large superfamily of ring-
forming AAA+ machines that convert ATP into mechanical work. Hsp104 
and ClpB are functional orthologs that recognize aggregated proteins as 
substrates, and remodel them in an ATP-dependent manner. In addition to 
its essential role in acquired thermotolerance development, Hsp104 is also 
essential for the inheritance, maintenance, and elimination of [PSI+], a 
yeast prion that increases translational read-through of nonsense codons. 
The ability to disaggregate stress-damaged proteins is strictly dependent on 
the M-domain that is a hallmark of the ClpB/Hsp104 family. While the 
three-dimensional structures of ClpB1,2 and Hsp1043,4 have been reported, 
the location of the M-domain is controversial and its function in protein 
disaggregation remains unclear.  
 
To address this on-going controversy, we examined the structure of Hsp104 
using a multi-pronged structural and biochemical approach. At this meeting, 
I will present unpublished, recent data from my lab suggesting that Hsp104 
and ClpB are more similar in structure than previously proposed. Moreover, 
I will present biochemical data of an engineered Hsp104 hexamer that 
provides new mechanistic insight into the structure-function relationship of 
Hsp104.  
 
 
References  
1. Lee et al. Cell 115, 229-240 (2003).  
2. Lee et al. Mol Cell 25, 261-271 (2007).  
3. Wendler et al. Cell 131, 1366-1377 (2007).  
4. Wendler et al. Mol Cell 34, 81-92 (2009).  
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RAPID FOLDING COMPLETION IN THE CAGE OR ESCAPING OUT 
OF THE CAGE; ALTERNATIVE FATES OF SUBSTRATE 
POLYPEPTIDE INTERACTING WITH GROEL/GROES INTERFACE 
REGION IN THE CRITICAL INTERMEDIATE OF CHAPERONIN-
ASSISTED FOLDING 
 
Fumihiro Motojima, Masasuke Yoshida 
 
Kyoto Sangyou University, Life Science, Kamigamo Motoyama, Kyoto, 
603-8555, Japan 
 
In the chaperonin-assisted protein folding, substrate protein undergoes 
folding in the chaperonin cage made by a GroEL central cavity and a GroES 
lid. The classic mechanistic model assumes that the substrate protein in the 
cage is isolated from outside and exists as a free polypeptide. However, we 
found that a part of unfolded polypeptide in the cage is always protruding to 
outside through narrow space near the GroEL/GroES interface. This state is 
rate-limiting in the whole chaperonin-assisted folding reaction. Then, the 
whole polypeptide is released either into the cage or into the outside 
medium. The former gains native structure in the cage ten times more 
rapidly than spontaneous folding (in-cage folding), and the latter undergoes 
spontaneous folding in the outside medium. GroES remains bound to 
GroEL and the cage is intact during these events. Partition of the in-cage 
folding and the escape varies among substrate protein and is affected by 
hydrophobic interaction between polypeptide and GroEL wall. The mutant 
GroEL with a small in-cage folding yield produces less amount of native 
model substrate protein in Escherichai coli cell. These observations 
necessitate revision of the classic mechanistic model of chaperonin. 
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FUNCTIONS AND MECHANISMS OF CYTOSOLIC CHAPERONES IN 
PROTEIN HOMEOSTASIS 
 
Elke Deuerling, Ansgar Koplin, Steffen Preissler, Yulia Ilina, Miriam Koch, 
Annika Scior  
 
University of Konstanz, Biology, Universitaetsstr. 10, Konstanz, 78457, 
Germany 
 
The yeast Hsp70/40 system Ssb/RAC binds to ribosomes and contacts 
nascent polypeptides to assist cotranslational folding. Here, we demonstrate 
that NAC, another ribosome-tethered system, is functionally connected to 
Ssb/RAC and the cytosolic Hsp70 network. Simultaneous deletions of 
genes encoding NAC and Ssb caused conditional loss of cell viability under 
protein folding stress conditions. Furthermore, NAC mutations revealed 
genetic interaction with a deletion of Sse1, a nucleotide exchange factor 
regulating the cytosolic Hsp70 network. Cells lacking Ssb or Sse1 showed 
protein aggregation which is enhanced by additional loss of NAC, however, 
these mutants differ in their potential client repertoire. Aggregation of 
ribosomal proteins and biogenesis factors accompanied by a pronounced 
deficiency in ribosomal particles and translating ribosomes only occurs in 
ssb∆ and nac∆ssb∆ cells suggesting that Ssb and NAC control ribosome 
biogenesis. Thus, Ssb/RAC and NAC assist protein folding and likewise 
have important functions for regulation of ribosome levels. These findings 
emphasize the concept that ribosome production is coordinated with the 
protein folding capacity of ribosome-associated chaperones.  
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THE HEAT SHOCK RESPONSE: INTEGRATED NEURONAL 
NETWORKS FOR METABOLIC CONTROL, STRESS, AND AGING 
 
Richard I Morimoto, Anat Ben-Zvi, Veena Prahlad, Laetitia Chauve  
 
Northwestern University, Biochemistry, Molecular Biology and Cell 
Biology, Rice Institute for Biomedical Research, 2145 Sheridan Rd., Tech 
MG90, Evanston, IL, 60208 
 
The stability of the proteome is of central importance to the health of the 
cell, and contributes significantly to the lifespan of the organism. Chronic 
expression of misfolded and damaged proteins associated with 
conformational diseases, exposure to stress, or aging results in proteostasis 
imbalance with devastating consequences on the stability of the proteome. 
Key to this balance are stress-inducible transcription factors including Hsf1 
that regulate the heat shock response (HSR). Hsf1 has also been shown to 
be essential for multiple lifespan regulatory pathways and is regulated by 
the metabolic state of the cell through the activity of the NAD-dependent 
sirtuin, Sirt1. During development and aging in C. elegans, there is a sharp 
decline in the capacity of the proteostasis network in early adulthood 
coincident with the peak of fecundity. The collapse of proteostasis coincides 
with an age-dependent dampening of the inducibility of the HSR and 
unfolded protein response (UPR). This decline can be suppressed by 
activation of Hsf1 (or DAF-16) in early development revealing a strategy to 
restore the youthful proteostatic state. These studies provide an 
understanding of stress responses and Hsf1 function at a cellular and 
molecular level. In C. elegans, the HSR is regulated at the organismal level 
by cell non-autonomous control by the AFD thermosensory neurons. The 
HS signal requires active neurotransmission via specific neurohormones 
and neuropeptides to somatic tissues to regulate HS gene expression. This 
stress sensing mechanism appears specific to the environmental signal as 
animals deficient for the AFD-dependent HSR are fully responsive to 
cadmium activation of HS genes in an Hsf1-dependent manner. This 
suggests that different neuronal networks sense distinct environmental 
stress signals to control proteostasis. This is further supported by the 
observation that an imbalance of cholinergic signaling and overexcitation 
results in the collapse of proteostasis in post-synaptic muscle cells. These 
results, reveal that the HSR is organized at the systems level of the 
organism to sense the stress signal through active neuronal activity, and 
together with the metabolic state, sets the proteostasis network to ensure 
stability of the proteome and the health of the organism. 
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INSIGHTS INTO HSP90-CLIENT PROTEIN INTERACTIONS FROM 
NMR 
 
H. Jane Dyson, Sung Jean Park, Maria A Martinez-Yamout  
 
The Scripps Research Institute, Molecular Biology, 10550 North Torrey 
Pines Road, La Jolla, CA, 92037 
 
The major function of the chaperone Hsp90 involves interactions with a 
relatively large set of proteins, termed client proteins. It is not clear in what 
state, whether folded, partly folded or alternatively folded, the client 
proteins participate in the interaction. We present NMR studies of the 
interactions between one client protein, the p53 DNA-binding domain, and 
fragments of Hsp90 of various sizes, comprising 1 and 2 domains of the 
protein, up to the full-length dimeric protein. Attenuation of the p53 
resonances in the complex, together with the observed lack of such 
attenuation in the Hsp90 domain spectra have led us to suggest that the p53 
DNA binding domain forms a "folded globule" state in the complex. This 
state is characterized by secondary structure indistinguishable from that of 
the free protein, but contains a manifold of states that are in intermediate 
exchange on the NMR time scale, thus causing resonance broadening and 
disappearance. Further evidence for the loose and flexible nature of the 
bound p53 client is provided by the fluorescence behavior of the dye 1-
anilinonaphthalene-8-sulfonic acid (ANS), which shows increased emission 
and a blue shift in the presence of the complex. Hydrogen/deuterium 
exchange rates of the amide protons of the p53 DNA binding domain are 
also significantly increased in the presence of a low concentration of Hsp90, 
consistent with a loosened structure for the p53 DNA binding domain in the 
complex. Further NMR experiments using samples with specifically labeled 
methyl groups and employing saturation transfer techniques have allowed 
the dissection of the interaction sites between the Hsp90 domains and the 
client protein. We conclude that the interaction between Hsp90 and p53 is 
complex, and involves a structural change in the client protein to a loosened 
state. These observations have profound implications for the understanding 
of Hsp90-client proteins in general, and may provide a reason for the 
persistent difficulty that has been experienced in the crystallization of 
Hsp90-client protein complexes for structural studies. 
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THE HSP110 MOLECULAR CHAPERONE MODULATES DYNEIN 
ACTIVITY 
 
Taras Makhnevych1, Philip Wong2, Oxana Pogoutse3, Franco J 
Vizeacoumar3, Yolanda Chong3, Charles Boone3, Andrew Emili3, Walid A 
Houry1  
 
1University of Toronto, Biochemistry, 1 King's College Circle, Toronto, 
M5S1A8, Canada, 2Institute of Bioinformatics and Systems Biology, 
German Research Center for Environmental Health, Ingolstadter 
Landstrasse 1, Neuherberg, 85764, Germany, 3University of Toronto, 
Molecular Genetics, 160 College Street, Toronto, M5S3E1, Canada 
 
In order to characterize the cellular pathways and protein complexes that 
require Hsp70/Hsp110 molecular chaperones in the cell, we carried out a 
systematic pull-down analysis of all the cytoplasmic/nuclear Hsp70 (Ssa1, 
Ssa2, Ssa3, Ssa4, Ssb1, Ssb2, Ssz1) and Hsp110 (Sse1 and Sse2) 
chaperones in yeast using strains in which these chaperones were 
endogenously N- or C-terminally TAP-tagged. This allowed us to map a 
protein interaction network consisting of 1069 unique interactions between 
the 9 chaperones and 473 proteins. The network highlights roles for 
Hsp70/Hsp110 chaperones in 14 broad biological processes. Analysis of the 
generated chaperone-protein interaction network demonstrated that a 
number of Hsp70/Hsp110 chaperones co-purified with several microtubule 
motors including dynein. Careful analysis of the chaperone deletion 
phenotypes revealed a function for Sse1 in mitotic spindle morphology. We 
demonstrated that deletion of SSE1 gene produced increased number of 
cells which were not able to properly position the nuclei at the bud neck in 
mitosis resulting in aberrant spindle morphology phenotypes. Imaging 
studies and biochemical analyses suggested that Sse1 is required for proper 
functioning of the cytoplasmic dynein motor, Dyn1. In the absence of Sse1, 
dynein was no longer concentrated at the plus ends of the cytoplasmic 
microtubules and, instead, was aggregating in the cytoplasm. The deletion 
of SSE1 gene also affected dynein interaction with components of the 
dynactin complex. Altogether, our data demonstrate that the Sse1 chaperone 
is necessary for dynein function and suggest that Sse1 might modulate 
dynein conformational states during the motor functional cycle. Further data 
on the effect of Sse1 on dynein activity will be presented at the meeting. 
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THE ROLE OF SMALL HEAT SHOCK PROTEINS IN PROTEIN 
FOLDING DISEASES 
 
Serena Carra, Alessandra Boncoraglio, Melania Minoia, Bart Kanon, 
Jeanette F Brunsting, Marianne P Zijlstra, Michel J Vos, Ody C Sibon, 
Harm H Kampinga  
 
UMCG & RuG, Cell Biology, Section of Radiation & Stress Cell Biology, 
Ant. Deusinglaan 1, Groningen, 9713AV, Netherlands 
 
The Human and Drosophila small Heat Shock Protein (sHSP) family 
comprises 10 and 11 members respectively. Some members of these sHSP 
have been implicated directly or indirectly in several neurodegenerative and 
neuromuscular disorders. Several members are upregulated in brain 
amyloidosis and mutations of several HSPB proteins have been associated 
with muscular and neurological disorders. Comparing the members from 
both species reveals at least two functionally distinct classes: some 
members support HSP70 dependent (re)folding activities, whereas another 
subclass specifically prevents aggregation of (disease-associated) proteins, 
which is largely HSP70 independent. Both types of activities can lead to 
lifespan extensions in Drosophila. By a series of functional studies, we 
furthermore identified the Drosophila ortholog of the human HSPB8. 
HSPB8 and its Drosophila ortholog cooperate with members of the BAG-
family of proteins to stimulate autophagy, hereby facilitating the clearance 
of other aggregation-prone proteins. Mutations in HSPB8 are associated 
with autosomal dominant distal hereditary motor neuropathy and Charcot-
Marie-Tooth disease type 2L. Using Drosophila as a model, we now show 
that besides a toxic gain of function, mutations in HSPB8 lead to a partial 
loss of function that likely contributes to disease progression. Our data 
furthermore imply that putative age-related decline in small HSP expression 
or -function could play a role in the onset of other folding diseases and in 
ageing in general. 
 
This work was financially supporter by Senter Novem (IOP genomics grants 
IGE03018 and IGE0700), the Prinses Beatrix Foundation (WAR05-0129) 
and the European Union (IRG 230908). 
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HOW DO INTRINSICALLY UNFOLDED CHAPERONES WORK? 
 
Dana Reichmann1, Marianne Ilbert1, Ying Xu2, Claudia M Cremers1, 
Michael C Fitzgerald2, Ursula Jacob1  
 
1University of Michigan, Department of Molecular, Cellular and 
Developmental Biology, 830 N.University Ave, Ann Arbor, MI, 48109-
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Hsp33, a highly conserved redox-regulated molecular chaperone, plays an 
important role in protecting bacteria against oxidative stress conditions that 
lead to protein unfolding. The specific activation of Hsp33 under oxidative 
stress conditions involves the oxidative unfolding of its own C-terminal 
redox sensor domain, making Hsp33 a member of a new class of 
chaperones, which are active in a partially natively unfolded state. This 
observation raises a number of intriguing mechanistic questions; how do 
natively unfolded chaperones discriminate between unfolded substrate 
proteins and their own unfolded regions? Moreover, how does the DnaK-
system, which triggers substrate release from Hsp33 upon return to reducing 
non-stress conditions, discriminate between unfolded Hsp33 and unfolded 
substrate proteins? To address these questions, we combined biophysical 
and computational studies with mass spectrometry and cell biology. We 
first elucidated the peptide binding specificity of active Hsp33 using peptide 
arrays. This analysis allowed us to establish an algorithm that predicts 
Hsp33 binding sites in protein sequences with high accuracy. While we 
were unable to identify a strong binding sequence, we identified a distinct 
group of amino acids, negatively charged residues and cysteines, which are 
strongly disfavored to bind Hsp33. Curiously, these are the very same 
amino acids that are strongly enriched in Hsp33’s unfolded redox switch 
domain as well as in most natively unfolded proteins. Chaperone assays 
confirmed that Hsp33 does not interact with natively unfolded proteins but 
requires at least some secondary structure elements for binding, explaining 
how intrinsically unfolded chaperones, like Hsp33, avoid binding their own 
unfolded regions. Furthermore, we found that Hsp33’s linker region 
undergoes substantial refolding and stabilization upon binding of the 
substrate proteins. While these results explained how Hsp33 prevents self-
recognition and interaction with the DnaK-system, they did not explain how 
the DnaK-system, which is known to bind substrate proteins in a largely 
unfolded conformation, recognizes the partially folded substrate proteins 
bound to Hsp33. Hsp33 might either unfold the substrate proteins directly 
upon its binding as part of an entropy transfer mechanism, or upon 
subsequent reduction of its disulfide bonds. In either case, our results 
experiments provide mechanistic insights as to how intrinsically disordered 
chaperones function in multi-chaperone networks to prevent aggregation 
and support refolding of proteins. 
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Prions are a unique group of proteins that can adopt a spectrum of physical 
and corresponding functional states in vivo. The physiological consequences 
of this conformational flexibility, ranging from neurodegenerative disease 
in mammals to heritable traits in fungi, are determined not only by the 
identity of the alternately folded protein but also by the efficiency with 
which the alternate fold is replicated and spread. The assembly of 
alternately folded prion protein into aggregates is believed to be a central 
event in these processes, but the biochemical identity of the active species 
has remained elusive, as prion aggregates are heterogeneous in size and 
potentially function. 
 
To explore the relationship between protein aggregation and phenotypic 
stability, we exploited the Sup35/[PSI+] prion system in Saccharomyces 
cerevisiae. Using a combination of mathematical modeling and in vivo 
analysis of aggregate dynamics in response to perturbations of the system, 
we have determined that non-heritable and heritable prion aggregates are 
interconvertible species and that the transition between these forms is 
regulated by the ratio of aggregated prion protein to the molecular 
chaperone Hsp104, the efficiency with which prion aggregates are 
remodeled by chaperones, and the cell division pedigree. Shifts in the 
aggregate size distribution, which are specified by either the conformation 
of the prion protein or changes in expression levels, create heterogeneity in 
the complement of prion aggregates present in individual cells due to a size 
threshold for transmission. This aggregate size-limited transmission has 
profound effects on prion biology by creating cell-to-cell phenotypic 
diversification that in extreme cases leads to prion loss. Together, our 
studies highlight how the interplay of prion protein biogenesis and the 
cellular context in which it occurs mediate the appearance, maintenance and 
spread of protein-based phenotypes.  
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The ubiquitous and highly conserved Hsp90 molecular chaperone is the 
central player in a multi-component complex that promotes ATP-dependent 
rearrangement and activation of essential substrate proteins including 
nuclear receptors and cell cycle kinases. While much is known about the 
abundant targets of Hsp90, significant questions remain unanswered 
including how dramatic conformational rearrangements, energy from ATP 
hydrolysis and critical cochaperone interactions contribute to rearrangement 
and activation of substrates. Using single particle electron microscopy 
(EM), we have determined 3-D reconstructions of Hsp90:AMPPNP and 
Hsp90:ADP that establish a three-state cycle with nucleotide binding alone 
triggering dramatic conformational changes in Hsp90. Using key 
crosslinking methods we have trapped these conformational states in yeast 
and human Hsp90s, establishing a universal cycle and a unique, species-
specific conformational equilibrium. More recently we have achieved a 
cryo-EM reconstruction of the human Hsp90:Hop complex that reveals Hop 
interaction sites and a novel Hsp90 client-loading conformation that is on-
path to the closed, hydrolysis-active state. Additional reconstructions of 
human Hsp90:Hop:Hsp70 and Hsp90:AMPPNP:FKBP52 identify active 
roles for co-chaperones, stabilizing Hsp90 conformational states and 
contributing to client protein activation. 
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Protein supra-domains are defined as recurring arrangements of two or three 
domains present adjacent to each other along a polypeptide chain. Such 
combinations have novel functions beyond those of the individual partner 
domains that compose them, which can exist in isolation. Here, we describe 
a new type of large supra-domain (~380 residues) in which one of the 
component partners (~200 residues) appears to be incapable of existing in a 
context other than immediately adjacent to the C-terminus of the well-
characterized Hsp90-like ATPase domain. We found that this supra-domain 
has a broad phylogenetic distribution, with examples in Archaea, Bacteria 
and Eukarya. There is strong selective pressure for this arrangement to 
occur as part of very large repeated regions. We identified multiple 
strategies of convergent evolution to attain such configurations. In humans, 
this supra-domain is present in triplicate at the N-terminus of the protein 
sacsin (4,579 residues), mutated in the neurodegenerative disorder known as 
Spastic Ataxia of Charlevoix-Saguenay, and thus we termed it "sacsin 
repeating region" (SRR). Biochemical characterization demonstrated that 
SRRs possess ATPase activity, which appears to be a requirement for sacsin 
function, as a disease-causing mutation leads to an alternate conformation 
completely incapable of hydrolyzing ATP. We also found evidence of a 
convergent evolutionary strategy to place SRRs in proteins containing C-
terminal J-domains, which we demonstrated here to be capable of 
stimulating the intrinsic ATPase activity of Hsp70. Our sequence and 
biochemical analyses indicate that SRRs necessitate nucleotide hydrolysis 
for their function, provided by the common Hsp90 ATPase domain, which, 
when coupled to the unique adjacent sequence, may give rise to a novel 
activity related to protein quality control. 
 18 
MECHANISM OF HSP40-FAMILY CO-CHAPERONES DNAJA1 AND 
DNAJA2 WITH HSC70 
 
Imad Baaklini, Michael J Wong, Jason C Young   
 
Department of Biochemistry, McGill University, 3649 Promenade Sir 
William Osler, Montreal, H3G OB1, Canada 
 
 
Human Hsc70 is the key cytosolic chaperone of the Hsp70 family important 
for the folding and sorting of various proteins. Its activity depends on ATP 
binding and hydrolysis, which requires the Hsp40 family of co-chaperones 
including the major type I forms DnaJA1 and DnaJA2. These have a J 
domain at the N-terminus and a C-terminal domain, subdivided into a 
proximal part containing a Cys-Zinc finger and a distal C-terminal region 
with a dimerization interface. The J domain function of Hsc70 ATPase 
stimulation is well established, while the C-terminal domain binds substrate 
polypeptide. Previous work suggested that DnaJA1 and DnaJA2 have 
distinct profiles in the biochemical properties of polypeptide binding, 
stimulation of the Hsc70 ATPase, and ability to support folding. 
Interdomain coordination appeared to be critical for function, possibly for 
the transfer of substrate from the DnaJA to Hsc70 by a still undefined 
mechanism. Furthermore, how such coordination is supported by the 
internal structures of the C-terminal domains remains poorly understood. To 
address this, we constructed chimeric and internal deletion mutants of 
DnaJA1 and DnaJA2. The mutants were tested for the activities of their 
separate domains, and for the ability to functionally cooperate with the 
Hsc70 chaperone. Mutations at the proximal and distal regions within the 
DnaJA C-terminal domain had a moderately negative effect on stimulation 
of the Hsc70 ATPase although the J domains were intact. Variable effects 
on substrate binding were also observed. Interestingly, disruption of either 
proximal or distal structures significantly inhibited the ability to promote 
refolding of denatured polypeptide by Hsc70. The local mutations also 
altered the overall configuration of the C-terminal domains. Experiments in 
cell culture systems confirmed functional differences in the mutants. We 
propose a model in which functional elements throughout the DnaJAs 
contribute to their activity with Hsc70.  
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In response to a variety of insults, eukaryotic cells reduce mRNA 
translation through phosphorylation of Ser51 on the α-subunit of eukaryotic 
translation initiation factor-2 (eIF2α). Mutation of Ser51 to Ala prevents 
phosphorylation and translation attenuation in response to cellular stresses. 
Cells with homozygous Ser51Ala mutation (A/A eIF2α cells) display 
increased sensitivity to endoplasmic reticulum (ER) stress and oxidative 
stress due to the deficiency or absence of properly adaptive translational and 
transcriptional responses. Paradoxically, phosphorylation of eIF2α increases 
synthesis of the activating transcription factor ATF4. Since A/A eIF2α 
mutant cells and Atf4–/– cells exhibit similar defects in transcriptional 
adaptive responses, it was expected that they should display similar 
increased sensitivity to ER-stress-induced death. However, it is here shown 
that while Atf4–/– cells are more sensitive to oxidative stress than wild type 
cells, they are more resistant to cell death induced by the ER stress agents 
tunicamycin (Tm) or thapsigargin (Tg). During ER stress, Atf4–/– cells 
exhibit increased and extended eIF2α phosphorylation likely due to reduced 
expression of GADD34, a regulatory subunit of protein phosphatase 1 that 
dephosphorylates eIF2α. Furthermore, overexpression of GADD34 reduces 
eIF2α phosphorylation and increases the sensitivity of Atf4–/– cells to ER 
stress. These results suggest that Atf4–/– deletion protects cells during ER 
stress by prolonging eIF2α phosphorylation, in spite of the defective 
adaptive transcriptional response caused by Atf4–/– deletion. 
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Using optical tweezers and all-atom molecular dynamics simulations, we 
studied the effect of chaperone SecB on the folding and unfolding pathways 
of maltose binding protein (MBP). In the absence of SecB, we find that the 
MBP polypeptide first collapses into a molten globule-like compacted state 
and then folds into a stable core structure, onto which several α-helices are 
finally wrapped. Interactions with SecB completely prevent stable tertiary 
contacts in the core structure, but have no detectable effect on the folding of 
the external α-helices. It appears that SecB only binds to the extended or 
molten globule-like structure and retains MBP in this latter state. Thus 
during translocation, energy is required only to remove SecB and not to 
disrupt stable tertiary interactions [Bechtluft et al., Science 318, (2007)]. 
Currently we are employing this single molecule approach to investigate 
how the chaperone trigger factor affects protein folding pathways. 
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When emerging from the ribosomal exit tunnel, nascent polypeptide chains 
are welcomed by ribosome-associated chaperones, in bacteria represented 
by trigger factor (TF). TF interacts with most emerging polypeptide chains 
and has been shown to support the folding of many different polypeptides in 
vivo, but how TF exerts its effect is unclear. Experiments measuring the 
activities of model substrates including firefly luciferase and the tetrameric 
β-galactosidase in vivo and in vitro suggest that TF causes a delay in the 
folding process (Agashe et al., 2004. Cell 117(2): 199-209). However, it is 
not known yet whether this is a general mechanism of TF function valid for 
different substrates and how this can be correlated to its chaperone function.  
In the present study, we investigated the effect of TF on the folding of 
various E. coli proteins in a coupled in vitro transcription/translation system 
by monitoring the kinetics of disulfide bond formation as an indicator of 
tertiary structure formation. Substrate proteins were selected based on their 
dependence on various chaperones for folding as well as variable structural 
features. Indeed, TF postpones the formation of some disulfide bonds 
during synthesis such as the wildtype disulfide bond in β-lactamase, while 
the formation of others is not affected. Furthermore, tethering a protein 
distant enough to the ribosome to allow complete folding nevertheless 
seems to constrain its folding abilities, suggesting that ribosome proximity 
can interfere with de novo folding of some newly synthesized polypeptides. 
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The molecular chaperone activity of the Small Heat Shock Proteins (sHSPs) 
renders them an important component of the cellular proteostasis network. 
Current models for their function dictate that they act to bind unfolding 
client proteins, holding them stable relative to insoluble aggregation, under 
conditions of cellular stress. Structurally the sHSPs are poorly understood, 
and few high-resolution structures exist for these oligomeric proteins. This 
stems primarily from their apparently dynamic quaternary and tertiary 
structure, and that many members coexist in multiple oligomeric forms. 
Here we describe the oligomeric structures of human αB-crystallin, an 
heterogeneous sHSP which populates a distribution of oligomers spanning 
between approximately 10 and 40 subunits. 
 
Our approach to structure determination is based on a combination of ion 
mobility mass spectrometry (IM-MS), methyl-TROSY NMR, electron 
microscopy (EM), X-ray crystallography and molecular modelling. 
Combining MS and NMR experiments allows us to correlate the quaternary 
and tertiary dynamics of polydisperse αB-crystallin ensemble. This provides 
a rationale for building oligomeric models of the sHSP based upon the 
crystallographic protomer, and these models are restrained by both the IM 
and EM data. As such we obtain not only pseudo-atomic structures for the 
oligomeric states populated by αB-crystallin, but also an understanding of 
the remarkable polydispersity of this protein. 
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Regulation of cell volume is of great importance because persistent swelling 
or shrinkage leads to cell death. Tissues experience hypertonicity in both 
physiological (kidney medullar cells) and pathological states 
(hypernatremia). Mild hypertonicity induces an adaptive gene expression 
program that leads to cell survival by induction of osmolyte transporters and 
the molecular chaperon HSP70, which helps to counterbalance the 
deleterious effect of macromolecular crowding due to the loss of water. 
Severe hypertonic conditions lead to cell death. We show that the balance 
between adaptive and apoptotic cellular responses to osmotic stress is 
controlled by phosphorylation of the translation initiation factor eIF2α, the 
master regulator of the stress response. Fibroblasts and cortical neurons 
deficient in eIF2α phosphorylation were protected from hypertonicity-
induced apoptosis. A novel link is revealed between eIF2α phosphorylation 
and translation initiation of mRNAs encoding pro- and anti-apoptotic 
proteins at internal ribosome entry sites (IRESs). Stress-induced 
phosphorylation of eIF2α tips the balance against the anti-apoptotic XIAP 
and Bcl-xL proteins. This regulation is independent of the global decrease 
of protein synthesis and of the induction of molecular chaperons but 
dependent on the cytoplasmic accumulation of the IRES-transacting factor 
hnRNP A1, which inhibits translation of XIAP and Bcl-xL mRNAs. We 
propose that eIF2α phosphorylation during hypertonic stress promotes 
apoptosis by increasing the cytoplasmic accumulation of hnRNP A1. The 
involvement of stress granules (sites of storage of translationally arrested 
mRNAs) in this process will be discussed. 
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What does amino acid sequence conservation (or lack thereof) observed in 
phylogenetic alignments really mean? Hsp90 is highly conserved at the 
amino acid sequence level in phylogenetic alignments. For example, yeast 
and human Hsp90 are 45% identical. Are invariant positions in 
phylogenetic alignments of Hsp90 more likely to lead to a fitness defect if 
mutated compared to highly variable positions? How accurate are fitness 
predictions based on evolutionary conservation? To begin to address these 
questions we used traditional point mutagenesis of Hsp90 to measure the 
fitness of yeast harboring these variants. The results of these small-scale 
experiments indicated that amino acids that are conserved across 
tremendous evolutionary times can be mutated without measureable 
impacts on fitness. These results spurred us to generate fitness 
measurements for a large set of Hsp90 point-mutants. To accomplish this, 
we developed a hi-throughput approach utilizing the power of deep-
sequencing to monitor the abundance of each point-mutant in a population 
of competing yeast over time. For Hsp90, the data from this approach has 
enabled us to generate quantitative relationships between the conservation 
of an amino acid across evolution and the experimental fitness of an amino 
acid substitution. 
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Cells must sense both internal and environmental conditions in order to 
respond appropriately to changing circumstances. These processes have 
been modeled as homeostatic, in which an ideal state is maintained, or, 
alternately, as acute stress responses, where dangerous conditions invoke 
protective programs. Heat shock factor 1 (HSF1p) is key transcriptional 
regulator of such a process, the heat shock response. High temperatures and 
misfolded proteins hyper-activate HSF1p and thereby up-regulate 
expression of protective proteins, such as chaperones. However, HSF1 is 
also essential for viability under normal conditions, because it plays roles in 
maintaining proteostasis. To explore the functions of HSF1p in both heat-
shock-induced and basal contexts, we designed a fluorescent reporter to 
measure HSF1p activity in a collection of yeast deletion strains spanning 
the entire genome. Activity was measured at room temperature and after 
heat shock of 1 or 8 hours at 37 degrees. We observed broad ranges of both 
basal and induced activity in the mutant strains, with related classes of 
genes clustering together. Furthermore, we found a striking relationship 
between basal and heat-shock-induced HSF1p activity: a large set of strains 
with high basal HSF1p activity are especially sensitive to heat shock. Our 
study sheds light on the dual roles of HSF1p as both a stress responder and 
a fine-tuned homeostatic regulator. 
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In protein misfolding diseases chaperones are able to recognize aberrantly 
folded proteins and aide in the refolding or clearance of these proteins. 
Amyloidogenic yeast proteins configure into self-perpetuating 
conformations and their propagation is facilitated by chaperones. Hsp104p 
is an AAA ATPase which functions as a disaggregase and is a requirement 
for prion propagation in vivo. Hsp104p is known to function in the severing 
of Sup35p aggregates to propagate the [PSI+] prion in the cytosol and 
facilitate faithful transmission from mother cell to daughter cell. Hsp104 is 
also required to propagate the yeast prion called RNQ+. Interestingly the 
over-expression of Hsp104 cures [PSI+] but not [RNQ+]. Recently, we 
found that a mutation in Hsp104 altered the recognition of RNQ+ prion 
variants differently. Together this data suggests that Hsp104p recognizes 
misfolded structures differently. Employing variants of the [RNQ+] protein 
in combination with mutants of Hsp104p, the requirements for chaperone 
recognition and processing are being elucidated in vitro to determine the 
biochemical properties required for handling of different Rnq prion variants 
by Hsp104. 
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Hsp70 plays a role as a molecular chaperone such as inhibition of protein 
denaturation (holdase), promotion of protein folding and renaturation of 
denatured proteins (foldase). Orchardgrass Hsp70 possesses a well 
conserved ATP binding site, Hsp70 domain and signature of cytosolic 
Hsp70 (EEVD motif), and plays as an ATPase, holdase and foldase in a 
dose-dependently. We also identified that Hsp70 binds to Arabidopsis 
calmodulin-2 (ACaM2) in a presence of Ca2+ via a conserved CaM binding 
domain on CaM-overlay assay. Hsp70 binding to Ca2+/CaM reduced 
intrinsic Hsp70 ATPase activity, but its activity is not changed by 
increasing the concentration of ACaM2. In addition, Ca2+/CaM binding 
decreased Hsp70 foldase activity. Based on the protein structure of bovine 
Hsc70 which is a highest structural homolog of orchardgrass Hsp70, a CaM 
binding domain is located near the ATP binding site. Therefore, Ca2+/CaM 
binds to Hsp70 in a 1 to 1 molar ratio, CaM covers the ATP binding pocket 
of Hsp70, and thus reduces Hsp70 chaperone activity through blocking of 
ATP hydrolysis. 
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Hsp90 is an ATP-dependent molecular chaperone. The best characterized 
inhibitors of Hsp90 target its ATP binding pocket, causing non-selective 
degradation of Hsp90’s client proteins. We found that the small molecule 
celastrol inhibits the Hsp90 chaperoning machinery by inactivating the co-
chaperone p23, resulting in a more selective destabilization of steroid 
receptors compared to kinase clients. Our in vitro and in vivo results 
demonstrate that celastrol disrupts p23 function by altering its three-
dimensional structure, leading to rapid formation of amyloid-like fibrils. 
This study reveals a unique inhibition mechanism of p23 by a small 
molecule that could be exploited in the dissection of protein fibrilization 
processes as well as the therapeutics of steroid receptor-dependent diseases. 
 29 
SYSTEMATIC ANALYSIS OF FACTORS UNDERLYING THE 
REFOLDING ACTIVITY OF DNAK 
 
Lyra Chang1, Andrea D Thompson1, Peter Ung2, Heather Carlson2, Jason E 
Gestwicki1  
 
1University of Michigan - Ann Arbor, Department of Pathology and the Life 
Science Institute, 210 Washtenaw Avenue, Ann Arbor, MI, 48109, 
2University of Michigan - Ann Arbor, Medicinal Chemistry, 428 Church 
Street, Ann Arbor, MI, 48109 
 
DnaK is a member of the ubiquitous Hsp70 family of molecular chaperones 
and it plays important roles in prokaryotic proteostasis. Like other Hsp70s, 
it consists of a nucleotide-binding domain (NBD), which hydrolyzes ATP, 
and a substrate-binding domain (SBD), which binds unfolded polypeptides. 
Nucleotide hydrolysis by the NBD controls substrate binding in the SBD 
and this important regulatory step is further tuned by the associated co-
chaperones DnaJ and GrpE. In this work, we generated ~ 31 mutations in 
the NBD to identify residues that impact allosteric communication in the 
DnaK-DnaJ-GrpE system. Of particular importance, we sought to 
understand how the various factors influencing ATPase activity controlled 
the folding of a model substrate, firefly luciferase. In vitro, many of the 
DnaK mutants exhibited altered ATPase and luciferase folding activities 
and their abilities to be stimulated by co-chaperones were changed. Using 
this unique series of mutants, we found a positive correlation between 
ATPase rate and luciferase refolding activity, which has been predicted by 
previous studies. Moreover, the Vmax of stimulation by DnaJ was 
positively correlated with refolding efficiency. Conversely, the stimulation 
by GrpE or substrate was less predictive of refolding activity, while the kcat 
for DnaJ stimulation was inversely correlated. In addition to these general 
trends, a number of DnaK mutants showed unique properties. For example, 
mutants were identified that, remarkably, completely blocked ATP 
hydrolysis but permitted refolding activity. To understand the structural 
basis of these ‘outlier’ mutants, we explored their ability to dimerize and 
studied their structure by partial proteolysis. These studies revealed that 
several mutants formed stable dimers and were highly susceptible to trypsin 
digestion, compared to the wild type DnaK. Together, these findings 
suggested that either the oligomerization or increased structural flexibility 
facilitated their unique properties. Currently we are working to determine 
whether these mutations impact the heat shock response or lambda phage 
replication in vivo. These studies are beginning to reveal aspects of 
allosteric control in the DnaK system and they support a model of complex, 
dynamic interactions in the chaperone complex. 
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When newly synthesized polypeptides leave the ribosome through the 
ribosomal exit tunnel, they encounter a set of ribosome-bound factors that 
interact with the nascent polypeptide. In Saccharomyces cerevisiae, the 
ribosome-associated complex (RAC) consisting of the Hsp70 homologue 
Ssz1p and the Hsp40 homologue Zuotin together with the Hsp70 
homologue Ssb1/2p forms a functional chaperone triade. However, despite 
the fact that RAC/Ssb is a chaperone complex, no folding substrates of 
RAC/Ssb have been identified so far. The precise function of RAC/Ssb on 
the ribosome therefore is still largely unknown. Besides RAC/Ssb, the 
nascent chain-associated complex (NAC) also makes contact to the 
emerging polypeptide. Yet, like for RAC/Ssb the role of NAC at the 
ribosomal exit remains elusive. 
 
As RAC/Ssb and NAC are among the first factors to encounter newly 
synthesized polypeptides, these complexes would be ideally suited to act at 
the interface of protein synthesis, protein folding, recognition of faulty 
proteins, and co-translational degradation. Different scenarios are 
conceivable in which co-translational degradation of proteins becomes 
necessary, e.g. readthrough of stop codons or translation of mRNAs such as 
nonsense- or nonstop-mRNAs. For the degradation of aberrant mRNAs 
different degradation pathways are known. However, little is known about 
the fate of the resulting proteins. Ribosome-bound factors like RAC/Ssb and 
NAC are good candidates to be involved in these processes. For this reason 
we started to analyse the genetic interaction of different mRNA decay 
factors with RAC/Ssb and NAC. Indeed, initial results point into the 
direction that ribosome associated protein biogenesis factors can influence 
the stability of proteins deriving from such mRNAs. 
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Protein disulfide isomerase (PDI) is a widely expressed enzyme, broadly 
distributed in eukaryotic tissues. PDI is relatively abundant, being found in 
the lumen of the endoplasmic reticulum (>400 µM), where it catalyzes the 
formation and rearrangement of disulfide bonds of secreted proteins. PDI is 
also known to be secreted from a variety of cell types. In addition to serving 
as a redox catalyst and isomerase, PDI-mediated reductive cleavage of 
disulfide bonds at the cell surface is critical to the entry and subsequent 
infectivity of a number of disease-causing agents, including human 
immunodeficiency virus (HIV), diphtheria toxin and Chlamydia 
trachomatis. PDI inhibitors, through blocking reductive cleavage of 
disulfide bonds associated with these pathogens, can prevent infectivity. A 
homogenous fluorescence-based assay was devised based upon PDI-
catalyzed reduction of insulin in the presence of dithiothreitol, resulting in 
the formation of insulin aggregates which bind avidly to a novel red-
emitting fluorogenic dye. Relative to analogous turbidometric assays of PDI 
activity, the fluorescence-based assay provides a vastly improved assay 
signal window, improved lower detection limit, and superior Z’-score 
(>0.8). Intra-plate and inter-plate CVs using the assay are typically 3-4%. 
Concentration-response plots were employed to determine the effects of 
bacitracin on PDI activity. These experiments were performed at constant 
enzyme and substrate concentrations while systematically varying 
bacitracin concentration. The IC50 of the PDI inhibitor was determined to 
be 309 ± 27 μM. The described assay has been specifically developed for 
use on a fluorescence microplate reader and can potentially be applied to 
high-throughput screening of PDI inhibitors from chemical libraries. 
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The S. cerevisiae Not4 RING finger E3 ubiquitin ligase is a subunit of the 
conserved Ccr4-Not complex, which plays a role in diverse cellular 
processes including transcription and RNA degradation. The first substrate 
identified for this E3 is a chaperone, namely the nascent-associated-
polypeptide complex or NAC, termed EGD in yeast. Our earlier studies 
show that ubiquitination of the EGD complex by Not4 is important for its 
association with the ribosome and the proteasome. This finding has 
suggested that Not4 may play a role in the quality control of nascent 
peptides. Recently we determined that Not4 is important for ubiquitin 
turnover, and for structural and functional integrity of the proteasome. 
Indeed, the deletion of Not4 leads to accumulation of poly-ubiquitinated 
proteins and reduced free ubiquitin, and consistently is synthetically lethal 
with the deletion of the Ubp6 or Doa4 deubiquitinating enzymes, which 
also lead to reduction of free ubiquitin. Furthermore, purification of the 
proteasome in the absence of Not4 reveals functional and salt-resistant 
interaction between regulatory particle (RP) and core particle (CP), 
instability of free RP, and reduced RP in higher order complexes lacking 
CP. The RING domain of Not4, not essential for Not4 association with the 
Ccr4-Not complex, is critical for appropriate control of proteasome 
assembly. However, association of Not4 within the Ccr4-Not complex also 
contributes to proteasome integrity. Our most recent results suggest that 
Not4 is important for functional integrity of the proteasome through its 
importance for the appropriate balance of proteasome chaperones. 
 33 
PI3K-MTOR REDUCES STRESS RESISTANCE BY ATTENUATING 
HSP70 TRANSLATION 
 
Crystal S Conn1, Jun Sun2, Yan Han2, Vincent Yeung 3, Shu-Bing Qian1,2  
 
1Cornell University, Molecular Biology and Genetics, Biotech Bldg., Ithaca, 
NY, 14853, 2Cornell University, Division of Nutritional Sciences, 303 
Biotech Bldg., Ithaca, NY, 14853, 3Cornell University, Biological Sciences, 
Ithaca, NY, 14853 
 
Protein translation is a key regulated cellular process that links nutrients 
with diverse biological processes.  It has been known that some cellular 
proteins continue to be synthesized under conditions where global 
translation is severely compromised. Under stress conditions such as 
starvation or heat shock, general translation is inhibited, yet some mRNAs 
are induced as a stress response.  One prominent example is the selective 
translation of heat shock proteins (HSP).  Though the transcriptional 
regulation of HSP genes have been well established, no precise mechanism 
has been demonstrated to explain how these up-regulated mRNAs are 
efficiently translated in mammals. 
Here we show that the stress-induced preferential translation of Hsp70 
mRNA is negatively regulated by PI3K-mTOR signaling. This pathway 
plays a pivotal role as a key sensor of the cellular environment through 
regulation from nutrients, energy and stress conditions. The chaperone-
mediated remodeling of mTOR and the pathway’s regulation is clearly 
affected under multiple stress conditions. Our results show that the 
translation of Hsp70 mRNA after heat shock is severely suppressed in cells 
lacking tuberous sclerosis complex 2 (TSC2). It seems that the hyperactive 
mTOR signaling in TSC2-/- cells disrupts the bi-functional switch between 
cap-dependent and a cap-independent translational mechanism. By further 
reducing the PI3K-mTOR signaling by siRNA-mediated knockdown or 
pharmacological inhibitors, HSP70 translation is further enhanced as well 
as stress resistance overall.   
This study may have critical implications for the pathologies associated 
with mTOR dysregulation. Unrestrained mTOR activity in mammals is 
associated with the occurrence of disease states including inflammation, 
cancer and diabetes. By contrast, decreased mTOR signaling by genetic or 
pharmaceutical approaches (e.g. rapamycin) has been shown to extend 
lifespan in a variety of organisms. Interestingly, a robust stress response is 
required for life span extension in these organisms. Our ongoing research 
may provide a plausible mechanism for the molecular connection between 
nutrient signaling and the cellular stress response.
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Study of Hsp-chaperones (Hsp) in the last few years revealed a multitude of 
roles for these molecules in physiology and pathology, expanding considerably 
the field of chaperonology. For example, Hsps were detected in the extracellular 
space and in circulation, and found to interact with immune system cells. These 
findings opened a new perspective for understanding autoimmunity and 
inflammation. Likewise, the realization that Hsps can cause or aggravate disease 
lead to the identification of the chaperonopathies as a new group of pathological 
conditions, prompting new strategies for studying pathogenetic mechanisms and 
developing therapeutic means. It has also become clear that understanding the 
chaperoning systems of primitive organisms can provide clues for elucidating 
the function of Hsps in higher eukaryotes, including human. Here, we report the 
results of our studies on the chaperoning system of the protistan Perkinsus 
marinus (Pm), which diverged early from an ancient lineage leading to the 
Dinozoa. Pm, a facultative intracellular a parasite of the oyster Crassostrea 
virginica, has adapted to withstand stress from the host’s defenses as suggested 
also by our findings. We have searched the Pm genome, using human sequences 
as queries and the chaperonomics protocol described earlier, and found about 60 
genes encompassing virtually all the main chaperoning families: Hsp90, Hsp70, 
Hsp60, CCT, Hsp40, Hsp10, sHsp, prefoldin, mitochondrial chaperones, Hip, 
Hop, and NAC. Iterative searches with the Pm sequences as queries revealed 
other related gene-candidates for future analysis, e.g., candidates related to 
Hsp90, 3; Hsp70, 12; Hsp60, 5; Hsp10, 2; mitochondrial Hsps, 2; prefoldin, 5. 
In addition, several gene-candidates related to Hsp40 are now under study. 
Initial phylogenetic analysis of the Hsp70 proteins showed that the newly 
identified gene-candidates cluster with the Pm Hsp70 genes previously found. 
Other chaperone genes were also found, e.g., co-chaperone hscB, tubulin-
specific chaperone B, chaperone-binding protein, GrpE, and a cytochrome c 
oxidase copper chaperone. Many of the genes have ESTs. Additional 
chaperonomics analyses are under way to define more precisely the Pm Hsp 
genes, which will be followed by experimental testing to identify genes that are 
induced by stressors typically affecting Pm, such as changes in temperature, 
salinity, and iron concentration; and exposure to host factors (oyster plasma and 
hemocyte extracts). The data thus far reveal a diversity and complexity of Hsp-
chaperone families that is remarkable, considering that Pm is a very ancient 
unicellular organism. 
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The chaperonopathies include inflammatory diseases among which COPD is one of 
the most important due to its frequency and impact on human health and economy. 
Previously, we showed that levels of the chaperones Hsp60 and Hsp10 in human 
airway epithelium declined from normal through metaplasia to dysplasia/cancer. In 
contrast, we found in COPD patients a positive correlation between increased Hsp60 
and Hsp10 levels in epithelium and disease severity, but these levels showed no 
correlation with FEV1 values or cigarette-pack/year consumption. To clarify this 
apparent discrepancy and to unveil the role of Hsp-chaperones in COPD, we 
measured Hsp10,27,40,60,70,90 and Hsp transcription factor HSF-1 in four groups 
of bronchial biopsies from patients with mild-moderate or severe COPD, all 
smokers, in comparison to smoker and non-smoker, age-matched, healthy controls. 
We also correlated Hsp levels with neutrophil and activated neutrophil numbers in 
lamina propria (a hallmark of COPD severity). We used immunohistochemistry and 
RT-PCR and applied the pertinent non parametric statistical tests (Kruskal-Wallis 
and Mann-Whitney U) to evaluate results and compare groups. In the bronchial 
epithelium and lamina propria Hsp10,40, and 60 proteins were significantly 
increased in the severe COPD group compared to control smokers and non-smokers 
but no significant differences were observed for Hsp27,70,90, and HSF-1 levels 
between the four groups. Levels of HSF-1 mRNA were significantly higher in the 
severe COPD group compared to control smokers while Hsp10,40 and 60 mRNA 
levels were not changed in the four groups, suggesting a prevalent post-
transcriptional regulation of Hsp proteins production. In all smokers the number of 
immunostained Hsp60 positive cells in the lamina propria significantly correlated 
with numbers of neutrophils and activated neutrophils expressing myeloperoxidase, 
suggesting a link between Hsp60 and the oxidative/nitrosative stress mediated by the 
activated neutrophils typically populating the bronchial mucosa in COPD. This 
correlation was also true for all COPD patients. No other correlations were found 
between inflammatory cells and Hsp levels or any other standard clinical or 
pathological parameter. Our results show for the first time that Hsp-chaperones are 
involved in COPD and open the road to investigate their role in pathogenesis (e.g., 
by initiating-perpetuating inflammation and/or airway remodeling) and to develop 
therapeutic means in which chaperones would be central players, either as targets for 
antichaperone compounds or as cytoprotective agents (chaperonotherapy), 
depending on whether the Hsp-chaperones play pro- or anti-pathogenetic roles. 
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The impact of cigarette smoke stress (a form of oxidative stress, OS) on human 
lung fibroblasts and epithelial cells, particularly its effect on mitochondrial 
chaperonins expression, has not been extensively characterized despite the 
growing importance of these molecules in various pulmonary diseases. We 
studied the effects of non-lethal doses of cigarette smoke extract (CSE) on the 
expression of Hsp60 and Hsp10 in human lung fibroblasts (HFL-1 line) and 
epithelial cells (16HBE line). We focused on the identification of mitochondrial 
chaperonins in extra-mitochondrial sites, such as cytosol and nucleus, using 
subcellular fractionation analyses (SFA), western bloting (WB), and 
immunocytochemistry (ICC). Database searches and chaperonomics were 
carried out to identify and compare the proteins and genes of interest, and 
bioinformatics was applied to gather “in silico” structural data useful for 
interpreting and complementing the “in vitro” results. ICC and SFA showed 
differences in the subcellular localization of the two chaperonins in both cell 
lines: Hsp60 was localized preferentially to mitochondria in contrast to Hsp10, 
which was found in the cytosol at high levels, and in the nucleus. WB with 
nuclear fractions confirmed the presence of Hsp10 in the nucleus of both cell 
lines. Experiments showed that exposure to CSE caused variations in the levels 
of nuclear Hsp10, suggesting a link between exposure to exogenous OS and a 
cell response, which likely involves as yet undescribed Hsp10 roles distinct 
from the its typical intramitochondrial functions. Comprehensive databases and 
literature searches revealed that Hsp10 can display a complex array of functions 
related to its three different locations: cytoplasmatic, mitochondrial, and 
extracellular. Extracellular Hsp10 has been described as EPF (Early Pregnancy 
Factor) because it appears to be a key marker and functional factor during the 
establishment of pregnancy. Here, we provide data showing for the first time 
the presence of Hsp10 in the nuclear compartment of both epithelial and stromal 
human lung cell lines, and indicating that intranuclear Hsp10 levels are affected 
by OS due to an exogenous stressor like cigarette-smoke. These findings open 
new paths toward elucidation of the roles of intranuclear Hsp10 in the stress 
response. Bioinformatics and structural analyses also provided support to the 
notion that Hsp10 is not restricted to mitochondria and can localize elsewhere, 
e.g., the nucleus, even if the typical Hsp10 lacks DNA-binding motifs or 
nuclear import signals. The questions now are by what mechanism Hsp10 
becomes a resident of the nucleus and what are its functions there. 
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Drugs that target novel surfaces on the androgen receptor and/or novel AR 
regulatory mechanisms are promising alternatives for the treatment of hormone 
refractory prostate cancer (HRPC). The 52 kDa FK506 Binding Protein 
(FKBP52) has been shown to be an important positive regulator of AR in 
cellular and whole animal models and represents an attractive target for the 
treatment of prostate cancer. We have identified a surface region on the 
androgen receptor (AR) hormone binding domain that, when mutated, displays 
a greater dependence on FKBP52 for normal function. Interestingly, the BF3 
surface is also hypothesized to participate in the interaction of AR with the co-
activator β-catenin, and co-expression of FKBP52 and β-catenin act in synergy 
to up-regulate both hormone-dependent and hormone-independent AR function. 
In addition, we have developed a series of small molecules that effectively 
inhibit the FKBP52 regulation of AR function and the synergistic up-regulation 
of AR function by FKBP52 and β-catenin. Surface plasmon resonance studies 
have confirmed that these inhibitors disrupt the regulation of AR by FKBP52 
and β-catenin through interaction with the AR hormone binding domain. We 
have demonstrated that these novel compounds do not compete with hormone 
for binding the hormone binding pocket, nor do they compete with coactivator 
peptide for binding AF2. In addition, we have shown that these compounds 
inhibit AR function by preventing hormone-dependent dissociation of the 
Hsp90-FKBP52-AR complex which results in less hormone-bound receptor in 
the nucleus. Preliminary assays in early and late stage prostate cancer cells have 
demonstrated our novel compounds inhibit both prostate specific antigen 
expression and androgen-dependent proliferation. In summary, we have 
identified a putative FKBP52 interaction surface on the AR hormone binding 
domain and identified a series of small molecules that inhibit AR function by 
targeting that surface. This class of compounds, now termed NR alternate site 
modulators (NRAMs), would be useful in hormone-resistant prostate cancer, 
where coregulator overexpression and other mechanisms result in receptor 
activation in the absence of exogenous ligands. In addition, we have identified a 
novel functional interaction between FKBP52 and β-catenin that has clear 
implications in prostate cancer progression to the hormone refractory state. 
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An increasing number of redox-regulated proteins have been identified that 
use reactive oxygen species (ROS) as posttranslational modulators of their 
activity. One redox-regulated protein is the highly conserved, general 
chaperone Hsp33. Hsp33 is specifically activated under oxidative stress 
conditions that lead to protein unfolding (i.e., hypochlorous acid stress) and 
protects bacterial cells against oxidative protein aggregation. Stress sensing 
in Hsp33 occurs via its C-terminal redox switch domain, which consists of a 
zinc center that responds to the presence of oxidants, and an adjacent 
metastable linker region that responds to unfolding conditions. Both regions 
are compactly folded in inactive Hsp33 and undergo substantial unfolding 
upon activation. This mechanism of activation makes Hsp33 a member of a 
growing group of chaperones, which are functional in a partially natively 
unfolded state. Here we show that single mutations in Hsp33’s N-terminus 
are sufficient to either partially (Hsp33-M172S) or completely (Hsp33-
Y12E) abolish the posttranslational regulation of Hsp33’s chaperone 
function. Both mutations appear to work predominantly via the 
destabilization of Hsp33’s linker region without affecting zinc coordination, 
redox sensitivity, or substrate binding of Hsp33. We found that the M172S 
substitution causes moderate destabilization of Hsp33’s linker region, which 
seems sufficient to convert the redox-regulated Hsp33 into a temperature-
controlled chaperone. The Y12E mutation leads to the constitutive 
unfolding of Hsp33’s linker region thereby turning Hsp33 into a 
constitutively active chaperone. Our results demonstrate that the unfolding 
of Hsp33’s linker region plays the central role in Hsp33’s activation process 
while the zinc center acts as redox-sensitive toggle that adjusts the 
thermostability of the linker region to the redox status of the cell. These 
results further imply that stress conditions that act mainly on destabilizing 
Hsp33’s linker without affecting the redox status of the zinc center, might 
be sufficient to activate Hsp33. This conclusion would not only explain 
recent findings, which showed that Hsp33 expression significantly increases 
bacterial resistance towards oxidative stress-independent stresses, but would 
entail that Hsp33 might be a much more versatile chaperone than previously 
anticipated. In vivo studies confirmed that even mild overexpression of the 
constitutively active Hsp33 mutant inhibits bacterial growth, providing 
important evidence that the tight functional regulation of Hsp33’s 
chaperone activity plays a vital role in bacterial survival. 
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The heat shock response (HSR) is orchestrated by inducible activators such 
as HSF-1 and feedback inhibitors including molecular chaperones such as 
Hsp70. The regulation of the HSR has been extensively investigated at the 
molecular level; however, much less is understood at the cellular and 
organismal level. To address this, we have employed genome-wide RNAi 
screens in C.elegans to identify new regulatory pathways for the HSR 
essential for its activation and repression. We have identified 13 genes that 
when knocked-down, block activation of the HSR reporter 
(C12C8.1p::GFP (hsp70)), and 55 genes that induce the reporter in the 
absence of stress in a tissue-specific manner. Included among these hits 
were hsf1, hsp1 (hsp70), and daf21 (hsp90). All 55 of the negative 
regulators induce the HS reporter in an HSF-1 dependent manner and nearly 
all induce another HS reporter, hsp16.2. The identified regulators are 
enriched in self-interactions and cluster into distinct networks that correlate 
with the tissue-specific reporter induction. To better understand the 
structure and function of the underlying regulation we performed an 
epistasis analysis, revealing complexity of the genetic pathways involved in 
the regulation of the HSR in metazoan organism. 
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One of the key features of molecular chaperones is their ability to bind 
nonnative proteins and thus suppress their unspecific aggregation. To 
understand the mechanistic features of this process we set up a minimal 
system mimicking this function by immobilizing the test proteins via a 
polyhistidine-tag on a matrix. This allows retaining their flexibility to regain 
their native state. Additionally, the polypeptide chains are spatially 
separated, which decreases unfavorable interactions.  
 
We compared the folding properties of isolated, matrix-attached proteins to 
those in solution and find striking differences in the folding and association 
kinetics. Interestingly, compared to folding in-solution, the matrix-assisted 
folding was more efficient for different proteins and seems to be 
comparable with chaperone-assisted protein folding.  
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In many diseases of aging, aberrant protein production is a common feature. 
Interestingly, the majority of these proteins are clients of the chaperone 
network. Many disease-associated clients that accumulate with age have 
intrinsically unstructured hydrophilic regions, such as the microtubule 
associated protein tau; however other disease-associated clients are the 
more typical globular proteins with a hydrophobic core such as the kinase 
Akt. Our recent work on tau and Akt suggests that while both types of 
proteins can interact with the chaperone network and be stabilized or 
degraded they may be processed through the chaperone pathway in different 
directions. One primary question that has emerged from these studies is 
why intrinsically unstructured proteins are clients of the chaperone 
machinery at all. We speculate that it is this akward interaction with the 
chaperones that may accidentally lead to the misfolding and production of 
toxic aggregated intermediates of these disordered proteins that ultimately 
result in neuronal death. We now have evidence that an altered tau 
conformation known as MC1, which is thought to initiate the progression of 
Alzheimer’s disease pathology, can be facilitated by molecular chaperones. 
This conformation is formed when the N-terminus of tau folds back on 
itself and interacts with the microtubule-binding domain. Thus, chaperones 
seem to be facilitating misfolding of tau. Moreover, we find that chaperones 
prevent heparin-induced tau fibrillarization, but produce other distinct 
amorphous aggregates. However, despite these seemingly deleterious 
biochemical effects, we have found that manipulating the activity of these 
chaperones with small molecules or by applying them exogenously to the 
brains of transgenic tau mice can improve neuronal function. Thus, 
manipulation of chaperones can have a beneficial role in models of 
neurodegenerative disease. We also show that chaperones do participate in 
the pathogenesis of disordered proteins, particularly tau, which 
pathologically accumulates in ~70% of all neurodegenerative diseases. 
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Protein misfolding is associated with several devastating neurodegenerative 
diseases, such as Alzheimer’s disease, Parkinson’s disease and 
Huntington’s disease (HD). In many cases, protein misfolding is closely 
linked to the formation of amyloids, which are characterized by a cross-beta 
structure and an unusual stability. Using the yeast prion [PSI+], we 
investigate the mechanisms, by which small molecules modulate amyloid 
formation and prion stability. We identified that the small molecule 
epigallocatechin gallate (EGCG) blocked prion formation, eliminated pre-
existing prions and solubilized amyloid proteins by disrupting intra- and 
inter molecular contacts. Thus, EGCG remodels amyloids in a manner 
reminiscent of molecular chaperones or protein remodeling factors. 
Notably, we also found that EGCG transforms one amyloid conformation 
into a different one. Moreover, we described how combining two small 
molecules, that antagonize prion formation by distinct mechanisms, 
synergized to directly inhibit and reverse the formation of diverse prion 
strains. 
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The AAA+ ATPase Hsp104p is required for the efficient propagation of 
yeast prions in vivo as well as the recovery of yeast from severe heat stress. 
Hsp104p has been proposed to disaggregate large aggregates and 
resolubilize aggregated and misfolded proteins by threading polypeptides 
through its central pore, but the mechanism of substrate recognition is 
largely unknown. We have identified and characterized a novel Hsp104 
mutant whose defect is specific to the [PSI+] prion. Yeast with this mutant 
appear [psi-] phenotypically and harbor no detectable Sup35 aggregates as 
assessed by a variety of biochemical assays. Interestingly however, this 
mutant propagates a cryptic form of [PSI+], as the [PSI+] phenotype 
appears in progeny from a cross to [psi-] cells expressing wild type Hsp104. 
Furthermore, this mutant dominantly cures a weak [PSI+] variant and 
inhibits [PSI+] induction when Sup35 is overexpressed. On the other hand, 
cells harboring this mutant hsp104 allele can recognize most substrates, as it 
retains full functionality in thermotolerance. In addition, this mutant does 
not generally inhibit propagation of prion and prion-like aggregates, as both 
the [RNQ+] prion and non-toxic polyQ103-GFP maintain aggregates. Due 
to its ability to process other known substrates normally, we hypothesize 
that this mutant is defective specifically in the recognition and processing of 
[PSI+] aggregates. This defect is due specifically to its interaction with 
Sup35 in the [PSI+] state as the mutant cannot be rescued by the 
overexpression of its chaperone co-factors and is reduced in its ability to 
functionally interact with the prion-forming domain of Sup35 in vitro. We 
propose that this defect stems from its decreased ATPase activity and 
suggest that various levels of activity are required to resolve different 
substrates. This may also explain why the overexpression of Hsp104 cures 
only [PSI+] among the well-characterized yeast prions. We are using this 
mutant to elucidate the role of Hsp104p in the propagation of variants of 
[PSI+] and investigate the mechanism of substrate recognition. 
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Protein quality control and subsequent elimination of terminally misfolded 
proteins occurs via the ubiquitin proteasome system. Tagging of misfolded 
proteins with ubiquitin for degradation depends on a cascade of reactions 
involving an ubiquitin-activating enzyme (E1), ubiquitin-conjugating 
enzymes (E2) and ubiquitin ligases (E3). While ubiquitin ligases 
responsible for targeting misfolded secretory proteins to proteasomal 
degradation (ERAD) have been uncovered and characterized, little is known 
about E3 enzymes responsible for elimination of misfolded cytoplasmic 
proteins in yeast.  
For finding novel factors in the protein quality control in the cytoplasm we 
have studied requirements for degradation of ER import defective mutated 
derivatives of carboxypeptidase yscY (∆ssCPY*, ∆ssCPY*-GFP, 
∆ssCPY*Leu2myc). Previously we were able to show that for degradation 
of such mislocalized proteins the E2s Ubc4 and Ubc5, the cytoplasmic 
Hsp70 Ssa chaperone machinery and the co-chaperone Ydj1 are needed. 
Now we were able to show that for this chaperone-assisted degradation of a 
misfolded cytoplasmic protein the E3 ligase of the N-end rule pathway 
Ubr1 is required. Presently we are characterizing the binding properties of 
Ubr1 to the misfolded proteins, which seem to be independent of known 
binding regions within the enzyme. 
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The hydrophobic effect is known to be a major determinant of protein 
tertiary structure. I have developed a simple, quantitative method for 
predicting optimal backbone burial in protein structures from patterns of 
sequence hydrophobicity. The optimum generated by the method matches 
well with the crystal structures of many proteins. By analyzing the 
sequences and structures of proteins such as myoglobin, UBC9, and VHL, I 
show that this method allows one to determine whether a primary sequence 
is that of a folded protein, a temperature-sensitive mutant, or a natively 
unstructured protein. 
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Prerequisite for antibody secretion and function is the assembly into a 
defined quaternary structure, composed of two heavy and two light chains 
in the case of IgG. Unassembled heavy chains are actively retained in the 
endoplasmic reticulum (ER) via the interaction of the molecular chaperone 
BiP with the antibody CH1 domain until they associate with light chains. 
Our mechanistic analysis of this critical quality control step revealed that, 
unlike all other antibody domains studied, the CH1 domain of the heavy 
chain is an intrinsically disordered protein in isolation. It adopts the typical 
immunoglobulin fold only upon interaction with its native partner, the CL 
domain. Structure formation proceeds via a trapped intermediate and can be 
accelerated by the ER-specific peptidyl-prolyl isomerase cyclophilin B. The 
molecular chaperone BiP modulates CH1/CL association by recognizing 
incompletely folded states of the CH1 domain within the assembly pathway 
and directly competes for CL binding to CH1. In vivo experiments 
demonstrate that requirements identified for folding the CH1 domain in 
vitro, including association with a folded CL domain and isomerization of a 
conserved proline residue, are essential for antibody assembly and secretion 
in the cell. Our data provide an explanation for the high fidelity of antibody 
quality control and extend the view on chaperone controlled protein 
assembly mediated by intrinsic structural features of the client proteins. 
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We have investigated the self-association propensities of aqueous unfolded 
(UAQ ) forms of eight outer membrane proteins, OmpA, OmpW, OmpX, 
PagP, OmpT, OmpLa, FadL and Omp85. We found that high urea 
concentrations maintain all of these OMPs in monomeric forms and that 
OmpA and OmpX remain monomeric upon dilution to 1M urea. A pH 
screen showed that basic pH supports the least amount of UAQ OMP self-
association, consistent with earlier studies showing that basic pH was 
optimal for better folding efficiencies. The addition of KCl increased in UAQ 
OMP self-association, although the magnitudes of the responses were 
varied. Urea can be used to tune the amount of UAQ OMP self-association 
and our results show that low urea concentrations may be useful in 
optimizing folding conditions. Ongoing work with periplasmic chaperones 
investigates their abilities to prevent UAQ OMP self-association and defines 
one of their functional roles. 
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The management of misfolded proteins is a key aspect of cellular 
physiology. Cells utilize compartment specific protein quality control 
(PQC) systems that function to repair or degrade misfolded proteins. 
Eukaryotic PQC systems have been characterized in many cellular 
compartments including the endoplasmic reticulum, cytoplasm, 
mitochondria, and nucleus. In the ER and cytoplasm, both protein synthesis 
compartments, there is strong interplay between the repair and destruction 
PQC pathways. However, little is understood about the interplay between 
destruction and repair machinery in a compartment that isn’t directly 
involved protein biosynthesis like the nucleus. The budding yeast 
Saccharomyces cerevisiae is an ideal organism to study the interaction 
between the repair and degradation pathways in the nucleus because 
multiple chaperone-mediated repair pathways have been characterized in 
the yeast nucleus and the first nuclear PQC degradation system, mediated 
by the ubiquitin ligase San1, was discovered in yeast. Unlike the ER and 
cytoplasm, we found that San1 does not utilize protein chaperones for 
substrate recognition, but instead recognizes its substrates through a unique 
flexible interface. In the process of examining the genetic interactions 
between San1 and chaperones with known nuclear localization (such as 
Hsp70, Hsp90, Hsp104, Hsp26, and Hsp42), we did find that Hsp90 and 
San1 have a synthetic genetic interaction that is exacerbated by expression 
of toxic, aggregation-prone, misfolded nuclear proteins. Furthermore, by 
examining the degradation of San1 substrates in the absence of Hsp90 
function, we found that Hsp90 may be negatively regulating San1-mediated 
degradation, and this may be the result of competition between San1 and 
Hsp90 for misfolded protein substrates in the nucleus. This is the first 
example where the repair and degradation arms of PQC compete rather than 
collaborate. 
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Controversy exists over whether GroEL forms a GroEL-(GroES)2 complex 
(football-shaped complex) during its reaction cycle. We have previously 
revealed the existence of the football-shaped complex in the chaperonin 
reaction cycle using a fluorescence resonance energy transfer (FRET) assay 
(Sameshima, T., Ueno, T., Iizuka, R., Ishii, N., Terada, N., Okabe, K. and 
Funatsu, T. (2008) J. Biol. Chem. 283, 23765-23773). Although denatured 
proteins alter the ATPase activity of GroEL and the dynamics of the 
GroEL-GroES interaction, the effect of denatured proteins on the formation 
of the football-shaped complex has not been characterized. In this study, a 
FRET assay was used to demonstrate that denatured proteins facilitate the 
formation of the football-shaped complex. The presence of denatured 
proteins was also found to increase the association rate of GroES to the 
trans-ring of GroEL. Furthermore, denatured proteins decrease the 
inhibitory influence of ADP on ATP-induced association of GroES to the 
trans-ring of GroEL. From these findings it is concluded that denatured 
proteins facilitate the dissociation of ADP from the trans-ring of GroEL and 
the concomitant association of ATP and the second GroES. 
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Hsp90 is a highly conserved ATP-driven molecular machine that is required 
for the activation and stabilization of a variety of client proteins. Substrates 
are involved in various cellular processes, ranging from steroid hormone 
receptors over transcription factors to an ever growing number of protein 
kinases. In order to activate substrates, Hsp90 has to hydrolyze ATP in a 
cyclic reaction and the hydrolysis energy is supposed to be transmitted to 
the substrate proteins via conformational changes in the Hsp90 dimer. The 
ATPase cycle is fine-tuned by co-factors which support or suppress 
hydrolysis, thereby accelerating or slowing down the turnover of the 
chaperone. As such, Hop/Sti1 was found to interact through its TPR domain 
with the very C-terminal MEEVD motif and with additional binding sites in 
the N- and M-domain of Hsp90. Interaction inhibits the N-terminal 
dimerization and prevents ATP hydrolysis. Other cochaperones have been 
described to inhibit the ATPase activity as well. Cdc37 was found to 
prevent N-terminal dimerization by inserting between the N-domains 
whereas p23/sba1 binds to an ATP-bound dimerized state, thereby 
decelerating hydrolysis. In contrast, Aha1 which binds to the N- and M-
domains is the only known activator so far. For growth factor maturation, 
the assembly of multi-protein complexes have been described. 
Nevertheless, the mechanistic details of cofactor assembly on the Hsp90 
scaffold leading to substrate activation remain elusive to date. Here, we use 
analytical ultracentrifugation to analyze the ability of Hsp90 cofactors to 
simultaneously form ternary complexes on the Hsp90 scaffold. 
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Reactive oxygen species arise continuously during aerobic metabolism and 
are the core of antimicrobial responses. In all cases, reactive oxygen species 
can damage macromolecules, cause oxidative stress when increasingly 
accumulated, and harm or kill cells. The extremely bactericidal reactive 
oxygen species hypochlorous acid (HOCl) is produced by the host immune 
system and observed in the gut and mucosal barrier epithelia. We use the 
gram-negative bacterium Escherichia coli as a model organism to study 
how bacteria withstand HOCl-stress. Using a library screen, we identified a 
novel transcription factor, YjiE, that confers HOCl-resistance. YjiE belongs 
to the LysR-type family of transcription factors, which typically bind to 
DNA as dimers or tetramers. We characterized YjiE in vitro and in vivo in 
order to understand its regulation. Purified YjiE binds to DNA and forms 
remarkable large oligomeric species. As shown by analytical 
ultracentrifugation and transmission electron microscopy, YjiE is a 
dodecamer in solution and forms hexagonal ring-like structures. These high 
oligomeric structures are maintained in the presence of low concentrations 
of HOCl. However in E. coli lysates we also observed smaller oligomers 
(dimer – hexamer). Considering that YjiE is a LysR-type transcription 
factor, such smaller oligomers are likely the active species. We found that 
the observed dodecameric structures are extremely stable and can only be 
dissociated in the presence of arginine, which is known to prevent 
intermolecular interactions. The smaller oligomers resulting from arginine 
treatment are currently characterized regarding DNA-binding activity and in 
in vitro transcription assays. Our work suggests that YjiE is a novel HOCl-
responsive transcription factor. Further research should lead to a model that 
describes the regulation of the transcription factor upon exposure to reactive 
oxygen species.  
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The Hsp90 family represents one of the most abundantly expressed and 
highly conserved families of molecular chaperones. The eukaryotic Hsp90 
is known to control the stability and the activity of more than 200 client 
proteins, including receptors, protein kinases and transcription factors, and 
to work in cooperation with several cochaperones. Despite the high degree 
of homology between the eukaryotic Hsp90 and the prokaryotic homolog, 
HtpG, the function of HtpG remains elusive. To better understand the role 
of E. coli HtpG we looked for conditions in which HtpG confers a 
phenotype to the cell. We found that overexpression of HtpG elicits a 
temperature sensitive phenotype under certain stress conditions. Using this 
in vivo assay, we screened for HtpG mutants generated by in vitro random 
mutagenesis. We have purified some of the mutant proteins and are using in 
vitro assays to test whether these residues are important for the activities of 
HtpG, including prevention of aggregation of client substrates, ATPase and 
reactivation of model substrates in conjunction with the DnaK chaperone 
system of E. coli. It is anticipated that this study will lead to a better 
understanding of the role of HtpG in E. coli and more generally to the 
Hsp90 chaperone family. 
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We have analyzed the role of molecular chaperones and proteases in the 
quality-control of presecretory proteins in Escherichia coli, and shown 
significant overlaps between the chaperone SecB and the ATP-dependent 
protease Lon, both in vivo and in vitro. Through genetic suppressor 
analysis, we have isolated mutations in the lon gene, which specifically 
alleviated the cold-sensitive phenotype of a secB null strain. Further genetic 
experiments demonstrated that the damaging action of Lon in the absence of 
SecB relied on its protease activity. In comparison with its respective single 
mutants, the double secB lon mutant strongly accumulated aggregated 
presecretory proteins at physiological temperature, suggesting that the 
chaperone and the protease share substrates in vivo. Such a phenomenon 
was not observed with mutations in the clpP or hslV protease encoding 
genes. Reconstitution of the system in vitro revealed that the main SecB-
Lon presecretory substrates identified were indeed highly sensitive to 
specific degradation by Lon, when compared to a cytosolic model protein. 
The Lon-sensitivity exhibited by SecB substrates was further confirmed by 
pulse-chase analyses. Finally, in vitro experiments demonstrated that Lon-
sensitive presecretory proteins were significantly protected by SecB, thus 
facilitating their subsequent transfer to the sec translocase at the inner 
membrane. A model summarizing the role of Lon and the chaperone in 
preprotein quality-control will be presented. 
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Chronic expression of aggregation-prone proteins in conformational 
diseases results in the accumulation of damaged or misfolded proteins and 
cellular dysfunction. Because toxicity is modulated by aging, environmental 
conditions, and genetic background, and only a subset of cells is strongly 
affected despite the often broad expression of the mutant protein, this 
dysfunction is dependent on the specific cellular and genetic environment. 
Our previous studies in C. elegans models implicated components of 
proteostasis networks, such as heat shock factor 1 (HSF1) and molecular 
chaperones, and life-span regulators, such as DAF-16, in regulation of 
aggregation toxicity. Furthermore, we found that toxic phenotypes due to 
the expression of polyQ or mutant SOD1 proteins in muscle or neuronal 
cells of C. elegans can be strongly modulated by the presence in the same 
cell of metastable proteins, encoded by the endogenous mildly destabilizing 
temperature-sensitive mutations. We hypothesize that these genetic 
interactions are mediated by competition for components of the proteostasis 
networks, leading to the general compromise of the protein folding 
environment. We are using C. elegans models to probe how variation in the 
genetic background and environmental conditions affects the ability of an 
individual to respond to proteotoxic challenge and to characterize the 
pathways that channel the phenotypic expression of aggregation toxicity. 
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Hsp12 of S. cerevisiae is up-regulated several hundred-fold in response to 
stress. Our phenotypic analysis showed that this protein is important for 
survival of a variety of stress conditions including high temperature. In the 
absence of Hsp12, we observed changes in cell morphology under stress 
conditions. Surprisingly, in the cell, Hsp12 exists both as a soluble cytosolic 
protein and associated to the plasma membrane. The in vitro analysis 
revealed that Hsp12, unlike all other Hsps studied so far, is completely 
unfolded, but in the presence of certain lipids, it adopts a helical structure. 
The presence of Hsp12 does not alter the overall lipid composition of the 
plasma membrane but affects its organization and increases membrane 
stability. 
 56 
COUPLED CHAPERONE ACTION IN THE BIOGENESIS OF FORM I 
HEXADECAMERIC RUBISCO 
 
Manajit Hayer-Hartl1, Cuimin Liu1, Anna L Young2, Amanda S.-Windhof1, 
Andreas Bracher1, Sandra Saschenbrecker1, Bharathi V Rao1, Karnam V 
Rao1, Otto Berninghausen2, Thorsten Mielke3, Roland Beckmann2, F. 
Ulrich Hartl1 
 
1Max Planck Institute of Biochemistry, Cellular Biochemistry, Am 
Klopferspitz 18, Martinsried, 82152, Germany, 2Gene Centre and Center for 
integrated Protein Science CiPSM, University of Munich, Chemistry & 
Biochemistry, Feodor-Lynen-Str. 25, Munich, 81377, Germany, 
3UltraStructureNetwork, USN, Max Planck Institute for Molecular 
Genetics, Ihnestrasse 63-73, Berlin, 14195, Germany 
 
After folding, many proteins must assemble into oligomeric complexes to 
become biologically active, but little is known about chaperone-mediated 
assembly reactions. Form I Rubisco, a complex of 8 large (RbcL) and 8 small 
(RbcS) subunits, catalyzes the fixation of atmospheric CO2 in photosynthesis. 
The limited catalytic efficiency of Rubisco has sparked extensive efforts to re-
engineer the enzyme with the goal to enhance agricultural productivity. 
Recently, we described the role of RbcX2 as a specific assembly chaperone of 
cyanobacterial Rubisco (Saschenbrecker et al, 2007). We have now analyzed 
the formation of form I Rubisco by in vitro reconstitution and cryo-electron 
microscopy (Liu et al, 2010). We show that RbcL subunit folding by the 
GroEL/ES chaperonin is tightly coupled with assembly mediated by the 
chaperone RbcX2. RbcL monomers remain partially unstable and retain high 
affinity for GroEL until captured by RbcX2. Cryoelectron microscopic analysis 
of a trapped RbcL8-(RbcX2)8 complex at ~9 Å resolution shows that RbcX2 acts 
as a molecular staple in stabilizing the RbcL subunits as dimers and facilitates 
RbcL8 core assembly. Specifically, RbcX2 captures the flexible C-terminal 
segment of one RbcL subunit in its central binding cleft and binds another 
subunit via its peripheral binding region. A further function of RbcX2 is to 
stabilize RbcL8 in a conformation close to that in the RbcL8S8 holoenzyme, 
competent for RbcS association. Upon binding of RbcS subunits, the RbcL8-
(RbcX2)8 complex undergoes an allosteric structural change that results in the 
dissociation of RbcX2 and formation of stable Rubisco holoenzyme. The 
strategies employed by RbcX2 in achieving substrate specificity and efficient 
product release may be more generally relevant in the formation of complex 
oligomeric structures when folding is closely coupled to assembly.  
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Innate immunity is required for host defense, but dysregulation and 
prolonged activation can trigger chronic inflammatory diseases such as 
obesity and atherosclerosis, two leading health concerns in the US. In 
atherosclerotic lesions as well as in mouse models of obesity, activation of 
the unfolded protein response (UPR) has been reported. However, precise 
characterization of the relationship and mechanisms underlying UPR 
activation and inflammatory gene regulation remain unknown. Studies have 
reported activation of the IRE1a and PERK signaling pathways of the UPR 
by proinflammatory mediators as well as in the initiation of inflammation, 
suggesting that UPR may play a role in the pathogenesis of these 
inflammatory disorders, but the underlying mechanisms of this complex 
interplay remain uncharacterized. Our study will elucidate the regulatory 
function of UPR in inflammation and identify the mechanisms underlying 
the cross-talk between these two pathways. Significantly, this may identify 
potential UPR-targeted therapeutics in the treatment of inflammatory 
disorders. 
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The co-chaperone Hep1 is required to prevent the aggregation of 
mitochondrial Hsp70 proteins. We have analyzed the interaction of Hep1 
with mitochondrial Hsp70 (Ssc1) and the determinants which make Ssc1 
prone to aggregation. The ATPase and the peptide binding domain (PBD) 
of Hsp70 proteins are connected by a linker segment that mediates 
interdomain communication between the domains. We show that the 
ATPase domain and the interdomain linker represent the minimal Hep1 
binding entity of Ssc1. Moreover, the ATPase domain in combination with 
the interdomain linker is crucial for aggregation of Ssc1. In the absence of 
Hep1, the ATPase domain with interdomain linker had the tendency to 
aggregate, in contrast to the ATPase domain with mutated linker segment or 
without linker, and in contrast to the PBD. Bacterial DnaK, the closest 
homolog of Ssc1, and a Ssc1 chimera, in which a segment of the ATPase 
domain of Ssc1 was replaced by the corresponding segment from DnaK, did 
not aggregate in Δhep1 mitochondria. The propensity to aggregate appears 
to be a specific property of the mitochondrial Hsp70 proteins. In conclusion, 
we suggest that interdomain communication makes Ssc1 prone to 
aggregation. Hep1 counteracts aggregation of Ssc1 by binding to the 
aggregation-prone conformer. 
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The cell surface of most Gram-negative bacteria contains 
lipopolysaccharide (LPS), which is responsible for maintaining the 
impermeability of the outer membrane (OM). Biogenesis of LPS involves 
synthesis at the inner membrane, transport across the cell envelope, and 
assembly at the cell surface. Here we probed the biogenesis and function of 
disulfide bonds of the Escherichia coli OM protein LptD, which is thought 
to mediate the last steps of LPS assembly at OM. Oxidation is essential for 
LptD function, not stability, yet no particular cysteine in LptD is essential. 
Two disulfide bonds between non-consecutive cysteines (C31-C724 and 
C173-C725) covalently link the N- and C- termini of LptD but either bond 
(C31-C724 or C173-C725) individually suffices for function and cell 
viability. The oxidase DsbA facilitates but is not required for LptD 
oxidation, likely because non-enzymatic oxidants can also oxidize LptD. 
Finally, even though disulfide bonds form between non-consecutive 
cysteines, the disulfide isomerase DsbC is not required either. Therefore, 
even though disulfide bond formation in LptD is essential, no particular 
cysteine residue in LptD is essential, and neither is the disulfide oxidase 
DsbA or the disulfide isomerase DsbC. LptD’s oxidation thus seems 
overbuilt for standard laboratory conditions, perhaps implying that this 
redundancy could be beneficial under certain environmental conditions. 
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To identify novel classes of Hsp90 inhibitors[1], we utilized structure-based 
virtual screening of a chemical database with docking simulations in the N-
terminal ATP-binding site of Hsp90[2], in vitro ATPase assay of yeast 
Hsp90[3], and cell-based Her2 degradation assay in a consecutive manner. 
As a result, five compounds were identified as novel Hsp90 inhibitors 
which exert anti-proliferative effect on MCF-7 breast cancer cells. Three 
inhibitors share the same scaffold of 3-phenyl-2-styryl-3H-quinazolin-4-one 
structure[4], and the other two compounds contain novel scaffolds of 
pyrimidine-2,4,6-trione and 4H-1,2,4-triazole-3-thiol[5]. Their binding 
modes to Hsp90 ATP binding pocket were analyzed using AutoDock 
program combined with molecular dynamics (MD) simulations. These 
results exemplify the usefulness of the structure-based virtual screening 
with molecular docking in drug discovery. We also demonstrate a novel 
tool for drug discovery, utilizing carboxylated polypyrrole nanotube 
(CPNT) field-effect transistor (FET) platform[6]. CPNTs were fabricated, 
immobilized on electrode, and functionalized with Hsp90. The resulting 
platform paved a way for rapid, sensitive, and specific detection of 17-AAG 
binding to Hsp90 in real-time, showing its potential as a convenient and 
sensitive interaction detector in a wide range of biological and 
pharmaceutical research area.  
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GroEL is an Escherichia coli chaperonin, which is composed of two 
heptameric rings. GroEL interacts with its cofactor GroES and assists 
protein folding in an ATP-dependent manner. It has been generally believed 
that an asymmetrical 1:1 GroEL-GroES complex (bullet-shaped complex) is 
only a functional form in the reaction cycle. Contrary to the belief, we have 
revealed that a symmetrical 1:2 GroEL-GroES complex (football-shaped 
complex) can be formed in the presence of denatured protein. However, the 
dynamics of GroEL-GroES interaction including a football-shaped complex 
is still unclear. To address this issue, we investigated the GroEL-GroES 
interaction using a single-molecule assay with zero-mode waveguides. We 
demonstrated that the first binding GroES does not always dissociate from 
the football-shaped complex prior to the second binding GroES. We also 
found the existence of two parallel pathways in the interaction cycle. These 
findings bear on the mechanism of protein folding mediated by GroEL. The 
implications for the cycle are discussed. 
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The molecular chaperone Hsp90 is a global cellular regulator critical for the 
folding and activation of diverse client proteins, including multiple kinases 
and transcription factors. Numerous studies demonstrate that inhibition of 
Hsp90 dramatically reduces both the accumulation and/or activity of client 
proteins. In contrast, we found that Saccharomyces cerevisiae expressing a 
mutant form of Hsp90 accumulate elevated amounts of Hbt1, a protein 
required for polarized morphogenesis. Increased Hbt1 expression was due 
to an approximate 10-fold increase in HBT1 mRNA expression in the 
Hsp90 mutant cells. Increased HBT1 expression was linked to derepression 
of Adr1, a transcription factor involved in regulating the transcriptional 
changes that accompany depletion of glucose. We used microarray analysis 
to determine the additional transcriptional changes occur in Hsp90 mutant 
cells. Approximately 150 genes exhibited a 4-fold or greater increase in 
expression in the Hsp90 mutant cells. In contrast, less than 10 genes were 
strongly down-regulated. Although some of the upregulated genes 
expressed are indicative of a general stress response, most of the 
upregulated genes are normally expressed at high levels only under 
conditions such as sporulation, starvation or stationary phase. Together, 
these results indicate that Hsp90 regulates transcriptional regulatory 
pathways that reflect the growth state of the cell. In particular, Hsp90 
appears to play a major role in preventing transcription of genes not 
required for optimal growth under normal laboratory conditions. 
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Molecular chaperones assist cellular protein folding as well as oligomeric 
complex assembly. In eukaryotic cells, several chaperones termed CLIPS 
are transcriptionally and physically linked to ribosomes and are implicated 
in protein biosynthesis. Here we show that a CLIPS network comprising 
two ribosome-anchored J-proteins, Jjj1 and Zuo1, function together with 
their partner Hsp70 proteins to mediate the biogenesis of ribosomes 
themselves. Jjj1 and Zuo1 have overlapping but distinct functions in this 
complex process involving the coordinated assembly and remodeling of 
dozens of proteins on the ribosomal RNA. Both Jjj1 and Zuo1 associate 
with nuclear 60S ribosomal biogenesis intermediates and play an important 
role in nuclear rRNA processing leading to mature 25S rRNA. In addition, 
Zuo1, acting together with its Hsp70 partner SSB, also participate in 
maturation of the 35S rRNA. Our results demonstrate that, in addition to 
their known cytoplasmic roles in de novo protein folding, some ribosome-
anchored CLIPS chaperones play a critical role in nuclear steps of ribosome 
biogenesis. 
 64 
A CHAPERONE PROTEIN MODULATES THE HOMEOSTATIC 
REGULATION OF THE UNFOLDED PROTEIN RESPONSE 
 
Hana El-Samad  
 
University of California-San Francisco, Department of Biochemistry and 
Biophysics, San Francisco, CA, 94158 
 
The unfolded protein response (UPR) is an intracellular signaling pathway 
that maintains proper function of the endoplasmic reticulum (ER), 
counteracting variable stresses that impair folding of proteins entering the 
secretory pathway. In that capacity, the UPR is at the center of many normal 
physiological responses and pathologies.Although the UPR is thought to be 
a homeostat that finely tunes ER protein folding capacity and ER abundance 
according to need, the mechanism by which the core ER stress sensor Ire1 
is activated in response to unfolded proteins and the role that the ER 
chaperone protein BiP plays in Ire1 regulation have remained unclear. Here 
we show that the UPR matches the response output to the magnitude of the 
stress by regulating the duration of Ire1 signaling. BiP binding to Ire1 
serves to desensitize Ire1 to low levels of stress and promotes its 
deactivation when favorable folding conditions are restored to the ER. 
Using quantitative dynamic measurements guided by careful computational 
modeling, we demonstrate that, mechanistically, BiP achieves these 
functions by sequestering inactive Ire1 molecules, thereby providing a 
barrier to oligomerization and activation, and a stabilizing interaction that 
facilitates de-oligomerization and deactivation. Thus, BiP binding to or 
release from Ire1 is not instrumental for switching the UPR on and off as 
previously posed. By contrast, BiP ensures an appropriate response to 
restore protein folding homeostasis to the ER by modulating the sensitivity 
and dynamics of Ire1 activity. 
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There have been several hypotheses regarding the mechanism of chaperonin 
function. Here, I will describe a novel hypothesis that chaperonins affect 
protein folding by an indirect mechanism, i.e. by affecting the water 
surrounding the protein during refolding within chaperonins. While much 
work has gone into understanding the role of water in the bulk, water in 
confined biological spaces (such as the ribosome exit tunnel or chaperonins) 
is still poorly understood. It is natural to consider that there will be 
deviations from bulk-like behavior, but how? What are the differences, how 
pervasive are the changes? And how does the change in water impact 
protein folding and function. I will present results from recent simulations 
and theory that suggest that non-bulk-like deviations play a role in protein 
folding and function in the cell. For example, simulations of water inside of 
the a chaperonin has predictive properties for chaperonin function. Also, 
simulations of the water inside ribosomes leads to specific predictions to the 
nature of the nascent peptide at its earliest stages of folding. I will conclude 
with a discussion of how this nature of water changes may suggest a general 
change in how we should consider water in vivo. 
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Hsp90 is a highly conserved molecular chaperone which contributes to the 
activation or conformational maturation steps of hundreds of specific client 
proteins. This activation process is strictly regulated at several levels. 
Intrinsically, the ATPase activity of Hsp90 is decelerated as a result of the 
slow conformational changes leading to the ATP hydrolysis competent 
state. In eucaryotes, Hsp90 associates with a distinct set of co-chaperones, 
some of which function as inhibitors or activators of the ATPase activity. 
Recently, it was shown that some of these co-factors target distinct 
conformational intermediates of Hsp90. In addition, posttranslational 
modifications of Hsp90 such as acetylation, nitrosylation and, importantly, 
phosphorylation provide an additional level of regulation. Here, we report a 
comprehensive analysis of yeast Hsp90 phosphorylation including 
identification of the sites modified in vivo by a combination of 
phosphopeptide enrichment and high-resolution mass spectrometry. The 
mechanistic consequences of Hsp90 phosphorylation were analyzed by 
phospho-mimetic Hsp90 mutants in vivo and in vitro. Our results show that 
the effect of phosphorylation on Hsp90 function depends strongly on the 
position of the phospho-sites in the protein structure and that distinct steps 
in the chaperone cycle of Hsp90 are affected. 
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In parallel with evolutionary developments, the Hsp90 molecular chaperone 
system shifted from a simple prokaryotic factor into an expansive network 
that includes a variety of cochaperones. We have taken high-throughput 
genomic and proteomic approaches to better understand the abundant yeast 
p23 cochaperone Sba1. Our work uncovered an unexpected Sba1 network 
that displayed considerable independence from known yeast Hsp90 (Hsp82) 
clients. Our data also revealed a broad nuclear role for Sba1, contrasting 
with the historical dogma of restricted cytosolic activities for chaperones. 
Validation studies demonstrated that Sba1 was required for proper Golgi 
function, had a role in ribosome biogenesis and was necessary for efficient 
DNA repair from a range of mutagens. Importantly, we found that the roles 
were conserved since mammalian p23 also affected these same pathways. 
Our high-throughput and corroborative studies demonstrate that the 
Sba1/p23 cochaperone serves a broad physiological network and functions 
both in conjunction with and sovereign to Hsp82/Hsp90. 
 
To understand how a p23 cochaperone intersects with a nuclear protein we 
followed up on the synthetic lethal genetic interaction between sba1Δ and 
gcn5Δ. Normally, GCN5 encodes for a histone acetyltransferase protein. 
Surprisingly, the connection does not involve chromatin events. Rather, we 
found that p23 and Gcn5 form a regulatory circuit that coordinately 
regulates the DNA-bound state of diverse proteins. Using Heat Shock 
Factor 1 (HSF1) as a model target, we observed that both p23 and Gcn5 
inhibited HSF1 DNA binding activity. p23 initiated disassembly of DNA-
bound HSF1 while Gcn5 prolonged the dissociated state by acetylating a 
lysine residue within the DNA binding domain. In addition, p23 can control 
the enzymatic activity of Gcn5, which likely serves to close the regulatory 
circuit. Notably, p23 and Gcn5 affected the DNA binding activities of a 
variety of proteins including other transcription factors and proteins 
required for DNA replication and telomere maintenance. Our data support a 
model in which p23 and Gcn5 constitute a general system for modulating 
protein DNA dynamics across the genome. 
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Species can remain unaltered for long evolutionary periods, but can also 
undergo rapid diversification. However, mechanisms that either promote 
stasis or facilitate change remain enigmatic. The protein chaperone Hsp90 
has been hypothesized to do both. Hsp90 facilitates maturation of 
metastable regulators of growth and development, but is expressed at a 
higher level than is normally required to fulfill these functions. This 
reservoir of Hsp90 can promote stasis by buffering genetic variation, 
allowing it to accumulate without phenotypic consequences. When 
environmental stress compromises the protein folding capacity of the 
organism, phenotypes arising from this variation are revealed. Hsp90 can 
also facilitate change by potentiating variation. In this case, new mutations 
depend on the reservoir of Hsp90 chaperone activity to produce their 
phenotypes. Such traits disappear when environmental stress compromises 
that reservoir. This hypothesis has been controversial because the adaptive 
value of Hsp90 buffered and potentiated variation is unclear. Indeed, only 
one such variant is known to be beneficial and certain buffered traits appear 
monstrous. Here, we establish that the interface between Hsp90 and 
environmental stress profoundly influences the phenotypic manifestation of 
natural genetic variation. In ecologically diverse strains of Saccharomyces 
cerevisiae a vast array of traits were buffered or potentiated by Hsp90. 
These traits were frequently beneficial to growth. We mapped hundreds of 
quantitative trait loci for such traits and dissected the causative 
polymorphisms for four (three coding, one regulatory). A simple change in 
growth temperature elicited the same broad phenotypic changes as Hsp90 
inhibition, demonstrating the strong link Hsp90 provides among protein 
homeostasis, environmental stress, and the manifestation of genetic 
variation. Across the many tens of thousands of polymorphisms present in 
48 ecologically diverse strains, selective manipulation of the reservoir of 
Hsp90 chaperone activity and changes in growth temperature each 
improved the correlation between genotype and phenotype, strongly arguing 
that Hsp90 has influenced genome evolution in this organism. 
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All organisms must be capable of adaptive responses that promote survival 
in stressful environments. While much attention has been paid to stress 
responses acting at a cellular level, little is known of whole organism 
responses to stress. In C.elegans, dispersal is a highly adaptive behavioral 
solution to the imposition of environmental stress. Experimentally, dispersal 
is observed as evacuation of the bacterial lawn. Reasoning that artificial 
inactivation of basic cellular processes might simulate the effects of 
environmental stress, we screened a library of ~3000 essential genes in 
search of gene knockdowns that elicit the dispersal response – despite the 
absence of an actual environmental stressor. We found that perturbation of 
many fundamental cellular processes elicits a robust dispersal response. 
These processes include transcription, translation, DNA repair, 
mitochondrial function, pH homeostasis, and protein homeostasis. Much of 
the protein homeostasis machinery (Hsp4, Hsp6/Hsp60, Hsp90, the CCT 
complex and the proteasome) acts upstream of dispersal behavior. Through 
examination of GFP stress reporters, we found that many of these gene 
knockdowns activated known cellular responses. A subset of gene 
knockdowns failed to activate any of our reporters, possibly indicating the 
discovery of previously unknown stress response pathways. An additional 
targeted screen implicated the hedgehog signaling pathway, nuclear 
hormone receptors, neuropeptides and G-protein coupled receptors 
(GPCRs) in dispersal behavior. These molecules may perform endocrine 
functions in stress adaptation. Epistasis analysis showed that insulin 
signaling and multiple FOXO transcription factors are differentially 
required within specific functional classes for dispersal. Distinct genetic 
requirements within protein homeostasis indicate that different protein 
folding and turnover pathways control dispersal behavior through a 
complex combination of mechanisms. Experiments with genetic lines in 
which RNAi is restricted to specific tissues showed that essentially any 
major tissue can produce an endocrine stress signal. We propose that 
dispersal behavior is a programmed component of stress adaptation that 
may be just as critical to organism survival as chaperone activity and other 
cellular responses under noxious environmental conditions. 
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The heat shock protein 70 (Hsp70) molecular chaperone plays a central role 
in protein homeostasis, governing folding, transport and quality control of 
substrate polypeptides. Hsp70 works in conjunction with other chaperone 
machines, including Hsp90, in a substrate specific manner. The Hsp110 
chaperone Sse1 is required for the activity of many Hsp90 client proteins in 
budding yeast, and functions as a nucleotide exchange factor (NEF) for 
cytosolic Hsp70. However, the precise roles Sse1 plays in client maturation 
through the Hsp70/Hsp90 chaperone system are not fully understood. We 
find that upon pharmacological inhibition of Hsp90, a model protein kinase, 
Ste11∆N, is rapidly degraded while heterologously expressed 
glucocorticoid receptor (GR) remains stable. Hsp70 binding and 
acceleration of nucleotide exchange by Sse1 was required for productive 
maturation of GR and mating pathway signaling through endogenous Ste11, 
as well as to promote Ste11∆N degradation. Overexpression of another 
functional NEF only partially compensated for loss of Sse1 in facilitating 
GR maturation and Ste11∆N degradation, while the paralog Sse2 fully 
restored both activities. Sse1 was required for ubiquitinylation of Ste11∆N 
upon Hsp90 inhibition, providing a mechanistic explanation for its role in 
substrate degradation. Hsp110 chaperones may play a global role in 
regulating protein degradation as ubiquitinylation of misfolded newly 
synthesized proteins was likewise impaired in sse1∆ cells. Sse1/2 co-
purified with Hsp70 and other proteins comprising the “early-stage” Hsp90 
complex, and was absent from “late-stage” Hsp90 complexes characterized 
by the presence of Sba1/p23. Together these findings support a model in 
which Hsp110 chaperones contribute significantly to the decision made by 
Hsp70 to fold or degrade a client protein. 
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The cell exploits the composition and dynamics of protein homeostasis 
(proteostasis) networks1-3 to generate and maintain the proteomic profiles in 
cytosol, and for folding and function of proteins trafficking the exocytic and 
endocytic pathways in complex cell, tissue and host environments. It is now 
apparent that in folding disease and during aging, protein misfolding 
challenges the proteomic composition of the cell and tissue, compromising 
human health and longevity. A major goal for biologists is to understand the 
composition, protein-protein interactions and signaling mechanisms that 
direct the operation of cell that preserves a physiological proteomic 
platform. The capacity of small molecules (proteostasis 
regulators/pharmacological chaperones) to harness the activity of a tunable 
range of PN components to protect biology from a wide range of folding 
diseases highlights the potential of managing proteostasis to benefit human 
health. 
1(Science (2008) 319:916; 2Ann. Rev. Biochem. (2009) 78:959; 3FEBS Lett. 
(2009) 583:2639) 
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The unfolded protein response (UPR) is an intracellular signaling pathway 
that maintains proper function of the endoplasmic reticulum (ER), 
counteracting variable stresses that impair folding of proteins entering the 
secretory pathway. As such, the UPR is thought to be a homeostat that 
finely tunes ER protein folding capacity and ER abundance according to 
need. The mechanism by which the core ER stress sensor Ire1 is activated 
in response to unfolded proteins and the role that the ER chaperone protein 
BiP plays in Ire1 regulation have remained unclear. We show that the UPR 
matches the response output to the magnitude of the stress by regulating the 
duration of Ire1 signaling. BiP binding to Ire1 serves to desensitize Ire1 to 
low levels of stress and promotes its deactivation when favorable folding 
conditions are restored to the ER. We propose that, mechanistically, BiP 
achieves these functions by sequestering inactive Ire1 molecules, thereby 
providing a barrier to oligomerization and activation, and a stabilizing 
interaction that facilitates de-oligomerization and deactivation. Thus BiP 
binding to or release from Ire1 is not instrumental for switching the UPR on 
and off as previously posed. By contrast, BiP ensures an appropriate 
response to restore protein folding homeostasis to the ER by modulating the 
sensitivity and dynamics of Ire1 activity. 
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Proper protein folding in the cell requires a delicate balance of diverse 
processes ranging from protein translation and degradation to control of 
membrane lipid content. As imbalance in these processes leads to stress and 
disease, it is essential to develop a comprehensive understanding of how 
they are coordinated to allow efficient protein folding. To do this, we have 
developed a strategy to (1) identify important players in a given process 
using a genetic screen, and then (2) make quantitative pairwise measures of 
genetic interactions among these players to create an organizational map. In 
yeast, this strategy has led to a remarkable array of functional information, 
including the identification of a conserved transmembrane protein complex 
and a mechanism for insertion of tail-anchored proteins. We are now 
extending this approach to metazoans using RNAi to identify genes that 
when compromised lead to protein misfolding. Toward this end, we have 
developed high-density lentiviral shRNA libraries that are easily adapted to 
allow knockdown of pairs of genes. Coupled with deep sequencing, these 
libraries allow measurement of genetic interactions in a high-throughput, 
simplified system that can be tailored to the study of any process of interest. 
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Steroid hormone receptors require the ordered assembly of various 
chaperone and cochaperone proteins in order to reach a functional state. The 
final stage in the receptor maturation process requires the formation of a 
mutimeric complex consisting of an Hsp90 dimer, p23, and one of several 
large immunophilins. Studies conducted previously demonstrated that the 
large immunophilin FKBP52 acts to potentiate glucocorticoid, androgen, 
and progesterone receptor signaling pathways. Although we have made 
progress in identifying regions of functional importance on FKBP52, the 
site of interaction between FKBP52 and the receptors remains to be 
elucidated. The aim of these studies was to identify and characterize 
FKBP52-specific inhibitors that would not only serve as tools for the 
pharmacological analysis of FKBP52-receptor interactions, but may also 
lead to novel drugs with significant therapeutic potential. A modified 
receptor-mediated reporter assay in yeast was used to screen a natural 
compound library for FKBP52 inhibitors, which led to the identification of 
multiple hits. Structure activity relationship studies using the yeast-based 
assays led to the characterization of fifteen additional inhibitors, some of 
which display dramatically increased potency. Surface plasmon resonance 
studies confirmed that these inhibitors disrupt FKBP52 function through 
interaction with the AR hormone binding domain. In addition, scintillation 
proximity binding and fluorescence polarization assays demonstrated that 
the compounds bind to a previously unrecognized regulatory surface on the 
AR LBD termed BF3. Interestingly, mutations within the BF3 surface lead 
to increased dependence on FKBP52 for normal function. Preliminary 
assays in LNCaP cells demonstrated that the compounds inhibit Prostate-
Specific Antigen expression and androgen-dependent proliferation. In 
summary we have identified molecules that inhibit FKBP52 regulation of 
AR function and represent an exciting new approach for the treatment of 
prostate cancer. In addition, these studies provide new insights into 
FKBP52-AR interactions. 
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Heat shock proteins 70 (Hsp70) are ubiquitous and conserved family of 
ATP-dependent molecular chaperones involved in plethora of cellular 
processes. They bind unfolded substrates in their substrate binding domain 
in a reaction regulated by nucleotides bound to nucleotide bound domain 
and modulated by interacting cochaperones. In mitochondria, a member of 
the Hsp70 family is involved in translocation of proteins into the organelle, 
their subsequent folding and also in biogenesis of Fe-S clusters. The 
conformational changes underlying its ATP-dependent cycle and their 
dynamics are key to understanding its numerous functions, yet are poorly 
understood. Here we used fluorescence spectroscopy to analyze, in real time 
and at single molecule resolution, the effects of nucleotides and 
cochaperones on the conformation of Ssc1, a major mitochondrial Hsp70 of 
yeast. The results of this analysis and their implications will be presented. 
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Hereditary protein conformational disorders are often associated with the 
expansion of polyQ repeats in the expressed proteins. These expansions 
lead to protein misfolding, neuronal toxicity and eventually cell death. 
While a definitive cure for these diseases has not been found, promising 
research has shown that enhanced expression of protein chaperones, 
mediated through the activation of the transcription factor HSF1, can 
suppress polyQ-dependent protein misfolding and prevent neurotoxicity. As 
such, pharmacological activation of HSF1 is likely to become an important 
part in the treatment of protein conformational disorders. However, our 
understanding of the biochemical mechanisms that regulate HSF1 activity 
remain limited. Our previous data show that human HSF1, when expressed 
in Saccharomyces cerevisiae, is constitutively maintained in a repressed 
state and unable to complement for the loss of the essential yeast HSF. 
Interestingly, many of the proteins previously linked to HSF1 repression in 
mammalian cells are conserved in yeast. Therefore, we hypothesize that 
gaining an understanding of the mechanisms by which human HSF1 is 
repressed in yeast will further our understanding of HSF1 regulation in 
metazoans. To explore these mechanisms we have utilized a variety of 
biochemical, genetic, and pharmacological approaches to identify novel 
hHSF1 repressor proteins. Among the negative regulators of HSF1 that we 
have identified are several protein kinases not previously linked to HSF1 
repression. We have also developed a high-throughput screen to identify 
novel small molecule activators of human HSF1 in yeast and have identified 
HSF1A, a unique molecule that activates HSF1 in metazoan cells and 
promotes the expression of Hsp70 and other protein chaperones in an 
HSF1-dependent manner. In addition, we show that HSF1A ameliorates 
protein misfolding and cell death in polyQ-expressing neuronal precursor 
cells and protects against cytotoxicity in a fly model of polyQ-mediated 
neurodegeneration. We show that HSF1A interacts with components of the 
TRiC/CCT complex, suggesting a potentially novel regulatory role for this 
complex in modulating HSF1 activity. 
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Protein folding in the endoplasmic reticulum (ER) is matched to the 
everchanging flux of proteins through the secretory pathway by the 
unfolded protein response (UPR) – a tripartite intracellular signaling 
pathway that transcriptionally and translationally regulates ER protein 
folding pathways. Signaling within the most conserved branch of the UPR 
is initiated by the sequence-specific cleavage of HAC1/XBP1 mRNA by the 
ER-stress induced kinase-endoribonuclease IRE1. IRE1 activation is 
directly linked to the ER folding environment through a cascade that is 
initiated by the stress-induced oligomerization of IRE1’s lumenal domain. 
The stress signal is propagated across the ER membrane to the cytosol 
through autophosphorylation of the IRE1 kinase domain that allows for the 
high affinity binding of ADP to the conventional nucleotide binding cleft of 
the kinase and subsequent stabilization of the active dimeric/oligomeric 
conformation of the endoribonuclease domain. We have discovered a novel 
ligand binding pocket in the cytosolic domain of yeast IRE1 that can be 
targeted to selectively modulate IRE1 signaling. A co-crystal structure of 
IRE1 cytosolic domain engaged by both ADP and the flavonol quercetin 
reveals quercetin binding to an unanticipated ligand binding site at the 
dimeric interface of IRE1’s Kinase-Extension-Nuclease domain. Ligand 
binding to this pocket enhances IRE1 endoribonuclease activity in vitro and 
in vivo and potentiates the effect of ADP binding at the conventional 
nucleotide binding site. Rational mutagenesis of IRE1 supports the 
functional relevance of the structural model of IRE1 activation through 
occupancy of this novel binding site and suggests the possibility for 
developing tools to explore the engagement of this pocket by endogenous 
ligand and other small molecules that may tune the IRE1 branch of the UPR 
independent of the state of the ER lumen. 
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Protein misfolding and aggregation is known to be a major contributor to 
neuropathogenic disease development. The causality between intracellular 
protein aggregation and the intrinsic thermodynamic stability of proteins 
has been shown by multiple studies. Indeed, single point mutations in the 
genes coding for e.g. superoxide dismutase and Alzheimer’s Aß peptide can 
trigger the formation of unfolded or alternately folded states and 
consequently affect the aggregation properties of these proteins 
dramatically. Alternately, extension of polyQ-stretches in proteins beyond a 
critical threshold leads to the formation of toxic species and intracellular 
aggregates, correlating to the development of a neuronal phenotype. The 
connection between protein aggregation and cellular damage is still unclear 
and the cellular factors and networks, directly governing this process are yet 
to be resolved. Using a novel aggregation-prone protein system, our study 
investigates how cellular proteins interact to affect aggregate and toxic 
species formation in vivo. Furthermore, we aim to identify cellular 
processes which are harmed by the occurrence of aggregates or aggregation 
intermediates. 
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Stress in the Endoplasmic Reticulum (ER) prompts cells to mount a 
transcriptional response, which is collectively known as the Unfolded 
Protein Response (UPR). While significant advances have been made 
regarding the pathways leading to the induction of ER chaperones and 
quality control genes, the pro-apoptotic branch of the UPR remains poorly 
understood. A better understanding of this latter branch may be particularly 
significant in understanding many degenerative diseases that manifest only 
after the death of ER-stressed cells. To study this pro-apoptotic branch of 
the UPR, we devised a facile assay system in which the ER of the 
developing Drosophila eye disc cells were overloaded with mutant 
Rhodopsin-1 that serves as a model for Retinitis Pigmentosa. The condition 
activated ER stress reporters, induction of pro-apoptotic genes reaper and 
hid, massive apoptosis and a partial ablation of the adult eye structure. 
Consistently, the elimination of these pro-apoptotic genes suppressed 
apoptosis caused by ER-stress. We used this apoptosis phenotype as a basis 
to perform a genetic screen and found Drosophila Mekk1, a MAP KKK 
family member, as a strong modifier of this phenotype. Specifically, 
apoptosis induced by misexpression of mutant Rh-1 was aggravated by 
overexpression of Mekk1, while the loss-of function mutant of Mekk1 
suppressed the cell death. On the other hand, Mekk1 did not affect cell 
death caused by polyglutamine proteins, which form aggregates in the 
cytoplasm. In cultured cells, Mekk1 was required to activate JNK and p38 
signaling pathways. Consistently, loss-of JNK (basket) function also 
blocked ER-stress-induced apoptosis in Drosophila eye discs. While 
showing a strong effect on apoptosis, Mekk1 did not affect the level of 
mutant Rh-1 expression or ER-stress markers, supporting the idea that it 
acts as a signaling molecule in the cytoplasm without directly affecting 
misfolded proteins in the ER. Additional epistasis experiments placed 
Mekk1/JNK upstream of the pro-apoptotic genes, reaper and hid. These 
findings indicate that the Mekk1/JNK genes constitute parts of a pro-
apoptotic UPR branch that mediates ER-stress-triggered apoptosis. 
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Rhodopsin associated retinal degeneration, known as retinitis pigmentosa 
(RP), is a protein conformational disorder. The clinically common mutation, 
P23H, results in a misfolded protein fraction that is predominantly retained 
in the ER. We have previously shown that pharamacological chaperones 
can significantly improve the efficiency of folding and trafficking of this 
protein. As part of our ongoing studies, we have manipulated the cellular 
folding environment with histone deacetylase inhibitors (HDIs) including 
valproic acid (VPA) and trichostatin A (TSA). At low concentrations both 
HDIs resulted in the 50-80% increase in the folded rhodopsin. With 
increasing concentrations, however, the yields of folded P23H rhodopsin 
were significantly reduced, while the yields of WT rhodopsin increased. 
Further, the retinas of P23H mice treated with VPA had approximately 30-
40% increase in the amounts of folded rhodopsin, which was statistically 
significant over the placebo treated animals. There was no substantial effect 
of VPA on the littermate controls or C57/B6 mice. In the retinas of S344ter 
opsin rats treated with VPA, the outer nuclear layer (ONL) had 2-3 rows of 
photoreceptor nuclei. In contrast, animals treated with PBS had only 1 row 
of nuclei in the ONL of the same retinal region. Separate quantitative data 
showed that the ONL thickness in treated animals was significantly higher 
than the controls. Finally, we treated RP patients with VPA, 250 mgs 2-3 
times per day. The visual fields (VF) of 5 of 7 patients increased with 
treatment. In one case, the improvement in functioning retinal area was 
confirmed at two time points (23 and 27 weeks). Of the 13 eyes examined, 
9 eyes had improved visual field on treatment, two eyes had decreased 
visual field and two eyes experienced no change with an overall average 
increase of 11%. Assuming typical loss in VF area without treatment, this 
increase in VF was statistically significant (p<.02). An average decrease in 
logMAR scores was seen in these 13 eyes, which was significant (p<.02) 
assuming no loss in acuity without treatment. Collectively, this work 
provides evidence that by manipulating the cellular folding environment 
with HDIs in both cellular and mice models, it is possible to develop 
rational therapies for PCDs like rhodopsin-associated RP. 
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A number of neurodegenerative diseases are caused by the toxic gain-of-
function of proteins with expanded polyglutamine (polyQ) tracts. However, 
the underlying mechanisms of toxicity are less well understood. One 
intriguing aspect of polyQ disorders is that despite the often ubiquitous 
expression of disease-associated polyQ proteins in neurons, these proteins 
differentially affect neuronal subtypes, resulting in unique disease 
pathologies. This points to the sequences flanking the polyQ tract driving 
important elements of toxicity, rather than the polyQ tract alone being 
responsible for disease. To elucidate the impact of sequences flanking the 
polyQ tract in disease associated proteins, we have expressed three such 
proteins (Huntingtin, the human Androgen Receptor, and Ataxin-3) with 
and without expanded polyQ tracts in the genetic model system C. elegans. 
We previously showed that when polyQ peptides are translationally fused to 
YFP and expressed in different tissues of C. elegans the resultant chimeric 
protein displays polyQ length- and age-dependent aggregation/toxicity. Our 
new models that take into account the effect of flanking protein sequences 
have revealed that different polyQ-containing proteins yield unique 
aggregation patterns and biophysically distinct aggregates in C. elegans. 
This is likewise the case even when comparing different disease-associated 
N-terminal fragments of Huntingtin, the protein affected in HD patients. 
With the availability of C. elegans genetic tools, such as genome-wide 
RNAi, we are molecularly dissecting the mechanisms underlying this effect 
of flanking protein sequences on polyQ protein aggregation. 
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Cross-β protein aggregates (amyloids) are associated with a variety of 
neurodegenerative disorders such as Alzheimer, Parkinson, Huntington and 
Creutzfeldt-Jacob diseases. Yeast [PSI+] is a self-perpetuating (prion) 
amyloid-based isoform of the translation termination factor eRF3 (Sup35) 
of Saccharomyces cerevisiae that serves as a model for studying amyloid 
formation and propagation. [PSI+] is eliminated by overproduction of the 
disaggregating chaperone Hsp104. A screen for mutants antagonizing 
excess Hsp104-dependent elimination of [PSI+] has produced mutant alleles 
of the genes GET2 and TOM1. Deletion of each of these genes also 
antagonized the Hsp104-mediated prion loss. Neither mutations nor 
deletions of GET2 and TOM1 influenced the Hsp104 function in 
thermotolerance, indicating that their effects are specific to the interaction 
of Hsp104 with amyloid aggregates.  
Get2 is a component of the GET (Guided Entry of Tail-Anchored proteins) 
pathway responsible for the trafficking of tail-anchored (TA) proteins to the 
ER membrane. Deletions of other components of the GET pathway also 
counteracted [PSI+] elimination by excess Hsp104. Disruption of the GET 
pathway leads to accumulation of aggregated TA proteins (and some GET 
proteins) in the cytoplasm. Preliminary data suggest that aggregates of TA 
and GET proteins interact with amyloids and/or co-chaperones, thus 
restricting the ability of Hsp104 to promote prion disaggregation.  
Tom1 is a HECT domain ubiquitin ligase (E3 enzyme). Our previous data 
(Allen et al., 2007 JBC 282:3004-3013) implicated the ubiquitin 
conjugating (E2) enzyme Ubc4 in modulating the effects of excess Hsp104 
on [PSI+]. The role of Ubc4 or Tom1 in the direct ubiquitination of Sup35 
has not been supported. Possibly, components of ubiquitin system influence 
a prion via ubiquitination of the auxiliary factors involved in prion 
propagation.  
Overall, our data demonstrate that chaperone effects on prions are 
modulated by other aggregated and misfolded proteins present in the yeast 
cell. As both GET and ubiquitination pathways are involved in the response 
for the metal, redox and temperature stresses, our results point to the 
possible mechanisms mediating effects of environmental factors on 
amyloids. 
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p97/VCP, a member of AAA(+) ATPase, is involved in diverse cellular 
processes including endoplasmic reticulum-associated degradation (ERAD), 
membrane fusion, transcriptional activation, cell-cycle and apoptosis as one 
of the most abundant proteins in the cell. It interacts with various adaptors 
for activity in different biochemical contexts. Among these adaptors are 
UBX and UBD domains. Fas-associated factor 1 (FAF1), a multifunctional 
protein that is associated with Fas-mediated apoptosis, NF-kB signaling and 
endoplasmic reticulum-associated degradation (ERAD), contains a UBX 
domain at the C-terminal, and is reported to interact with p97/VCP. The 
crystal structures of UBX alone and bound to the N-terminal domain of 
p97/VCP have been determined and details will be described. 
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Aberrancy of protein folding in the endoplasmic reticulum (ER) is known to 
trigger a cellular signaling pathway to induce various genes functioning in 
the ER. An ER-located transmembrane protein Ire1 is a key component of 
this cellular response, namely the unfolded protein response (UPR) or the 
ER stress response. By using yeast system, we and others previously 
revealed molecular steps by which unfolded proteins activate Ire1. BiP, 
which is a major ER-located molecular chaperone, binds to and represses 
Ire1. Upon accumulation of unfolded proteins in the ER, BiP dissociates 
from Ire1, and Ire1 forms high-order homo-oligomers. Unfolded proteins 
then directly interact with the Ire1 oligomers, which leads to full induction 
of the UPR. However, it has not been clear how other stress stimuli, 
including depletion of inositol from medium, activate Ire1. Our analyses of 
yeast Ire1 mutants presented here indicate that Ire1 neither forms high-order 
homo-oligomers nor directly associates with unfolded proteins upon its 
activation under some stress conditions. BiP dissociation also seems 
unnecessary. We then propose “aberrancy of membrane” activates Ire1 by a 
mechanism which is different from that for unfolded proteins. Considering 
also a wide variety of UPR target genes, the UPR is less likely to be only 
“by and for” unfolded proteins. 
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Prions are, in simplest terms, infectious proteins. These pathological entities 
arise from normal, functional proteins by spontaneously assuming alternate 
conformations and engaging in a self-templating mode of replication. In 
mammals, the formation and persistence of prions and related amyloid 
proteins have devastating consequences, being largely incurable and 
typically lethal. Countless investigations have indicated that a complex and 
essential relationship exists between cellular chaperone machinery and the 
transition between various physical stages of prion growth and 
development. Our current interest focuses on the chaperones that drive the 
prion “life cycle”, specifically members of the Hsp40, Hsp70 and Hsp100 
families. Numerous reports have indicated vital roles for the Ssa group of 
Hsp70s as well as Hsp40 cochaperone partners like Sis1p and Ydj1p. Past 
genetic screens have yielded chaperone mutants that have significant effects 
on various yeast prions. One notable mutant identified in previous work is 
the L483W mutant of SSA1, which is of considerable interest due to its 
apparent inability to stably host the yeast prion [PSI+]. In order to identify 
mutants of the SIS1 gene that negate the weakened [PSI+] phenotype 
exhibited by the L483W (SSA1-21) mutant and to ultimately uncover 
mechanistic details of the relationship between proteins of the Hsp70 and 
Hsp40 families relative to yeast prions, a series of Sis1p truncations and 
amino acid substitutions were analyzed through a genetic screen in 
conjunction with both wild type and Ssa1p mutants. Through this analysis, 
we show that the dimerization domain of Sis1p is essential for weakening 
[PSI+] in the L483W mutant and for eliminating [PSI+] in cells 
overexpressing Hsp104p. Results also indicate that the glycine/methionine-
rich (G/M) region of Sis1p operates in an essential capacity to confer 
viability to the cell in the presence of the prion. The latter of these results is 
shown to be independent of soluble Sup35p levels and represents one of 
only a few conditional lethality mutants in yeast known to be contingent 
upon a prion. 
 86 
LUCIFERASE AS A FOLDING SENSOR FOR ACUTE AND CHRONIC 
STRESS CONDITIONS IN C. ELEGANS 
 
Janine Kirstein-Miles, Richard I Morimoto  
 
Northwestern University, BCBMB, 2205 Tech Drive, Evanston, IL, 60208 
 
An imbalance in protein homeostasis can result in severe molecular damage 
to the cell, dysregulation of key tissues leading to pathology, and 
susceptibility to neurodegenerative diseases. Adaptation and survival 
requires an ability to sense damaged proteins and to coordinate induction of 
protective stress response pathways, chaperones and clearance networks. To 
better understand the mechanistic details of the proteostasis network it 
would be valuable to have tools to assess the chaperone capacity upon 
proteotoxic stress. 
My goal is to develop such folding sensors that report on proteostasis in C. 
elegans. Firefly luciferase has been widely used as a model substrate to 
study protein folding, because of its rapid and sensitive bioluminescent 
activity that depends entirely on proper folding. De novo folding as well as 
refolding after chemical or thermal denaturation of this labile protein 
requires the assistance of chaperones, making luciferase an ideal model 
substrate and reporter to assess proteostasis.  
Indeed, I could observe a decline in luciferase activity upon proteotoxic 
challenges induced either by the expression of aggregation prone proteins 
such as polyQ or mutant SOD1 or by exogenous stressors such as heat or 
oxidative stress. However, the most dramatic effect can be observed upon 
aging, indicating that the chaperone capacity decreases along the lifespan. 
To combine the functional read-out of the folding sensor with a visual 
assessment of its folding state, a C. elegans line expressing luciferase fused 
to YFP was created. The expression of luciferase-YFP using different 
promoter constructs allows for visualization and biophysical inspection of 
the luciferase moiety upon proteotoxic challenges in various tissues. I could 
indeed observe a shift from a soluble expression pattern of luciferase-YFP 
under control conditions to the formation of aggregates upon exogenous 
stressors, mirroring the loss of function under these conditions in e.g. body 
wall muscle cells. In addition, luciferase has proven to be also an excellent 
tool to assess inter-compartmental proteostasis reporting on the folding 
capacity of specific organelles upon compartment-specific or cellular 
folding perturbations.  
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Accumulation of misfolded protein causes several neurodegenerative 
disorders, and protein aggregation is closely related to cytotoxicity. Here, 
we examine aggregation and disaggregation of amyotrophic lateral sclerosis 
(ALS)-linked mutant Cu/Zn superoxide dismutase 1 (SOD1). A significant 
portion of mutant SOD1 in the aggregate is mobile and can be exchanged 
with soluble cytosolic SOD1. However, little is known about how SOD1 
exchanges between the aggregate and soluble forms, or the biological 
relevance of this exchange in terms of the toxicity of mutant SOD1. To 
elusidate the dynamics of SOD1 aggregation and disaggregation in human 
cultured cells, fluorescence correlation spectroscopy (FCS) and 
fluorescence resonance energy transfer (FRET), which can analyse the 
oligomerization/aggregation state, were employed. These analysis revealed 
that soluble oligomers and soluble aggregates of mutant SOD1 are 
disaggregated into cytosol during the recovery of proteasome activity. 
Surprisingly, the cellular toxicity by mutant SOD1 was observed during the 
disaggregation process rather than the aggregation process. Thus, the toxic 
characteristics of soluble mutant SOD1 oligomers may differ between the 
disaggregation and accumulating processes.  
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The protein folding and maturation of human RET is adversely affected by 
a range of missense mutations found in patients with Hirschsprung's disease 
(HSCR), a complex multigenic disease. Here, we present the crystal 
structure of the two amino-terminal cadherin-like domains (CLD(1-2)) from 
human RET which adopt a clam-shell arrangement distinct from classical 
cadherins. Surprisingly, CLD1 structural elements and disulphide 
composition are unique to mammals indicating structural diversity within 
higher and lower vertebrate RET CLD regions. We identify two unpaired 
cysteines that predispose human RET to maturation impediments in the 
endoplasmic reticulum and show how "misfolding" mutations, found in 
patients with HSCR disease, are correctly folded and surface localised when 
present in human RET without the unpaired cysteines. This finding was 
applied to establish a quantitative cell-based RET maturation assay that 
offers a biochemical correlate of HSCR disease severity. Our findings 
provide a key conceptual framework and means of testing and predicting 
genotype-phenotype correlations in HSCR. 
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In most cases, proteins adopt a single three-dimensional fold, specifying a 
unique function in the cell. Prions, however, are an exception to this rule, 
adopting more than one fold in vivo. Despite this conformational flexibility, 
prion forms are self-replicating, a mechanism which allows each functional 
or phenotypic state to be stably propagated. This self-replication is mediated 
through an oligomeric complex of prion state protein, which acts as a 
template for the conversion of newly made protein to the prion form. 
Efficient self-replication can only occur, however, if these prion complexes 
are fragmented to generate additional templates and to ensure their efficient 
transmission. In yeast, Hsp104 directs prion self-replication by fragmenting 
prion complexes through its disaggregase activity. Upon deletion of 
Hsp104, prion complexes increase in size and decrease in mobility, leading 
to prion loss or curing by decreasing both the rate of prion self-replication 
and the rate of transmission to daughter cells.  
 
While all known yeast prions are dependent upon Hsp104 for propagation, 
the Sup35/[PSI+] prion is unique in that excess Hsp104 also induces loss of 
the prion form although the molecular mechanism by which this occurs is 
currently unknown. To gain insight into this process, our focus has been to 
investigate the cis and trans requirements for [PSI+] curing by assessing the 
changes in prion complex dynamics that accompany Hsp104 over-
expression. Our analyses indicate that excess Hsp104 induces prion loss by 
inhibiting the activity of this chaperone. This effect is mediated through a 
sequence element in the Sup35 protein that is conserved among prionogenic 
homologues of Sup35 in fungi but not in those incapable of adopting the 
prion form. We hypothesize that upon overexpression, Hsp104 interacts 
non-productively with aggregates due to limitations of an as yet 
unidentified co-factor that directly binds to Sup35.  
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Small heat shock proteins (sHsps) are molecular chaperones involved in the 
maintenance of protein homeostasis and in protein folding diseases as well 
as cancer. In this protein family, a conserved core domain, the so called α-
crystallin or Hsp20 domain, is flanked by highly variable non-conserved, 
sequences that are essential for the chaperone function of these proteins.  
The analysis of more than 8,700 sHsp sequences revealed a broad variation 
of the primary sequences within the superfamily as well as phyla-dependent 
differences. Especially the number of sHsps per genome, the amino acid 
composition and the length distribution of the different sequence parts vary 
significantly.  
The reconstruction of the evolutionary tree for the sHsp superfamily 
unraveled an unconventional evolutionary concept, in which the conserved 
α-crystallin domain and its flanking sequences evolved independently of 
each other. Interestingly, the flanking regions fall into several subgroups 
indicating that they were remodeled several times in parallel, but 
independent of the evolution of the α-crystallin domain.  
Conclusions 
The evolutionary history of sHsps is set apart from that of other protein 
families in that two, exon-boundary-independent evolutionary strategies are 
combined: the evolution of the conserved α-crystallin domain and the 
independent evolution of the N- and C-terminal sequences. This scenario 
allows variability in specific small parts of the protein and thus promotes 
functional and structural differentiation of sHsps, which is not reflected in 
the general evolutionary tree of species. 
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Missense mutant proteins, such as those produced in individuals with 
genetic diseases, are often misfolded and subject to processing by 
intracellular quality control systems. Previously, we have shown using a 
yeast system that enzymatic function could be restored to I278T 
cystathionine beta-synthase (CBS), a cause of homocystinuria, by 
treatments that affect the intracellular chaperone environment. Here, we 
extend these studies and show that it is possible to restore significant levels 
of enzyme activity to 17 of 18 (94%) disease causing missense mutations in 
human cystathionine β-synthase (CBS) expressed in S. cerevisiae by 
exposure to either ethanol, proteasome inhibitors, or deletion of the Hsp26 
small heat shock protein. All three of these treatments induce Hsp70, which 
is necessary but not sufficient for rescue. In addition to CBS, these same 
treatments can rescue disease-causing mutations in human p53 and the 
methylene tetrahydrofolate reductase gene. These findings do not appear 
restricted to S. cerevisiae, as proteasome inhibitors can restore significant 
CBS enzymatic activity to CBS alleles expressed in fibroblasts derived 
from homocystinuric patients and in a mouse model for homocystinuria that 
expresses human I278T CBS. These findings suggest that proteasome 
inhibitors and other Hsp70 inducing agents may be useful in the treatment 
of a variety of genetic diseases caused by missense mutations. 
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The last two decades of cancer research has proven the complexity of the 
processes leading to cancer and confirmed the functional diversity and 
multiple cellular actions of the proteins involved in these processes. The 
evolutionarily conserved tid (tumorous imaginal discs) gene, encoding 
DNAJA3 protein family members, was originally identified and confirmed 
as a tumor suppressor by gene therapy using the fruit fly Drosophila 
melanogaster (Dm). The tid genes encode three splice forms - long (L), 
intermediate (I) and short (S), encoding three cytosolic and three 
mitochondrial proteins. The distinct hTid molecules interact with diverse 
physiological partners in diverse cellular compartments (1-3 and literature 
cited here). In general, two modes of action of the Tid proteins can be 
discerned: i) interaction with cytosolic molecules, such as the APC tumor 
suppressor (2) or the IKB Inhibitor of NF?B signaling (4) or ii) binding to 
receptors mediating signal transduction, e.g. Ptc) (1) and ERBB-2 (5). Here 
we show that hTid binding to diverse ligands takes place simultaneously in 
the cells. The partners build topologically determined complexes with 
further molecules, components of signaling cascades determining cell 
polarity, pattern formation and cell cycle regulation. The interactions seem 
to be essential for the homeostasis of the aforementioned signaling, the 
off/on status. We show that the three forms are differentially expressed in 
normal tissues. In general, the expression profile is common for diverse 
cells. This pattern changes in diverse cancers of epithelial origin, such as 
basal cell carcinomas (BCCs) (1), colon cancers (3) and breast tumors 
associated with HER-2 overexpression. With regard to the latter our data 
suggest an association of hTidL elevation with well differentiated status of 
the tumors and its drastic drop down in metastasizing tumors with poor 
prognosis. The expression profiles determined in normal and tumor tissues 
suggest that the concentration of the distinct htid splice forms is precisely 
regulated at both physiological and non physiological conditions.  
 
References: (1) Canamasas I, Debes A, Natali PG, Kurzik-Dumke U. 2003. J. Biol. 
Chem. 278:30952-30960. (2) Kurzik-Dumke and Czaja. 2007. Celllular Signaling 
19:1073-1985. (3) Kurzik-Dumke U, Hörner M, Nicotra MR, Czaja J, Simiantonaki 
N, Koslowski M, Natali PG. 2008. Int. J. mol. Oncol. 21:19-31. (4) Cheng H, 
Cenciarelli C, Tao M, Parks WP, Cheng-Mayer C. 2002. J. Biol. Chem. 277:20605-
20610. (5) Kim S-W, Chao T-H, Xiang R, Campbell MJ, Fearns C, Lee J-D. 2004. 
Cancer Res. 64:7732-7739. 
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A complex forms between the G protein β1 subunit (Gβ1) and the cytosolic 
chaperonin containing the tailless-complex polypeptide 1 (CCT) during the 
folding of nascent Gβ1, enabling Gβ1 to assemble into the G protein 
heterotrimer and act in downstream signaling. We have isolated the Gβ1-
CCT complex from insect cells over-expressing human recombinant Gβ1 
protein with an antibody-affinity tag. The complex was subjected to 
structural determination by cryo-electron microscopy in an effort to 
determine Gβ1-CCT interactions and the mechanism by which the Gβ1 
subunit is folded into its native state. Reconstructions of cryo-EM images 
reveal that Gβ1 forms a globular structure within the CCT folding cavity. 
Gβ1 was mostly folded and bound to the apical domains of two adjacent 
CCT subunits, CCTβ and CCTζ. The Gβ1 binding sites on CCTβ were 
identified through mutagenesis and co-immunoprecipitation. A hydrophobic 
groove between two helices and another hydrophobic loop of CCTβ 
contribute significantly to the Gβ1 binding. By elucidating the mechanism 
of Gβγ assembly, we can identify therapeutic targets in the assembly 
process that could be exploited to control the amount of Gβγ being made by 
the cell and thus the level of G protein signaling. 
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Most cases of Cystic Fibrosis (CF) are caused by the ΔF508 mutation in the 
ABC transporter protein CFTR. In the endoplasmic reticulum (ER), 
CFTRΔF508 mis-folds into a kinetically trapped, reversible structure which is 
degraded through a ubiquitin-dependent process termed ER-associated 
degradation (ERAD). The genes involved in CFTRΔF508 recognition, 
processing, and degradation are poorly understood. To better understand 
these mechanisms, we have modeled ΔF508-dependent defects in the 
nematode C. elegans using the closely related C. elegans ABC transporter 
pgp-3. Like CFTR, PGP-3 is trafficked to the apical plasma membrane of 
polarized epithelial cells. Introduction of the ΔF508 mutation destabilizes 
the protein and blocks apical membrane localization. Like human 
CFTRΔF508, PGP3/CFTRΔF508 stability and localization are rescued by 
mutants that produce high levels of the chemical chaperone glycerol, 
suggesting some ΔF508-dependent quality control mechanisms are 
conserved between C. elegans and humans. Currently, we are investigating 
the specific post-transcriptional mechanisms impacted by the ΔF508 
mutation. Furthermore, we are performing forward and reverse genetic 
screens to identify genes that promote instability of the PGP3/CFTRΔF508 
protein. Our C. elegans model represents the first high-throughput genetic 
animal model system for CF studies. The genes identified in our screens 
may provide new drug targets for CF therapies and could illuminate novel 
modifier loci that influence CF onset, severity, or progression. 
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HSF1 and HSF2 are related members of the HSF family known to regulate the 
stress response. Mouse knockout experiments have shown that HSF1 is a 
maternal factor which severely alters oocyte meiosis and provokes female 
infertility (1, 2). In contrast, Hsf2-/- females are fertile and can produce offspring 
(3-5). In most tissues and cells lines (e.g. lung, liver, heart), HSF1 and HSF2 are 
co-expressed and accumulating data have recently shown these factors are able 
to interact to regulate common target genes (6, 7). Nevertheless, we found that 
oocytes contain 100 fold more transcripts encoding HSF1 than HSF2 and 
previous attempts to detect HSF2 protein in oocytes were unsuccessful. These 
observations suggest that these factors might control different transcriptome 
depending on germinal or somatic cellular context.  
These data prompted us to perform genome wide comparative transcriptomic 
analysis using wild-type, Hsf1-/- and Hsf2-/- oocytes. We used 200 oocytes per 
genotype (4-5 ng of RNA) to generate cDNAs that were hybridized to 
NimbleGen microarrays (that had 42600 transcripts represented on the array). 
Using a 1.5-fold differential threshold comparing knockout to wild type 
oocytes, we identified 1665 genes regulated by HSF1, 959 regulated by HSF2 
and 130 regulated by both factors (p-value ≤ 0.05). 
We compared our results with a previous HSF1 microarray experiment 
performed in somatic cells (MEFs) by Trinklein and al. (8). 93% of the genes 
regulated by HSF1 in oocytes and fibroblasts are different suggesting that 
maternal function of HSF1 in oocyte differs from its function in somatic cells. 
Moreover, GO term analysis revealed enrichment in different processes between 
oocytes and fibroblasts strengthening the hypothesis that HSF1 controls distinct 
transcriptome in oocytes and somatic cells.  
Regarding HSF2 transcriptome, it is interesting to highlight that, despite the 
absence of any phenotype in Hsf2-/- oocytes, HSF2 regulates around 1000 
genes. Thus, although it is dispensable, HSF2 may play a role in oocyte which 
remains to be identified.  
 
All these data will help us to better understand the role played by HSF1 and 
HSF2 in this particular germ cell, oocyte. 
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Pendrin is an 82 kDa membrane transporter for monovalent anions such as 
I-, Cl-, and HCO3- in thyroid follicular cells, inner ear epithelia, and renal 
cortical collecting ducts. Mutations in SLC26A4 gene which produces 
Pendrin are considered as major causes for Pendred syndrome characterized 
by inherent sensorineural hearing impairment and thyroid goiter. Recent 
studies revealed that overexpression or some mutations of SLC26A4 gene 
perturbs the folding of Pendrin and causes its retention in endoplasmic 
reticulum (ER) followed by endoplasmic reticulum associated degradation 
(ERAD). However, the specific mechanisms of ERAD process for Pendrin 
are still unknown. It has been shown that treatment of thyroid cells with 17-
AAG, an Hsp90 inhibitor, inhibits efflux of I-, suggesting the potential roles 
of Hsp90 or other chaperones in regulation of Pendrin or other I- exporters. 
When 17-AAG was treated to human embryonic kidney cell line (HEK293) 
transiently expressing Pendrin, Pendrin protein levels increased. This result 
implies that Hsp90 might be involved in regulation of folding or 
degradation of Pendrin. We will also discuss about the roles of other 
chaperones in regulation of the stability and membrane translocation of 
Pendrin. 
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AtNTRC, an electron donor of a chloroplast 2-Cys Prx, was induced by 
heat- and cold-shocks in the light, and overexpression of AtNTRC 
(AtNTRCOE) in Arabidopsis (Arabidopsis thaliana) led to an acquired 
thermotolerance, whereas a knockout mutant (ntrc1) showed heat sensitive 
phenotype. Biochemical and transmission electron microscopic analyses 
showed that the recombinant and native AtNTRC proteins exhibit diverse 
quaternary structures. High molecular weight (HMW) complex of AtNTRC 
was revealed to display a higher chaperone activity but a lower disulfide 
reductase activity; in contrast, the low molecular weight (LMW) AtNTRC 
exhibited a higher disulfide reductase activity but a lower chaperone 
activity. Heat treatment of recombinant AtNTRC induced HMW complex 
formation which is facilitated by addition of NADPH, and C-terminal 
thioredoxin domain is required for the HMW complex formation. Analysis 
of AtNTRCOE and ntrc1 also showed that AtNTRC confer freezing 
tolerance on plants. Recombinant AtNTRC exhibited a cryoprotection 
activity for MDH and LDH, and it also bound to RNA and DNA protecting 
them from RNase A and metal catalyzed oxidation damages, respectively. 
Proteomic analyses of WT, NTRCOE and ntrc1 indicated many proteins 
involved in chloroplast biogenesis, metabolism and stress response are up- 
or down-regulated. These results indicate AtNTRC functions not only as an 
electron donor for 2-Cys Prx but also as a protector for macromolecules in 
chloroplast. [Supported by EB-NCRC & BK21 program] 
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We found that Arabidopsis AtTDX, a heat-stable and plant-specific 
thioredoxin (Trx)-like protein, exhibits multiple functions, acting as a 
disulfide reductase, foldase chaperone, and holdase chaperone. The activity 
of AtTDX, which contains 3 tetratricopeptide repeat (TPR) domains and a 
Trx motif, depends on its oligomeric status. The disulfide reductase and 
foldase chaperone functions predominate when AtTDX occurs in the low 
molecular weight (LMW) form, whereas the holdase chaperone function 
predominates in the high molecular weight (HMW) complexes. Because 
deletion of the TPR domains results in a significant enhancement of AtTDX 
disulfide reductase activity and complete loss of the holdase chaperone 
function, our data suggest that the TPR domains of AtTDX block the active 
site of Trx and play a critical role in promoting the holdase chaperone 
function. The oligomerization status of AtTDX is reversibly regulated by 
heat shock, which causes a transition from LMW to HMW complexes with 
concomitant functional switching from a disulfide reductase and foldase 
chaperone to a holdase chaperone. Overexpression of AtTDX in 
Arabidopsis conferred enhanced heat shock resistance to plants, primarily 
via its holdase chaperone activity. [This research was supported by BK21 
and EB-NCRC programs] 
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The molecular chaperone Hsp90 is required for the activation of cellular 
substrates, including protein kinases, transcription factors and steroid 
hormone receptors. In particular steroid hormone receptors define at which 
stages of the activation cycle Hsp90-cochaperones associate with Hsp90. 
The but the molecular events, which lead to the entry of one co-chaperone 
and the exit of another co-chaperone during the chaperone cycle are still 
enigmatic.  
In order to precisely describe these events, we set out to study the Hsp90 
chaperone cycle by fluorescently labeling individual components of the 
hetero-oligomeric protein complex. We used analytical ultracentrifugation 
in combination with other biochemical tools to reconfigurate the chaperone 
cycle. We identified novel complexes, which are required for the 
progression of the chaperone cycle as potential intermediary organizations. 
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The voltage-gated sodium channel (Nav) 1.8 contributes substantially to the 
rising phase of action potential in small dorsal root ganglion neurons. 
Nav1.8 is majorly localized intracellularly and its expression in the plasma 
membrane is regulated by exit from the endoplasmic reticulum (ER). 
Previous work has identified an ER-retention/retrieval motif in the first 
intracellular loop of Nav1.8 which prevents its surface expression. Here we 
demonstrate that the transmembrane segments of Nav1.8 also contain ER-
retention/retrieval signals that cause Nav1.8 to be retained in the ER. The 
acidic amino acid-containing motifs are critical in determining the 
functional signals. In addition, we show that the ER-retention/retrieval 
signals in the transmembrane segments result in increased degradation of 
proteins through calnexin-dependent ER-associated degradation (ERAD) 
pathway. Thus our results reveal a critical role of transmembrane segments 
in the surface expression and degradation of Nav1.8. 
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Hundreds of membrane proteins possess a single carboxyl-terminal 
transmembrane domain (TMD), thus termed as tail-anchored (TA) proteins, 
play various but important roles in multiple cellular processes, such as cell 
apoptosis, protein translocation and vesicular transportation. Endoplasmic 
reticulum (ER) specific TA proteins are post-translationally targeted to their 
destination by a cytosolic factor termed TRC40 through a TMD-dependent 
capturing mechanism. How the highly hydrophobic TMDs of TA proteins 
are effectively captured by TRC40 upon their release into the crowded 
cytosol was unknown. Recently in our lab, we identified a conservative 
ribosome-associated chaperone complex comprising of three different 
proteins, Bat3, Ubl4A and TRC35, respectively, that specifically recognizes 
and shields the TMDs of TA proteins, and transfers the TA substrates to 
TRC40 for targeting to the ER. Depletion of the Bat3 complex from the 
cytosol caused non-TRC40 factors to compete for the TMD of TA 
substrates, while the efficient capture by TRC40 is restored by adding back 
purified Bat3 complex. Meanwhile, we observed that TA proteins are 
efficiently poly-ubiquitinated in the absence of either membranes (RMs) or 
TRC40, suggesting that under stressing conditions, TA substrates that fail to 
target to the ER will be degraded through the ubiquitin-proteasome 
pathway. Complete deletion of the TMD or hydrophilic mutations made in 
the TMD of TA substrates abolished the poly-ubiquitination, indicating the 
putative E3 ligase (s) are recruited by the TMD itself or TMD-selective 
binding factor (s). Since two of the three components of Bat3 complex, the 
Bat3 and Ubl4A contain ubiquitin-like (UBL) domain, we speculate that 
Bat3 complex could perform the scaffold or adaptor role in connecting the 
TA proteins to the putative E3 liagse(s). In fact, depletion of Bat3 complex 
from the cytosol specifically led to reduced poly-ubiquitination of TA 
proteins. Therefore, the Bat3 chaperone complex acts as the triage factor of 
TA membrane proteins at the ribosome, facilitating their efficient targeting 
to the ER or directing them to the ubiquitin-proteasome pathway depending 
on an unknown regulating mechanism. 
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gp96 (grp94 and HSP90b1), the HSP90 paralogue in the endoplasmic 
reticulum, was discovered three decades ago and has been implicated in 
controlling protein homeostasis in the secretory pathway. However, the 
fundamental questions of gp96 as a molecular chaperone remain 
unanswered. Using a conditional gp96 knockout mouse (Yang et al. 
Immunity, 2007), we have uncovered new functions of gp96 and have 
revealed its novel mechanism of action. These discoveries include: (a) gp96 
is a master chaperone for Toll-like receptors (TLRs); (b) gp96 is critical for 
the folding of a majority of integrins; (c) gp96 selectively regulates T and B 
lymphopoiesis but not myelopoiesis; (d) gp96 is dispensable for the folding 
of immunoglobulin in vivo; (e) gp96 is essential for the assembly of the 
platelet glycoprotein Ib-IX-V complex and loss of gp96 results in a disorder 
that is clinically and hematologically indistinguishable from Bernard-
Soulier syndrome; (f) gp96 regulates the intestinal homeostasis; (g) gp96 
folds TLRs in a manner that is dependent on its intrinsic ATPase activity 
and a TLR-specific co-chaperone in the endoplasmic reticulum. We will 
provide a comprehensive update on the function and mechanism of gp96, 
arguably the last frontier of HSP90 biology. 
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Mutations in the myocilin protein cause an inherited form of open angle 
glaucoma, a prevalent neurodegenerative disorder usually associated with 
increased intraocular pressure. Myocilin forms part of the trabecular 
meshwork extracellular matrix, which is presumed to regulate intraocular 
pressure. Missense mutations, which cluster in the olfactomedin (OLF) 
domain of myocilin, render the protein prone to aggregation in the 
endoplasmic reticulum of trabecular meshwork cells, causing cell 
dysfunction and death. Cell biological studies have demonstrated 
temperature-sensitive secretion of myocilin mutants, but difficulties in 
expression and purification in the past decade have precluded extensive 
biophysical characterization of wild-type myocilin and disease-causing 
mutants in vitro. We have overcome these limitations by purifying from E. 
coli wild-type and glaucoma-causing mutant forms of the myocilin OLF 
domain fused to maltose binding protein (MBP). Monomeric fusion 
proteins can be isolated in solution. To determine the relative stability of 
wild-type and mutant OLF domains, we developed a stability assay without 
removal of MBP. The assay provides the first direct evidence that mutated 
OLF is folded but less thermally stable than wild-type. We tested the ability 
of chemical chaperones to stabilize mutant myocilin. Several compounds 
stabilize the mutants to near or better than that of wild-type OLF. Our work 
lays the foundation for detailed structure/function investigations. In the long 
term, we hope to identify tailored small molecules capable of stabilizing 
mutant myocilin and promoting secretion to the extracellular matrix, to 
better control intraocular pressure and ultimately delay the onset of 
myocilin glaucoma. This therapy would be the first of its kind for 
glaucoma. 
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Inhibition of molecular chaperones by drugs, siRNA depletion or 
expression of dominant-negative chaperones impairs HSV-1 infection. For 
example, the ATPase activity of Hsc70 is required for the formation of viral 
replication centers, efficient virus production and for the nuclear transport 
of the HSV-1 capsid protein UL6. Additionally, Hsp90 ATPase activity is 
required for the nuclear import of the HSV-1 polymerase and the major 
capsid protein and production of infectious virus. The heat shock response 
is regulated by the transcription factor heat shock factor 1 (HSF-1). In this 
study, we investigated whether the cellular heat shock response is induced 
during HSV-1 infection. When activated during heat stress, HSF-1 
trimerizes, becomes hyperphosphorylated and upregulates the transcription 
of heat shock responsive genes such as hsp70. Hyperphosphorylation of 
HSF-1 can be detected as a mobility shift by SDS-PAGE in cells heat 
shocked at 42°C. Interestingly, HSV-1 infection at 37°C is sufficient to 
induce a mobility shift of HSF-1 in infected fibroblast cell lines suggesting 
activation of the heat shock response. Hsp70 protein levels do not, however, 
increase during HSV-1 infection, raising the possibility that the inducible 
heat shock response is only partially activated during infection. A small 
molecular inhibitor of the heat shock response, KNK437, inhibits the 
induction of chaperones such as Hsp70 during heat stress. We found that 
KNK437 inhibits replication compartment formation, gene expression and 
inhibits production of progeny virus. Furthermore, HSF-1 does not undergo 
a change in mobility in infected cells treated with KNK437 suggesting that 
the target of KNK437 may be HSF-1. Our data suggest that the inducible 
heat shock response may be required for HSV-1 infection at the level of 
early gene expression; however, the virus may inactivate other aspects of 
the heat shock response. This is reminiscent of other examples in which 
DNA viruses like herpesviruses manipulate cellular response pathways by 
activating some components and inactivating others in order to create 
environments conducive to their own replication. 
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BiP, the mammalian Hsp70 orthologue in the endoplasmic reticulum (ER), 
participates in most functions of this organelle. It takes part in the 
maturation of unfolded nascent proteins and is also involved in selecting the 
ultimately misfolded proteins and directing them to the ER associated 
degradation (ERAD) machinery. How BiP distinguishes between substrates 
having these contradictory fates remains a question. Some ER-localized 
DnaJ-like (ERdj) proteins bind directly to substrates and can recruit BiP to 
them. We hypothesized that the apparently opposing functions of BiP might 
be regulated by distinct ERdj proteins. Our previous data showed that 
unassembled Ig γ heavy chains (HC), which have very long half-lives in 
plasmacytoma cells, are associated with ERdj3 (Shen and Hendershot, 
MBC, 2005). We did not observe any association of these HC with ERdj4 
but did find small but detectable levels of ERdj5 bound to them. When 
ERdj3 levels were decreased with shRNA, the HC turned over more rapidly 
and were associated with components of the ERAD machinery. In addition, 
there was an increase in the association of the HC with both ERdj4 and 
ERdj5. Over-expressing ERdj4 in transient transfection experiments 
resulted in a faster degradation of the HC and of a non-secreted Ig LC that 
also binds to BiP. Finally, we co-expressed an ERdj3 mutant that remains 
stably bound to substrates due to an inability to interact with BiP to 
determine if ERdj3 must be released from the substrate to promote 
degradation. We found that this mutant diminished the turnover of the NS-1 
LC. Based on these observations, we hypothesize that ERdj3 assists in 
folding and stabilization of γ HC before they assemble with LC. Releasing 
ERdj3 from the substrate allows ERdj4 and/or ERdj5 to bind and targets the 
unfolded protein for degradation. These studies provide insights into how 
ERdj proteins allow BiP to function both in folding and degradation of 
secretory pathway substrates. 
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Group II chaperonins occur in archaea and eukaryotes and their subunits are 
similar. Here we focus on the lone chaperonin subunit (Cpn-Pf) of the 
archaeon Pyrococcus furiosus and those from humans found to have 
disease-associated mutations, CCT4, CCT5, and the CCT8-related BBS6 
(MKKS), BBS10, and BBS12. Amino acid identities and similarities 
between Cpn-Pf and CCT4 and CCT5 are 40-60 percent, i.e., the same as 
between CCT4 and CCT5; similarities between Cpn-Pf and BBS6, 10, and 
12 are low due to extra segments in the latter three. Structurally, the 
archaeal and eukaryotic chaperonins have equivalent domains (equatorial, 
intermediate, and apical) and, functionally, play similar roles in protein 
folding via essentially the same mechanism. However, the process is 
considerably simpler in archaea than in eukaryotes, particularly in P. 
furiosus because it has only one type of subunit to build the chaperoning 
machine. We, therefore, are developing an archaeal model for investigating 
the functional effects of mutations and post-translational modifications in 
the chaperonin molecule that would reproduce those observed in human 
chaperonopathies, which have not yet been elucidated due to the complexity 
of the mechanisms and the multiplicity of subunit types of eukaryotes. We 
found that the alpha helix, 21GRDAQRMNILAARIVAETIR40, in the N 
terminal segment of Cpn-Pf was essential for double-ring formation, which 
was necessary for ATPase and chaperoning activities. Deletion of the helix 
formed by 21GRDAQRMNIL30 resulted in the limited assembly of 
assorted tetramers, dimers, and monomers. Site-directed mutagenesis of 
each residue in this helix revealed that Arg22, Asn28, and Ile29 are critical 
for oligomerization. Two antiparallel alpha helixes from adjacent molecules 
form the interaction interface. Arg22 together with Glu37 from an adjacent 
helix constituted a stable ion pair, and one such ion pair located at each end 
of the helix doublet locked the two helices, stabilizing the oligomer. Arg26 
may also have the potential to form an ion pair with Glu37. Although no 
interaction partners for Asn28 and Ile29 were found, their mutations (i.e., 
N28A, N28Q, N28K and I29A, I29L, I29K) caused oligomer dissociation, 
indicating that any change at these two residues can result in excess 
flexibility to the helix, decreasing the probability of formation of the 
stabilizing ion pairs. This is the first report of a comprehensive mutational 
analysis of the oligomerization pathway of group II chaperonins. Mutations 
at equivalent residues on the human orthologs will provide insights into 
their assembly and clues for understanding chaperonopathies at the 
molecular level. 
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The endoplasmic reticulum (ER) of eukaryotic cells is a unique chemical 
environment for protein folding. Immunoglobulins (Ig) are an important 
class of proteins which are folded and assembled in the ER of B-cells by 
specialized chaperone complexes. The Hsp70 member BiP (heavy chain 
binding protein) and its Hsp40 co-chaperone ERdJ3 are key players in this 
process.  
To elucidate the dynamics and conformational prerequisites for substrate 
processing by BiP, an IgG domain and a peptide derived from this domain 
were used as endogenous model substrates. The thermodynamics and 
kinetic parameters for their interaction and the conformational changes 
during the chaperone cycle of BiP were analyzed by single molecule FRET 
experiments, revealing the domain communication of BiP during the 
chaperone cycle. Besides the modulation of the domain orientations in BiP 
by nucleotides, the effects of bound substrates as well as the influence of 
ERdJ3 on BiP conformations were analyzed. 
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Deleted in Breast Cancer 2 (DBC2/ RhoBTB2) is a tumor suppressor gene 
from human chromosome 8p21.3: a chromosomal region that was 
commonly found deleted in a screen of breast cancer samples. DBC2/ 
RhoBTB2 is a member of the atypical RhoBTB subfamily. It contains an N-
terminal Rho-like GTPase domain, a linker region containing a PEST motif, 
followed by a tandem pair of BTB (broad complex/bric-a-
brac/poxvirus/zinc finger) domains, a putative RING domain and a Ser-rich 
C-terminus. DBC2 has been demonstrated to interact with and be 
ubiquitinated by Cullin 3 and reported to lack GTP binding activity. DBC2 
was a protein that was found to specifically co-adsorb from cell lysate with 
Cdc37. The specific interaction of DBC2 with the Hsp90 chaperone 
machinery was confirmed by reconstitution of the interaction with DBC2 
generated de novo by coupled transcription/ translation in reticulocyte 
lysate. Domain dissections of DBC2 indicated that DBC2 interacted with 
the Hsp90 chaperone machine, primarily through its Rho domain, and 
retains the capability to bind GTP. GTP binding shows hallmarks of being 
an Hsp90 dependent process as it is reduced by the Hsp90-specific inhibitor 
geldanamycin. Ubiquitination of DBC2 was confirm by the specific 
adsorption of higher molecular weight adducts of DBC2 by immobilized 
ubiquitin-binding domains. LC/MS analysis of DBC2 pull downs indicates 
that DBC2 specifically interacts with the Cullin 3 E3 ligase, as well as 
components of the Hsp90 chaperone machinery. Over-expression of DBC2 
in MCF7 cells, a cell line that does not express DBC2, induces cell death. 
However, Hela cells, which normally express DBC2 are immune to the 
effects of DBC2 over-expression. In Hela cells endogenously expressed 
DBC2 turns over very rapidly, and is immunoadorbed from cell lysates as a 
high molecular weight adduct in a complex with a high molecular weight 
adduct of Hsp90. Our studies suggest that Hsp90 modulates DBC2 activity 
and is involved in the mechanism of regulation of DBC2’s tumor suppressor 
function. (This work was support by a grant from OCAST: HR-06 070). 
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DOMAIN OF HEAT SHOCK PROTEIN 27 (HSP27) IN ITS 
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Cells under stress accumulate misfolded and aggregated proteins which can 
be toxic and may lead to disease states. The induction of small heat shock 
protein (sHsp) expression enables cells to defend against protein 
aggregation. Hsp27 forms dynamic oligomeric complexes that can 
dissociate into binding competent dimers depending upon the 
phosphorylation state of the protein1. Hsp27 consists of a highly conserved 
α-crystallin domain which is flanked by a short C-terminal extension and a 
non-conserved N-terminal domain. We are using spectroscopic tools to 
examine the role of the N-terminal domain in the recognition and binding of 
substrate. Residues along the N-terminal domain were replaced with 
cysteines, spin labeled, and analyzed for changes in EPR lineshape and 
solvent accessibility. EPR data, in the absence of phosphorylation, has 
revealed a sterically packed and solvent-inaccessible environment for the N-
terminal domain. Upon phosphorylation of Hsp27, EPR spectra of spin 
labels report a transition to a more solvent-exposed environment suggesting 
the exposure of the N-terminal domain. In contrast, phosphorylation does 
not change the environment of the α-crystallin domain. Binding of Hsp27 to 
destabilized T4 lysozyme (T4L) mutants results in a distinct transition in the 
environment of the N-terminal domain from solvent-exposed to solvent-
inaccessible. We propose that the interaction between the N-terminal 
domain of Hsp27 and substrate in its non-native state is a critical event for 
chaperone activity. 
 
1. Shashidharamurthy, R., Koteiche, H.A., Dong, J., Mchaourab, H.S. 
(2004) J. Biol. Chem. 280, 5281-5289 
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ClpB of prokaryotes and Hsp104 of yeast are AAA+ (ATPases Associated 
with various cellular Activities) proteins and members of the Clp/Hsp100 
family of molecular chaperones. They are essential for the survival of cells 
during extreme stress and function by disaggregating and reactivating 
proteins damaged by stress conditions. In vivo and in vitro, they act in 
conjunction with the DnaK/Hsp70 chaperone system. However, in vitro 
they are able to perform some protein remodeling activities in the absence 
of the DnaK/Hsp70 system, when mixtures of ATP and ATP gamma S are 
used as the nucleotide source. Structural studies have shown that 
ClpB/Hsp104 exists as a hexameric ring with each protomer consisting of 
an N-terminal domain followed by two AAA+ nucleotide-binding domains, 
the first of which is interrupted by the insertion of a long coiled coil middle 
domain.  
To gain insight into substrate recognition by ClpB/Hsp104 when acting 
independently of the DnaK/Hsp70 system, we have compared protein 
unfolding by ClpB/Hsp104 using GFP fusion proteins containing N- or C-
terminal peptides of different lengths and sequences as substrates. Although 
ClpB and Hsp104 share high sequence homology, our experiments show 
that they differ in substrate preference. To further explore substrate 
recognition, we have engineered chimeras by swapping domains of Hsp104 
and ClpB. Several chimeras have been purified and characterized in vitro. 
Results suggest that some variants recognize the preferred substrates of 
Hsp104 and others the preferred substrates of ClpB. 
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The AAA+ chaperone ClpB mediates the reactivation of aggregated 
proteins in cooperation with the DnaK chaperone system (KJE), an activity 
that is crucial for the survival of eubacteria during severe stress. KJE has an 
essential function during the initial phase of the disaggregation process, the 
mechanistic requirement for this activity is, however, not well understood. 
Here, we have analyzed in vivo the binding of DnaK/DnaJ and ClpB 
chaperones to their physiological substrates: stress-induced and polar 
localized protein aggregates. By using fluorescent chaperone fusion proteins 
we demonstrate that DnaJ, DnaK and ClpB bind in a hierarchic manner to 
protein aggregates. The interaction of ClpB with aggregated proteins strictly 
requires initial coating of aggregates by DnaJ/DnaK, providing a rationale 
for the requirement of KJE in ClpB-mediated protein disaggregation. In 
agreement with a crucial role of KJE in targeting ClpB to substrates, we 
demonstrate that switching ClpB substrate specificity allows for KJE-
independent substrate disassembly by ClpB. This ClpB only mediated 
“disaggregation activity” requires ATP hydrolysis and allows for dissecting 
the role of coordinated ATP hydrolysis for ClpB activity. 
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Protein folding in the cell is assisted by a large group of proteins termed 
molecular chaperones, one of the most important members being the 
chaperonins or Hsp60s (Heat Shock Proteins of 60 kDa). The eukaryotic 
cytosolic chaperonin CCT (chaperonin containing TCP-1), also know as 
TRiC) is the most complex of all chaperonins, an oligomeric structure built 
by two identical rings, each composed of single copies of eight different 
60kDa subunits called α, β, γ, ζ, ε, δ, θ and η. This macromolecular complex 
of 1 MDa has crucial relevance in several essential biological processes, 
emerging as a key molecule due to its role in the folding of many important 
molecules including actin, α and β tubulins. An electron density map at 5 Å 
resolution has enabled us to build the CCT complex and to dock one of its 
well-known substrates inside the cavities. Here we present the crystal 
structure of this protein machine in complex with tubulin, providing 
information about the molecular mechanism by which this macromolecular 
complex aids the tubulin folding process. Our data provide new important 
insights into the function of this molecular machine. 
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REGULATOR OF THE HEAT SHOCK FACTOR HSF-1 
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The heat shock transcription factor HSF-1 has important roles in stress 
tolerance, aging, innate immunity, cancer, and protein diseases. Activation 
of HSF-1 leads to heightened expression of target genes such as heat shock 
proteins (HSPs) that promote protein homeostasis and cellular adaptation to 
stress. Because active HSF-1 mediates resistance to a wide variety of 
proteotoxic stressors, drugs that upregulate HSF-1 may be therapeutic for a 
variety of protein misfolding diseases, such as Huntington’s disease. 
However, recent studies suggest that HSF-1 activity may also be involved 
in undesirable phenotypes, including cellular transformation to a cancerous 
state. While global regulation of HSF-1 might be undesirable, identification 
of regulators of HSF-1 may allow us to find more nuanced ways to control 
its activity. To identify such HSF-1 regulators, we conducted a high-
throughput RNAi screen for regulators of an HSF-1-dependent reporter 
transgene in Caenorhabditis elegans. Our screen covered 17,540 genes and 
identified 43 regulators of an HSF-1-dependent reporter. RNAi inhibition of 
these genes did not similarly affect an HSF-1-independent reporter, 
suggesting that they specifically regulate HSF-1-dependent phenotypes. 
One gene identified by our screen was smo-1, which encodes the sole C. 
elegans SUMO homolog. SUMO is a small ubiquitin-like molecule used to 
post-translationally modify proteins. Repression of smo-1 led to hyper-
activation of the HSF1-dependent reporter, but only following activation of 
the reporter by heat shock. Consistent with this phenotype, smo-1(RNAi) 
also improved whole-animal thermotolerance. Sequence analysis of HSF-1 
revealed a consensus site for sumoylation at the N-terminus, and recent 
studies from other labs confirm that HSF1 is post-translationally 
sumoylated. These results suggest that SUMO may directly modify HSF-1 
in C. elegans in response to specific activating conditions and that such 
modifications inhibit HSF-1-regulated gene expression and stress resistance 
in vivo. Our findings have implications for sumoylation as a future target for 
therapies intended to regulate HSF-1. 
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Charcot-Marie-Tooth 1 disease is a common inherited neuropathy. This 
pathology is characterized by the loss of myelin sheath integrity in the 
peripheral nervous system (PNS) resulting in slowed nerve conduction 
velocity, hind limb muscular atrophy, and postural abnormalities. It is 
caused by mutations in a wide range of genes; one of them is Myelin 
Protein Zero (MPZ), which is expressed by Schwann cells, the myelin 
forming glia of the PNS. MPZ encodes the most abundant protein of 
peripheral myelin and is required to compact its structure allowing fast 
conduction. When MpzS63Δ, a mutant causing CMT1B in humans, is 
expressed in mouse with wild type alleles, it produces a demyelinating 
neuropathy that mimics the corresponding human disease. MpzS63Δ is 
correctly expressed and translated but it does not reach the myelin sheath 
being retained in the endoplasmic reticulum (ER). The ER accumulation of 
unfolded proteins is generally followed by induction of the Unfolded 
Protein Response (UPR), an adaptive mechanism aimed to relieve ER 
stress. P0S63Δ accumulation triggers a dose dependent, UPR with increased 
phosphorylation of eIF2α, Atf6 cleavage, Ire-1 induced Xbp-1 splicing and 
Chop induction. Genetic ablation of Chop restores motor capacity and 
ameliorates electrophysiological and morphological abnormalities in S63Δ 
mice, suggesting that the UPR is pathogenetic and maladaptive. Since Chop 
is downstream of the Perk/eIF2α pathway, we studied the effects of Perk 
ablation in normal and S63Δ mice. Preliminary behavioral, morphological 
and biochemical data from these mice suggest that Perk is maladaptive in 
S63Δ nerves. 
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Fragmentation of wakefulness and sleep are expected outcomes of advanced 
aging. We hypothesize that metabolically active wake neurons are 
susceptible to age related changes in the unfolded protein response and that 
dysfunction with age might contribute to the observed wake impairments. In 
this series of experiments we sought to more fully characterize age-related 
changes in wakefulness and then, in relevant wake neuronal populations, 
explore functionality and endoplasmic reticulum homeostasis. We report 
that old mice (22-24 month old) show greater sleep/wake transitions in the 
active period with markedly shortened wake periods, shortened latency to 
sleep at the end of subjective night, and less wake time is observed in the 
subjective day in response to a novel social encounter. Consistent with 
sleep/wake instability and reduced social encounter wakefulness, we find 
that noradrenergic and orexinergic wake neurons in the aged mice display 
reduced c-fos with enforced wakefulness and endoplasmic reticulum 
dyshomeostasis with reduced BiP, persistent p-PERK and nuclear 
translocation of CHOP. We further hypothesize that transgenic mice with 
reduced BiP, like aged mice, would display wake impairments correlated to 
decreased neuronal activity and increased ER stress. Data from 12 month 
old BiP (+/-) and wild-type littermates will also be presented. 
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Interferon regulatory factor 1 (IRF-1) is a tumor suppressor protein that 
plays a central role in DNA damage and antiviral responses. There is 
currently a dearth of information concerning the IRF-1 proteome and how 
its structure and interactome relates to its function. We recently 
demonstrated the association of IRF-1 with members of the molecular 
chaperone family including Hsp70 and Hsp90. Like other Hsp90 client 
proteins, treatment with inhibitors such as 17AAG induces the proteasomal 
degradation of IRF-1. Conversely, upregulation of Hsp90 results in the 
accumulation of transcriptionally active nuclear, rather than cytoplasmic 
IRF-1 protein. Hsp70, which binds to sites in the N- and C-terminus of IRF-
1, mediates the effects of Hsp90. The C-terminal Hsp70 binding site on 
IRF-1 is a discrete Pro-Leu rich motif encompassing a co-signature LXXLL 
repressor motif. Mutation of the C-terminal Hsp70 binding motif is 
sufficient to render IRF-1 refractive to 17AAG induced degradation, 
suggesting that binding of Hsp70 plays a key role in IRF-1 regulation. 
 
Although the E3-ubiquitin ligase CHIP (C-terminus of Hsc70 interacting 
protein) can form a complex with IRF-1 through its association with Hsp70, 
we have also identified a direct interaction between these two proteins that 
is sufficient to signal IRF-1 ubiquitination. The interaction between CHIP 
and an Arg-Lys-Ser rich domain that forms a novel multi-protein binding 
interface on IRF-1 (Mf2-domain) is required to form a high affinity 
interaction; however, the CHIP:IRF-1 interface is complex and also 
involves additional weaker points of contact. CHIP, together with ubiquitin 
E2 enzymes of the UbcH5 and UbcH6 families, can efficiently ubiquitinate 
IRF-1 in the absence of Hsp70. Furthermore, both full length IRF-1 and the 
isolated Mf2 domain pull down CHIP from cells in a stress regulated 
manner. Thus, upon exposure to heat stress or heavy metals, soluble IRF-1 
protein levels decrease and it is found in complex with CHIP. Further, 
formation of the IRF-1:CHIP complex correlates with increased IRF-1 
ubiquitination. Our data suggests that IRF-1 function is highly regulated 
through the concerted actions of members of the chaperone family and that 
CHIP is an E3-ubiquitin ligase for IRF-1 under some stress conditions.  
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GRP94, the endoplasmic reticulum Hsp90, is a metazoan-restricted 
chaperone essential for early development in mammals, yet dispensable for 
mammalian cell viability. This dichotomy suggests that GRP94 is required 
for the functional expression of secretory and/or membrane proteins that 
enable cells to function in the context of tissues. To explore this hypothesis, 
we have identified the Drosophila ortholog of GRP94, Gp93, and report 
that Gp93 is an essential gene in Drosophila. Loss of zygotic Gp93 
expression is late larval lethal and causes prominent defects in the larval 
midgut, the sole endoderm-derived larval tissue. Gp93-null larvae display 
pronounced defects in the midgut epithelium, most prominently in the 
copper cell region. The copper cell region contains copper cells, the 
Drosophila equivalent of mammalian parietal cells, in register with 
interstitial cells. In Gp93-null larvae, the copper cells display highly 
aberrant apical membrane morphology, reduced gut acidification function, 
defects in the septate junctions (paracellular cell-cell interaction sites), and 
depressed gut motility. The defects in copper cell structure/function 
accompanying loss of Gp93 expression resemble those reported for 
mutations in labial, an endodermal homeotic gene required for copper cell 
specification and morphogenesis, and α-spectrin, thus suggesting an 
essential role for Gp93 in the functional expression of secretory/integral 
membrane protein-encoding lab protein target genes and/or integral 
membrane protein(s) that interact with the spectrin cytoskeleton, and which 
serve critical roles in cell morphogenesis, intercellular interactions, and 
epithelial membrane specialization. 
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The bacterial AAA+ chaperone ClpB cooperates with the DnaK (Hsp70) 
chaperone system in the solubilization and refolding of aggregated proteins. 
DnaK acts at initial stages of the disaggregation reaction, enabling ClpB to 
extract single unfolded proteins from an aggregate via ATP driven 
threading through its axial pore. ClpB harbors an N-terminal domain of 
unknown function, two AAA domains and a ClpB-specific middle domain 
(M-domain) that is essential for protein disaggregation. While the basic 
principle of ClpB-mediated protein disaggregation has been analyzed, 
central aspects of the disaggregation reaction are still poorly understood 
including the organization and structural dynamics of the ClpB hexamer. 
While hexameric models of ClpB based on cryo electron microscopy have 
been reported, such models are different in various central aspects and also 
do not provide a structural rationale for the unique disaggregation activity 
of ClpB. 
We analyzed the conformational changes occuring within ClpB upon 
oligomerization, ATP binding and ATP hydrolysis by proton-deuterium 
exchange experiments. We found that the M-domain showed dramatic 
structural changes upon ClpB oligomerization, suggesting that it is an 
integral part of hexameric ClpB assemblies. Upon ATP binding further 
structural changes are observed in the conserved motif 2 but not motif 1 of 
the M-domain, indicating that M-domain respond to nucleotides in a spatio-
specific manner. Further analysis of ClpB variants harboring mutations in 
either AAA-1 or motif 2 of M-domain reveals an interdependent 
communication between both domains. The implications of these findings 
on the mechanism of protein disaggregation will be discussed. 
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IRE1, an ER-localized transmembrane protein, plays a central role in the 
unfolded protein response. Upon ER stress, IRE1 senses the accumulation 
of unfolded proteins in the ER, and transfers signal from the ER to the 
cytosol. Recent studies indicate that the luminal domain of yeast Ire1 senses 
the unfolded proteins via a two-step mechanism. In the first step, BiP 
dissociation allows yeast Ire1 to make stable self-associate (or cluster). In 
the second step, direct association of unfolded proteins with the luminal 
domain of clustered Ire1 leads to its activation on the cytosolic effector 
domain. However, it has been unclear whether a similar mechanism is 
applicable to mammalian IRE1α. 
 
In this study, to elucidate the dynamic association mechanism of 
mammalian IRE1α, fluorescence correlation spectroscopy (FCS) was 
employed in living cells. FCS can analyse the association state of 
fluorescent molecules from diffusion measurement. This analysis revealed 
that upon ER stress IRE1α makes a transient and relatively small complex. 
Because the complex-formation was not detected in D123P mutant that is 
defective in self-association, this complex would represent the self-associate 
of IRE1α. Such a transient self-association in mammalian IRE1α is different 
from the stable cluster-formation of yeast Ire1. This implies the difference 
between the two sensors on the mechanism of ER stress sensing. 
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Alzheimer's disease (AD) is a neurodegenerative disorder characterized by 
neurofibrillary tangles, senile plaques, and cerebral amyloid angiopathy. 
Massive reactive gliosis with increased expression of the small heat shock 
proteins (sHsp) Hsp27 and αB-crystallin is found in association with 
diffused plaques. Strong association between sHsp immunoreactivity and 
severity of the AD-specific changes has been reported. However, the source 
of the normally intracellular chaperone has remained unclear. It has been 
suggested that it may accumulate passively after its release from dead or 
dying cells. Here we studied the expression pattern of Hsp27 and αB-
crystallin in 2 different mouse models (APP PS1 double transgenic mice 
and Tg2576 transgenic mice). The transgenic mice models accumulate 
plaques but show no cell death and are useful in delineating between 
passive release of chaperones and an act of cellular defense against protein 
aggregation. Immunostaining confirmed the induction of Hsp27 in plaques 
ridden areas of brains in transgenic specimens but showed a low basal 
expression in corresponding age-matched non-transgenic specimens. 
Interestingly, Hsp27 immunoreactivity showed a halo like pattern around 
the plaques. Costaining of the sections for Hsp27 and markers for neurons 
and glial cells showed no clear correlation with NeuN positive neurons and 
GFAP microglia with induced Hsp27. Thus, our results suggest that 
elevation of Hsp27 around the plaques is an active phenomenon, which 
needs further work to determine the cellular source. 
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The endoplasmic reticulum (ER) is an organelle composed of a continuous 
membrane system in which apparently opposite processes, such as protein 
folding and unfolding, take place. How proteins can either be properly 
folded and after passing ER quality control be transported, or if they fail to 
do so, be unfolded and targeted for retrotranslocation is not currently 
understood, especially for non-glycosylated substrates, which are handled 
by the ER Hsp70 BiP and its associated co-chaperones. There is evidence 
for the existence of an ER quality control compartment, but whether it is a 
constitutive or a transient structure is not known. Additionally, whether 
non-glycosylated BiP substrates are targeted to such ER compartments has 
not been tested. Since it has been reported that some proteins involved in 
endoplasmic reticulum associated degradation (ERAD) are enriched in the 
smooth ER, we are investigating whether proteins involved in protein 
folding and those involved in protein unfolding and degradation segregate 
differentially to the rough or smooth ER. We are particularly interested in 
how the ER DnaJ (ERdj) proteins, which regulate BiP’s ATPase activity as 
well as its interaction with substrates, localize within the ER. We are 
currently measuring the localization of several chaperones, co-chaperones 
as well as proteins involved in ERAD by subcellular fractionation and 
determining whether inducing ER stress changes their localization. In 
addition, we have observed an interaction between endogenous ERdj 
proteins and retrotranslocon components by co-immunoprecipitation, which 
is in agreement with a role for some ERdj proteins in the later stages of 
ERAD. These studies will help us determine whether BiP substrates are 
targeted to different ER subdomains for folding or unfolding and whether 
the ERdj proteins play a role in this process. 
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Tumor cells encounter an environment that has a decreased supply of 
oxygen and nutrients and increased accumulation of acidic by-products, 
which impinge on the folding capacity of the endoplasmic reticulum 
resulting in an increased amount of unfolded proteins. Cancer cells adapt to 
this microenvironment by activating cellular stress pathways including the 
Unfolded Protein Response (UPR). The UPR is a complex 
transcriptional/translational adaptation that assists in decreasing the 
unfolded proteins accumulated in the ER by transiently inhibiting protein 
translation, upregulating expression of ER chaperones and increasing the 
degradative capacity of the cell. To characterize the UPR in a solid tumor 
model we performed microarray analysis in Daoy, a human 
medulloblastoma cell line treated with a conventional UPR inducer 
thapsigargin. Increased expression of the expected UPR targets was 
observed, as were several proangiogenic factors including VEGF, FGF2, 
angiogenin and IL-8. Using real time PCR, we confirmed that these 
transcripts were elevated in several rat and human cancer cell lines, as well 
as mouse embryonic fibroblasts. Gene ontology analyses of the microarray 
data revealed significant enrichment of genes associated with regulation of 
angiogenesis. 19 genes annotated to angiogenesis were positive regulators. 
Of these, 14 genes have a greater than 2 fold increase in expression on UPR 
activation. To better characterize the role of the UPR, we first focused on 
VEGF. Real-time PCR analyses revealed that the UPR increases VEGF 
transcription rate and in some cell lines induction of VEGF with a 
conventional UPR inducer was even greater than that achieved with 
hypoxia, a well known inducer of VEGF. XBP-1(S), an UPR-inducible 
transcription factor binds to two regions on the VEGF promoter, also, 
ATF4, another UPR-inducible transcription factor binds to a regulatory 
region in the VEGF gene. We have also shown that VEGF mRNA stability 
is increased in response to UPR activation via AMP and p38MAP kinases. 
These results indicate that the UPR plays a significant role in regulating 
VEGF expression and is likely to be important and have widespread 
implication in angiogenesis and tumor growth. 
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C. ELEGANS MODELS OF PROTEIN MISFOLDING DISEASE. 
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Northwestern University, Department of Biochemistry, Molecular Biology, 
and Cell Biology, 2205 Tech Drive, Evanston, IL, 60208 
 
The heat shock response is a highly conserved response of all cells to stress 
and protein misfolding and in isolated cells, is autonomously initiated by 
protein damage. We showed previously that within the metazoan C. elegans 
the heat shock response is cell non-autonomously regulated by the 
thermosensory neuronal circuitry. Although affecting only 2 of the 959 
adult cells of C. elegans, mutations of the thermosensory (AFD) neurons 
alone were able to impair the transcriptional induction of heat shock 
proteins (HSPs) throughout the organism. Our studies suggested a model 
whereby neuronal signaling inhibited the cell autonomous response to heat 
shock allowing for the integration of the stress response throughout the 
organism. We are currently investigating how neuronal regulation 
influences protein folding homeostasis in C. elegans. We find that 
mutations in the thermosensory circuitry affect the aggregation of YFP-
tagged polyQ proteins in a tissue specific manner. While theremosensory 
neurons do not significantly change polyQ aggregation within muscle cells, 
the aggregation of polyQ repeat containing polypeptides within the intestine 
is significantly rescued in the AFD mutants in an HSF-1-dependent manner. 
Our studies are thereby consistent with the prediction that neuronal 
signaling within an organism inhibits the cell autonomous response to 
protein misfolding, and integrates the cellular responses to stress across the 
organism. We are using genetic, cell biological and biochemical studies to 
understand how neuronal function regulates protein folding. We anticipate 
that these studies will shed light on why in neurodegenerative diseases such 
as Huntington's disease, cells often fail to induce this protective response, 
leading to cellular dysfunction and death. 
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CYTOSOLIC PROTEINS 
 
Rupali Prasad, Shinichi Kawaguchi, Davis Ng  
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Research Link, Singapore, 117604, Singapore 
 
Intracellular quality control systems monitor protein conformational states. 
Irreversibly misfolded proteins are cleared through specialized degradation 
pathways. Their importance is underscored by numerous pathologies caused 
by aberrant proteins. In the cytosol, where most proteins are synthesized, 
quality control remains poorly understood. Stress-inducible chaperones and 
the 26S proteasome are known mediators but how their activities are linked 
is unclear. To better understand quality control of cytosolic proteins, a panel 
of model misfolded substrates was analyzed in detail. Surprisingly, their 
degradation occurs not in the cytosol but in the nucleus. Degradation is 
dependent on the E3 ubiquitin ligase San1p, known previously to direct the 
turnover of damaged nuclear proteins. San1p, however, is not required for 
nuclear import of substrates. Instead, the Hsp70 family proteins Ssa1p and 
Ssa2p are needed for efficient import and degradation. These data reveal a 
new function of the nucleus as a compartment central to the quality control 
of cytosolic proteins. 
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Liu Yang1,3, Shengyi Sun1,3, Yin He1,3, Zhen Xue1, Yewei Ji1, Sheng Xia1, 
Cindy Wang1, Haibo Sha1, Qiaoming Long1, Hui Chen2, Ling Qi1  
 
1Cornell University, Divison of Nutritional Sciences, 309 Biotech Building, 
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Unfolded protein response (UPR) is a key cellular defense mechanism 
associated with many human “conformational” diseases, including cancer, 
neurodegeneration, obesity and diabetes. In spite of its fundamental and 
clinical importance, little is known about UPR activation under 
physiological and pathological conditions. Here we have developed a 
sensitive Phos-tag-based system that allows for direct visualization of the 
early initiating events in UPR signaling in various in vivo conditions. Using 
this powerful tool, we characterized UPR activation in diverse tissues under 
various physiological and pathological conditions including fasting-
refeeding, obesity, and plasma cell differentiation. Strikingly, our data 
challenges the notion that plasma cell differentiation and obesity are 
associated with overt UPR activation; rather, we reveal two novel modes of 
non-canonical UPR activation in vivo. 
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SENSING CHAPERONE AVAILABILITY 
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A proper balance between synthesis, maturation and degradation of cellular 
proteins is crucial for cells to function properly. The costly process of 
protein synthesis is tightly coupled to energy status and nutrient levels by 
the mammalian target of rapamycin complex 1 (mTORC1), whereas the 
quality of newly synthesized polypeptides is largely maintained by 
molecular chaperone and ubiquitin-proteasome systems. Little is known 
about how cells sense both the quantity and quality of translational products 
to maintain intracellular homeostasis.  
 
Here we demonstrate that cells are able to distinguish moderate reductions 
in the quality of intracellular proteins from severe protein misfolding by 
differentially regulating mTORC1 signaling. This order-of-severity sensing 
mechanism relies on molecular chaperones. Reduction of chaperone 
availability enhances mTORC1 signaling, whereas depletion of chaperone 
availability under severe stress conditions suppresses mTORC1 signaling. 
We found that molecular chaperones regulate mTORC1 assembly by 
coordinating with nutrients. Analogous to the chaperone-mediated 
regulation of heat shock factor 1 (HSF1), this remodeling mechanism 
enables mTORC1 to rapidly detect and respond to environmental cues, 
while sensing intracellular protein misfolding. The tight linkage between 
protein quality and quantity control provides a plausible mechanism about 
how protein misfolding fuels metabolic dyshomeostasis. 
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We have reported a method to link protein folding to antibiotic resistance 
(1). We found that heterologous proteins inserted into TEM-1 β-lactamase 
will generate high levels of penicillin resistance if the heterologous protein 
is well folded. In the absence of efficient folding, the inserted protein is 
prone to degradation, separating β-lactamase into two parts. As a result, the 
host shows low level of resistance to PenV.  
 
We reasoned that one should be able to select for a folding enhancing host 
by plating cells on increasing concentration of β-lactam antibiotics. To 
minimize the possibility of obtaining mutations that merely increase 
intrinsic PenV resistance of the host (e.g. by altering cell wall permeability), 
a second system was developed utilizing another easily selectable 
phenotype: DsbA mediated resistance to cadmium. Similar to the β-
lactamase system, a guest protein is inserted into a permissive site of DsbA. 
It is noted that those two selection systems are independent of each other. 
They only have the inserted protein in common; the two markers (β-
lactamase and DsbA) and the principles of Penicilin and cadmium 
resistance are very different. Therefore, the host would be likely to show 
both increased PenV and CdCl2 resistance only if the folding of the guest 
protein is enhanced. 
 
Together, this dual system should be able to effectively select for a strain 
that improves the folding or stability of poorly folded proteins. A host strain 
was co-transformed with the β-lactamase plasmid and the DsbA plasmid 
containing a destabilized variant of the protein Im7. The resulting strain was 
mutagenized by EMS and selected for PenV resistance. Colonies with 
higher PenV resistance were screened for CdCl2 resistance. A number of 
strains that increase both penicillin and cadmium resistance were obtained; 
their characteristics will be described. 
 
 
1. Foit, L., Morgan, G. J., Kern, M. J., Steimer, L. R., von Hacht, A. A., 
Titchmarsh, J., Warriner, S. L., Radford, S. E., & Bardwell, J. C. (2009) 
Molecular cell 36, 861-871. 
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E. coli DegS is a protease, which can bind peptide signals exposed in 
misfolded outer-membrane porins (OMPs). This event activates cleavage of 
a transmembrane regulator (RseA) and ultimately transmits a signal that 
activates gene expression of stress genes in the cytoplasm. We will discuss 
the detailed allosteric mechanisms that are responsible for OMP-peptide and 
substrate-mediated activation of DegS. We also will discuss an independent 
regulatory mechanism, involving the RseB protein, that prevents cleavage 
of RseA unless a second stress signal is detected. 
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Mitochondria are multifunctional, reticulated organelles intimately 
embedded in cellular physiology. Dysfunction of mitochondria has severe 
cellular consequences and is linked to aging and neurodegeneration in 
human. 
 
Various intraorganellar proteases limit mitochondrial damage and prevent 
the accumulation of misfolded polypeptides with possibly deleterious 
effects on cellular integrity. These include AAA proteases, conserved ATP-
dependent proteases in the inner membrane, which exert versatile activities 
within mitochondria: 1) they conduct protein quality control surveillance 
and degrade misfolded and damaged inner membrane proteins; 2) they 
regulate mitochondrial biogenesis acting as processing peptidases; and 3) 
independent of their proteolytic functions, they mediate the ATP-dependent 
membrane dislocation of proteins. A mutational analysis of AAA domains 
of AAA protease subunits revealed that a coordinated ATP hydrolysis 
within AAA ring complexes is required for maximal force generation by 
these proteolytic machines. 
 
On an organellar level, fusion and fission of mitochondria contributes to the 
maintenance of mitochondrial activities and allows the selective removal of 
damaged mitochondria. Increasing evidence points to an intimate link of 
AAA protease function to mitochondrial dynamics and the dynamin-like 
GTPase OPA1, mutated in dominant optic atrophy. OPA1 is required for 
mitochondrial fusion, regulates cristae morphogenesis, and protects cells 
against apoptosis. Stress conditions and mitochondrial dysfunction induce 
degradation of OPA1 isoforms and trigger the fragmentation of the 
mitochondrial network allowing their autophagic degradation. 
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The bacterial AAA+ protein ClpB solubilizes and reactivates aggregated 
proteins in cooperation with DnaK and DnaJ (KJ). KJ act at initial stages of 
the disaggregation process, enabling ClpB to extract unfolded polypeptides 
from aggregates via substrate threading through its central channel. We 
show that this activity of KJ is essential to target ClpB to aggregates both in 
vitro and in vivo. However, substrate unfolding and threading can be 
rendered independent of KJ if the ClpB N-domain is replaced by that of V. 
cholerae ClpV, thereby generating a chimera which disassembles VipAB 
tubules. This system now allows to analyse the correlation between 
threading and ATPase activity in absence of the DnaK ATPase. 
To gain further insight into the disaggregation process we mapped the 
conformational changes within ClpB throughout the ATPase cycle by HD 
exchange and mutant analysis. Dramatic conformational changes were 
observed within the coiled coil (middle) domain upon oligomerisation, 
suggesting that it becomes integral part of the core of the hexameric ring 
structure. Upon ATP binding further structural changes occurred in 
particular in conserved motif 2 of the M-domain. Further analysis of ClpB 
variants harboring mutations in either motif 2 or the first ATPase domain 
reveals an interdependent communication between both domains. 
Conserved residues of the middle domain including Y503 are essential for 
cooperation with KJ to mediate access of substrates to the central pore of 
ClpB. The mutant phenotypes observed in vitro correlate to aggregate-
targeting/disaggregation defects in vivo. 
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Misfolded proteins in the lumen of the endoplasmic reticulum (ER) are 
eliminated by a pathway called ER-associated protein degradation (ERAD) 
or retro-translocation. Luminal proteins selected for ERAD (ERAD-L 
substrates) are moved across the ER membrane, poly-ubiquitylated and 
released into the cytosol for proteasomal degradation. The mechanism of 
retro-translocation of ERAD-L substrates is largely unknown but requires a 
complex containing the ubiquitin ligase Hrd1p and three other membrane 
proteins (Hrd3p, Usa1p, and Der1p). We have developed an in vivo photo-
crosslinking assay to identify the binding partners of an ERAD-L substrate 
along the ERAD pathway. We find that the substrate interacts initially with 
Hrd3p and the luminal lectin Yos9p and is then transferred to the ubiquitin 
ligase Hrd1p. Hrd1p-crosslinking requires an intact degradation signal and 
is affected by mutations in certain ERAD components. Usa1p is needed at a 
subsequent step in which Hrd1p undergoes oligomerization. Surprisingly, 
ubiquitination is required prior to the function of Usa1p. Our results define 
a pathway of ERAD-L and indicate that Hrd1p is its central component. 
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Selective destruction of misfolded proteins can occur by dedicated quality 
control QC ubiquitination pathways. The E3 ligases responsible for these 
pathways are tasked with recognition of structural features shared by many 
misfolded substrates. For such QC pathways to be useful biologically 
useful, they must allow the selective destruction of misfolded variants of 
normally-stable proteins, but be sufficiently general to mediate the 
degradation of many diverse proteins. Furthermore, they should alleviate 
the physiological effects of proteotoxic stress. It is known that chaperone-
dependent ubiquitination of misfolded proteins occurs in the eukaryotic 
cytosol, but the E3s involved have remained unclear.  
 
Using a variety of approaches in yeast, we have discovered that the 
ubiquitin ligases Ubr1 and San1 are required for destruction of misfolded 
proteins that originate in the cytosol. These E3s function to detect and 
eliminate a wide variety of cytoplasmic misfolded proteins, by providing 
parallel but independent pathways for QC ubiquitination. In both cases, 
Hsp70 chaperones and specific co-chaperones are required for successful 
ubiquitination of cytoplasmic substrates, and damaged proteins are 
selectively targeted. In each case, a role in cytoplasmic QC for these E3s is 
surprising. The San1 E3 is a nuclear ligase required for degradation of 
misfolded proteins in that compartment. Our date indicate that misfolded 
cytoplasmic substrates are delivered to the nucleus in a chaperone-
dependent manner. The highly conserved Ubr1p ligase is traditionally 
known for its involvement in the N-end rule, by which proteins with 
specific destabilizing N-termini are subject to rapid degradation. The QC 
function of Ubr1p is distinct from the N-end rule function, and targets 
misfolded proteins in the cytosol. Phenotypic studies indicate that both 
Ubr1 and San1 can serve to eliminate proteotoxic stresses, and that the Urb1 
ligase may be central to alleviation of cellular stresses that occur in the 
cytoplasmic compartment. We have developed an in vitro assay to directly 
study the action of these ligases on misfolded proteins, and the details of the 
chaperone requirement in each pathway. Our current model is that 
cytoplasmic proteins are subject to both biochemical and cell biological 
versions of chaperone-mediated triage, thus ensuring their degradation by a 
number of available degradation mechanisms both in and separate from 
their cytoplasmic place of origin. 
 133 
CHAPERONE-ASSISTED SELECTIVE AUTOPHAGY (CASA) IS 
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How are biological structures maintained in a cellular environment that 
constantly threatens protein integrity? Here we elucidate proteostasis 
mechanisms affecting the Z-disk, a protein assembly essential for actin 
anchoring in striated muscles, which is subjected to mechanical, thermal 
and oxidative stress during contraction. Based on the characterization of the 
Drosophila melanogaster co-chaperone Starvin (Stv), we define a conserved 
chaperone machinery required for Z-disk maintenance. Instead of keeping 
Z-disk proteins in a folded conformation, this machinery facilitates the 
degradation of damaged components, such as filamin, through chaperone-
assisted selective autophagy (CASA). Stv and its mammalian ortholog 
BAG-3 coordinate the activity of Hsc70 and the small heat shock protein 
HspB8 during disposal that is initiated by the chaperone-associated 
ubiquitin ligase CHIP and the autophagic ubiquitin adaptor p62. Impaired 
CASA results in Z-disk disintegration and progressive muscle weakness in 
flies, mice, and men. Our findings reveal the importance of chaperone-
assisted degradation for the preservation of cellular structures, and identify 
muscle as a tissue that highly relies on an intact proteostasis network, 
thereby shedding light on diverse myopathies and aging.  
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Accumulation of misfolded proteins in the cell is associated with a variety 
of diseases including liver diseases, cystic fibrosis and neurodegeneration. 
Misfolded proteins in the endoplasmic reticulum (ER) are typically 
degraded by ER associated degradation (ERAD), which involves 
retrotranslocation of the protein from the ER to the cytosol and degradation 
by the proteasome. However, some misfolded proteins are poorly 
recognized by the ERAD system, necessitating their disposal by other 
pathway(s) that are not well characterized.  
 
To understand these alternate pathways, we created a fluorescent protein-
tagged misfolded variant of the prion protein that is efficiently targeted to 
the ER, but does not appear to undergo ERAD, which we call PrPmisf. Using 
time-lapse live cell imaging in combination with other FP-tagged markers, 
we have analyzed the fate of this misfolding PrP variant. We observe that in 
steady state conditions, PrPmisf is localized primarily to ER and can also be 
found in lysosomes. However upon treatment with ER-stressors, the entire 
ER-localized population of PrPmisf is synchronously segregated from ER-
resident proteins and transported to lysosomes via the Golgi apparatus. 
 
These findings establish a simple and robust system to study selective 
sorting and lysosomal targeting of misfolded ER-retained proteins. We are 
currently using this model to identify the key factors and molecular 
mechanisms involved in the selective recognition, segregation, and 
transport of misfolded proteins from the ER to lysosomes. We are 
addressing the role of ER-stress response in triggering this degradation 
pathway. The findings from this study may provide novel insights into the 
regulation of degradation pathways utilized by other disease-related 
proteins that transit the secretory pathway. 
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Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis 
of several neurodegenerative diseases. In Parkinson's disease (PD), ER 
stress markers are significantly increased in postmortem brains, and 
neurotoxins used to induce the degeneration of dopaminergic neurons in 
vivo can trigger ER stress. Here we show that parkin, which is mutated in 
the majority of autosomal recessive parkinsonism, is transcriptionally 
regulated by the unfolded protein response (UPR) pathway and prevents ER 
stress-induced damage of mitochondria. Up-regulation of parkin under ER 
stress is mediated via the PERK/ATF4 branch of the UPR by binding of 
ATF4 to a specific site within the parkin promoter. In addition, we show 
that c-Jun can bind to the same site within the parkin promoter, but acts as a 
transcriptional repressor of parkin gene expression. Parkin-mediated 
protection of cells from ER stress-induced cell death is independent of the 
proteasome and does not decrease the level of ER stress. Instead, parkin can 
suppress mitochondrial dysfunction and damage induced by ER stress. Our 
study emphasizes an important role of ER and mitochondrial stress in the 
pathogenesis of PD and indicates that parkin plays a role in the 
interorganellar crosstalk between the ER and mitochondria to promote cell 
survival under stress. 
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Mitochondria have been the cornerstone of longevity research in yeast, 
worms, flies and rodents to connect rates of metabolism with longevity. The 
initial finding that mitochondrial reduction during a specific time in the 
worm’s life cycle could be uncoupled from mitochondrial metabolic activity 
suggested that mitochondria might establish the rate of aging in a manner 
that is independent of previously anticipated modes, such as generation of 
reactive oxygen species. In our search for this signaling mechanism we 
report that key tissues are essential for establishing and maintaining the 
prolongevity cue from altered mitochondria. Additionally, we find that the 
mitochondrial unfolded protein response is essential and specific for the 
ETC longevity pathway. Finally, we find that mitochondrial perturbation in 
one tissue can be perceived and acted upon in distal tissues that have not 
undergone mitochondrial perturbation. This last finding indicates that 
mitochondrial stress in one cell can be communicated to unaffected cells in 
a multicellular organism. 
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To understand the structural basis of protein aggregation and of chaperone 
action in reversing aggregation, we have determined crystal structures for 
some 60 fibril-like microcrystals of segments of aggregating proteins, and 
also of small heat shock proteins of the alpha crystallin class. The fibril-like 
structures have common features, consisting of pairs of tightly 
interdigitating beta sheets, with a dry interface. Several fibril-forming 
segments crystallize in more than one polymorph, illuminating the atomic 
basis of amyloid polymorphism. 
 
The alpha crystallins show unusual polymorphic interfaces, essentially 
encoding polydisperse intermolecular contacts. One interface is domain 
swapped, in two different ways. Another shows three distinct antiparallel 
beta interactions, with ratchet-like character.  These polymorphic interfaces 
ensure polydisperse solutions of alpha-crystallin, preventing crystallization 
even at its high concentration in the eye lens, thereby preventing light 
scattering in the lens. 
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Mutant and wild type transthyretin (TTR) molecules are the amyloid 
precursors in the systemic amyloidoses Familial Amyloidotic 
Polyneuropathy and Cardiomyopathy and Senile Systemic (Cardiac) 
Amyloidosis. TTR transgenic models express many of the features of the 
respective diseases. The molecular mechanisms of TTR aggregation, fibril 
formation and cytoxicity for cultured target cells have been defined in detail 
as have the similar processes related to Aβ, the toxic protein in human 
Alzheimer’s disease (AD). We previously reported that crossing a mouse 
strain over-expressing the wild type human transthyretin gene (that 
develops age dependent systemic deposition) with the well characterized 
APP23 transgenic model of human AD profoundly suppresses the 
neuropathologic and abnormal behavioral features seen in APP23 mice 
expressing only the human AD-associated transgene. Further the AD-like 
neurodegenerative disease is accelerated when the APP23 AD gene is 
expressed on the murine TTR knockout background. Surface plasmon 
resonance revealed that recombinant human and murine TTR interact with 
Aβ 1-40/1-42 . Our recent data indicate that the majority of hippocampal and 
cortical neurons from human AD brains and APP23 mice stain with an 
antibody to TTR (not seen in control brains) indicating that those neurons 
contain TTR. We now report that primary neurons from APP23 mice 
transcribe 10 times as much TTR mRNA as do those from control WT B6 
mice. They also synthesize and secrete TTR protein. Both characteristics are 
even more prominent in primary neurons from the APP23 x hTTR 
transgenic animals. Confocal images of primary neurons from mice 
expressing both the human AD gene and TTR show intracellular co-
localization of TTR and Aβ or its precursors. Co-immunoprecipitation 
experiments of APP23 cortical brain extracts with anti-TTR and anti-Aβ 
antibodies show that the two proteins intimately interact in vivo. The data 
suggest that the biologically protective effect of TTR in the APP23 murine 
model of human AD is related to the direct interaction of TTR and some 
form of Aβ. We have also shown that TTR inhibits seeding of Aβ nuclei in 
vitro and the cytotoxicity produced by Aβ oligomers in tissue culture. The 
relevance of the interaction to disease pathogenesis is further suggested by 
the induction of TTR transcription in neurons in response to the 
introduction of the Aβ precursor by lentiviral infection. The data are 
consistent with the systemic amyloid precursor TTR serving a chaperone-
like function for some form of Aβ as part of a transcriptionally regulated 
anti-amyloidogenic neuronal proteostatic response. 
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The formation of protein misfolded oligomers is a constant challenge for any living 
organism and a causal event of many diverse human diseases. It is increasingly 
recognized that early oligomers, rather than mature fibrillar aggregates, are the 
pathogenic species in protein deposition diseases. We have designed protocols to 
form two types of oligomers from the HypF-N protein. The first is toxic when added 
to cultured cells and injected into rats' brains, whereas the second type is benign. We 
have also used established protocols to form toxic oligomers from the Aβ peptide 
associated with Alzheimer’s disease. We have tested the effect of five molecular 
chaperones, namely human Hsp70, human αB-crystallin and the three known 
extracellular chaperones (human clusterin, aptoglobin and α2-macroglobulin) on the 
toxicity of pre-formed oligomers. All five chaperones were found to be effective in 
suppressing or decreasing remarkably the toxicity of both HypF-N and Aβ 
oligomers, whereas they were found to have no effect on the non-toxic HypF-N 
oligomers. Such an effect is chaperone-dependent as control proteins such as 
lysozyme and BSA were found to leave the toxicity of preformed oligomers 
unaffected. The suppression of the oligomers toxicity by the chaperones was 
monitored by all the measurables of cell viability. This means that while HypF-N 
toxic oligomers cause an entry of extracellular calcium into the cytosol, an increase 
of the cellular ROS levels, a permeabilization of the cell membrane to the oligomers 
and to the calcein probe and mitochondrial dysfunction, the five tested chaperones 
suppressed all these events. To gain molecular insight into the interaction between 
the chaperones and the pre-formed oligomers we have focused on HypF-N 
oligomers and αB-crystallin. We found that the ThT-binding of the preformed 
HypF-N oligomers was not affected by αB-crystallin, indicating that the oligomers 
are not disassembled by the chaperone. αB-crystallin did not change the pyrene 
fluorescence at three critical positions within preformed HypF-N oligomers 
(involved in the difference between toxic and non-toxic oligomers), indicating that 
the chaperone did not cause a structural reorganization of the oligomers. Analyses 
performed with SDS PAGE and intrinsic fluorescence of the soluble and insoluble 
fractions indicated binding between the HypF-N oligomers and αB-crystallin, 
suggesting that the chaperone suppresses toxicity by shielding the reactive surfaces 
on the oligomers. Overall, the data present evidence on the ability of chaperones to 
bind and neutralize preformed toxic oligomers and offer molecular insight into their 
mechanism of action. 
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Neurodegenerative diseases constitute a class of illnesses marked by 
pathological protein aggregation in the neurons of affected individuals. 
Although these disorders are invariably characterized by the death of highly 
specific sub-populations of neurons, protein aggregation occurs in all cells, 
which indicates that disease states arise only when aggregates manifest a 
toxic gain-of-function in particular cellular environments. The precise 
determinants of this toxic effect are not well defined. The starting point for 
uncovering the origins of neurodegenerative disease pathology must 
therefore be a thorough understanding of the protein folding quality control 
system that eukaryotic cells employ to mitigate the potentially toxic 
consequences of aggregation. Here we show that an essential factor in 
preventing aggregate-induced toxicity in human cells is the proper 
compartmentalization of soluble and insoluble aggregates. We find that the 
toxicity of ALS-linked aggregates of mutant superoxide dismutase 1 
(SOD1G93A) and the enhanced toxicity of a mutant glutamine-expanded 
Huntingtin is due to their localization in the JUNQ, a central cellular quality 
control compartment that is normally a destination for soluble misfolded 
proteins to be refolded or degraded. By localizing to the JUNQ, these 
poorly soluble proteins retain Hsp70, an essential chaperone, thereby 
impairing the solubility of other JUNQ substrates. Enhancing the 
sequestration of toxic SOD1G93A in an insoluble compartment, the IPOD, 
alleviates the harmful effects of SOD1 aggregation on cell viability. Our 
results underline the importance of spatial organization of cellular quality 
control in avoiding unproductive and harmful interactions between toxic 
aggregates and essential chaperones. We propose that diverting toxic 
aggregates from the JUNQ to the IPOD sequestration compartment as a 
potential strategy for alleviating the toxicity underlying neurodegenerative 
diseases. 
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The copper-zinc superoxide dismutase-1 (SOD1) is a highly structured 
protein and, a priori, one of the least likely proteins to be involved in a 
misfolding disease. However, more than 140, mostly missense, mutations in 
the SOD1 gene cause aggregation of the affected protein in familial forms 
of amyotrophic lateral sclerosis (ALS). The remarkable diversity of the 
effects of these mutations on SOD1 properties has suggested that they 
promote aggregation by a variety of mechanisms. Experimental assessment 
of surface hydrophobicity using a sensitive fluorescent-based assay, 
revealed that diverse ALS-causing mutations provoke SOD1 
amyloidogenesis by increasing their propensity to expose hydrophobic 
surfaces. These findings could not be anticipated from analysis of the amino 
acid sequence. Our results uncover the biochemical nature of the misfolded 
amyloidogenic precursor and reconcile the seemingly diverse effects of 
ALS-causing mutations into a unifying mechanism. Furthermore, the 
method we describe here will be useful for investigating and interfering 
with aggregation of various proteins and thereby provide insight into the 
molecular mechanisms underlying many neurodegenerative diseases. 
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Protein misfolding and aggregation have the potential to seriously damage 
living cells, and can be involved in neurodegenerative diseases such as 
Alzheimer’s and Huntington’s. Several artificially designed peptides with 
alternating hydrophobic and hydrophilic residues have previously been 
described. These β-peptides form stable amyloid structures and are toxic to 
cells. This system has allowed us to study amyloid aggregation in cells without 
any interference from loss of function effects that complicate studies on 
naturally occurring amyloidogenic proteins. It has long been postulated that 
amyloids exert their toxicity at least in part through aberrant interactions with 
other components of the proteome.  
 
We have tested this possibility by expressing myc-tagged versions of such β-
peptides in HEK293T cells followed by immunoprecipitation and analysis of 
the interacting partners using quantitative mass spectrometry. Using this 
approach, we have found more than 100 interactors of a toxic β-peptide. 
Analysis of the physical properties of these interactors shows that they contain 
significantly more predicted regions of intrinsic disorder than the average 
protein found in the lysate, suggesting that the β-peptides are able to target a 
portion of the proteome which is already in a partially unfolded state.  
 
We have furthermore used a pulsed-SILAC technique to show that the β-
peptides preferentially interact with proteins early during their lifetimes, 
perhaps before they have completed correct folding. There is, however, a subset 
of proteins which interact with the β-peptides later during their lifetimes, 
presumably after they have folded. These proteins are particularly enriched in 
predicted disorder, emphasizing the importance of disorder for binding to 
amyloid. We also show that chaperones, particularly Hsp110, interact strongly 
with the β-peptides early during the aggregation process, and in amounts 
correlating to the toxicity of the β-peptide.  
 
Taken together, these results suggest that amyloidogenic peptides interact with 
an unstable portion of the proteome; either with proteins which have yet to 
properly fold, or with proteins that contain intrinsically disordered regions. This 
second portion of the interactome also tends to be involved in a large number of 
cellular interactions, and contains components of many important regulatory 
pathways. Loss of function of such a segment of the proteome could lead to the 
collapse of key cellular functions and thus to severe toxicity. 
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A common pathological denominator of different neurodegenerative 
disorders, such as Alzheimer's disease or Prion diseases, is the formation of 
aberrant protein conformers and the occurrence of pathognomonic 
proteinaceous deposits. However, there is an ongoing debate about the 
nature of the toxic protein species and how they selectively damage 
neuronal populations. Interestingly a previous study in transgenic mice 
revealed that the heat shock factor (HSF) 1, the major transcriptonal 
regulator of the cytosolic heat shock response (HSR), can modulate 
neuronal survival in a mouse model of infectious prion diseases (Steele et 
al, PNAS, 105, 2008). We have now established a novel cell culture model 
to specifically study the impact of infectious and mutant prion proteins on 
the regulation of the cytosolic HSR and to analyze whether the HSR might 
be protective against toxic effects of aberrant PrP conformers. Neither PrPSc 
nor neurotoxic PrP mutants induced the HSR, however, they lowered the 
threshold for an induction of the HSR and sensitized cells to stress-induced 
cell death. Moreover, expression of an constitutively active HSF1 or the 
overexpression of cytosolic HSP70 alleviated the toxic effects of infectious 
PrPSc and neurotoxic PrP mutant. These data emphazise a protective role of 
the HSR in neurodegenerative disorders and suggest that infectious and 
mutant prion proteins might activate similar intracellular signaling 
pathways. 
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Since proteins are responsible for most biological functions, the physiology 
of a cell, tissue, organ or organism depends on the proper quality of the 
proteome. Proteins are protected against misfolding by molecular 
chaperones, which constitute a central element of the cellular machinery of 
protein quality control. Terminally misfolded proteins are degraded by the 
proteolytic arm of quality control. The proper balancing of folding, 
refolding and degradation is critical in maintaining protein homeostasis (or 
proteostasis). The disturbance of proteostasis is associated with numerous 
diseases, including neurodegenerative conditions such as Huntington’s and 
Parkinson’s disease. To measure and compare the status of the protein 
quality control system in different conditions, we generated a series of 
proteostasis sensors. These proteins are increasingly destabilized versions of 
firefly luciferase, a protein known to require molecular chaperones for 
folding and refolding. The mutant proteins were employed to compare the 
folding capacity of different mammalian cell lines. We showed further that 
the gradual collapse of the proteostasis network during aging results in the 
aggregation of GFP-tagged versions of the sensor proteins in C. elegans. In 
summary, we have generated a set of widely applicable proteostasis sensors 
from a single reporter protein, which can be used to study the dysregulation 
of proteostasis in different disease states. 
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Propagation of all known yeast prions requires the disaggregating activity 
of the hexameric AAA+ chaperone Hsp104. Intriguingly, overproduction of 
Hsp104 "cures" cells of the [PSI+] prion, while having little to no effect on 
other yeast prions. Previous studies demonstrated that Hsp104’s ability to 
cure [PSI+] is independent of activities related to thermotolerance and 
disaggregation, as the amino-terminal domain of Hsp104 is required for 
curing but dispensable for disaggregation. Also, earlier evidence suggests 
that the Hsp70 mutant Ssa1-21 impairs [PSI+] by a similar mechanism. Here 
we confirm this link by finding deletion of STI1, which suppress Ssa1-21 
impairment of [PSI+], also blocks Hsp104 curing of [PSI+]. Hsp104's TPR 
interaction motif was dispensable for curing, but cells expressing Sti1 
mutants defective in Hsp70 or Hsp90 interaction cured less efficiently and 
the Hsp90 inhibitor radicicol abolished curing. These results imply Sti1 acts 
in curing through Hsp70 and Hsp90 interactions, possibly by coordination 
of their activities. Accordingly, strains lacking constitutive or inducible 
Hsp90 isoforms cured at reduced rates. We confirm an earlier finding that 
elevating free ubiquitin enhances curing, but it did not overcome inhibition 
of curing caused by Hsp90 defects, suggesting Hsp90 is important for the 
contribution of ubiquitin to curing. We also find curing associated with cell 
division. Our findings identify Sti1 and Hsp90 as crucial for efficient curing 
of [PSI+] by overexpressed Hsp104, point compellingly to a role for Hsp70 
in prion curing, and provide evidence supporting the earlier suggestion that 
destruction of prions by protein disaggregation does not adequately explain 
the curing. 
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Tetratricopeptide repeat (TPR) motif containing co-chaperones of the 
chaperone Hsp90 are considered control modules that govern activity and 
specificity of this central folding platform. Here, we compared the influence 
of the TPR proteins FK506 binding proteins 51 and 52, protein 
phosphatase-5, C-terminus of Hsp70 interacting protein, cyclophillin 40, 
hepatitis-virus-B X-associated protein-2, and tetratricopeptide repeat 
protein-2 on all six steroid hormone receptors in a homogeneous 
mammalian cell system. To be able to assess each cofactor’s effect on the 
transcriptional activity of on each steroid receptor we employed transient 
transfection in a reporter gene assay. In addition, we evaluated the 
interactions of the TPR proteins with the receptors and components of the 
hsp90 chaperone heterocomplex by coimmunoprecipitation. In the 
functional assays, corticosteroid and progesterone receptors displayed the 
most sensitive and distinct reaction to the TPR proteins. Androgen 
receptor’s activity was moderately impaired by most cofactors, whereas the 
Estrogen receptors’ activity was impaired by most cofactors only to a minor 
degree. Second, interaction studies revealed that the strongly receptor-
interacting co-chaperones were all among the inhibitory proteins. 
Intriguingly, the TPR-proteins also differentially co-precipitated the 
heterochaperone complex components Hsp90, Hsp70, and p23, pointing to 
differences in their modes of action. Thus, the results of this comprehensive 
study provide important insight into chaperoning of diverse client proteins 
via the combinatorial action of (co)-chaperones. 
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Formation of aberrant protein conformers is a common pathological 
denominator of different neurodegenerative diseases, such as Alzheimer's 
disease or prion diseases. Increasing evidence indicates that soluble 
oligomers are associated with early pathological alterations in these entities. 
Moreover, oligomeric assemblies of different disease-associated proteins 
may share common structural features. However, little is known about 
possible co-factors and signaling pathways implicated in neuronal cell 
death. Using a novel cell culture assay we show that expression of the 
cellular prion protein (PrPC) sensitizes cells to toxic effects of soluble 
amyloid-β (Aβ) oligomers, secreted by transfected cells or prepared from 
synthetic peptides. Both the unstructured N-terminal domain and the C-
terminal glycosylphosphatidylinositol anchor of PrPC are required to 
mediate toxic effects of Aβ. Interestingly, the same domains of PrPC are 
required to mediate toxicity induced by the scrapie prion protein (PrPSc). 
Moreover, adverse effects of both Aβ and PrPSc could be blocked by an 
NMDA receptor antagonist and an oligomer-specific antibody. Our study 
emphasizes that PrPC is involved in toxic signaling of pathogenic protein 
conformers associated with different neurodegenerative diseases. 
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Cellular quality control processes such as ER associated degradation 
(ERAD) and the Unfolded Protein Response (UPR) occur at varying 
timescales and impact protein concentrations and intracellular localization1-
4. We investigated the UPR during heterologous protein expression in S. 
cerevisiae by evaluating single-cell level protein expression, trafficking, 
and dynamics in vivo using fluorescent protein (FP) variants and confocal 
microscopy. Our experimental system includes live cell imaging of ER 
luminal (BiP, PDI, Scj1) and membrane proteins (Sec61, Doa10, Hrd1) 
expressed as FP fusions under the endogenous promoters. Using this 
system, we can continuously monitor protein trafficking during protein 
translocation, protein folding/maturation, and ERAD in order to: analyze 
localization effects of proteins involved in ERAD; examine organelle 
dynamics under various environmental conditions to initiate ERQC; and 
confirm the existence of cellular variability during UPR activation. In 
addition, we have quantified the expression, localization, and activity of 
heterologous proteins (i.e. G-protein coupled receptors (GPCRs)) and 
identified specific mechanisms that play a role in trafficking of GPCRs. By 
understanding these interactions and verifying the results with Western 
analysis and pulse-chase, we have been able improve GPCR trafficking and 
localization in S. cerevisiae.  
 
 
1. McCraken, A. and Brodsky, J. Evolving questions and paradigm shifts in 
endoplasmic-reticulum-associated degradation (ERAD) BioEssays (2003) 25:868-
877. 
2. Brodsky, J. The protective and destructive roles played by molecular chaperones 
during ERAD (endoplasmic-reticulum-associated degradation) Biochem. J. (2007) 
404:353-363. 
3. Schroder, M. and Kaufman, R. ER stress and the unfolded protein response. 
Mutation Research (2005) 569:29-63. 
4. Ng, D., Spear, E., and Walter, P. The Unfolded Protein Response Regulates 
Multiple Aspects of Secretory and Membrane Protein Biogenesis and Endoplasmic 
Reticulum Quality Control. J. Cell Bio. (2000) 150:77-88. 
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It remains largely unexplained why the most aggressive p53 missense 
mutations possess dominant-negative activity and why they often display 
gain of oncogenic activity. Since p53 is active as a tetramer, the current 
view is that dominant-negative effects arise from the formation of inactive 
mixed tetramers that incorporate both mutant and wild type p53. Gain-of-
function is believed to result from a poorly defined conformational 
perturbation of the wild type by mutant p53 within the tetramer. Here we 
show, both in cultured cells and in murine and human tumours, that the 
dominant-negative activity of p53 mutants is not tetramer-dependent but 
instead results directly from the increased aggregation propensity of these 
mutants. Upon aggregation, mutant p53 is able to induce misfolding and 
aggregation of wild-type p53 into cellular inclusions. Further, we show that 
aggregation of p53 induces heat-shock response and is responsible for the 
inactivation by co-aggregation of its paralogues p63 and p73. Suppression 
of the aggregation propensity in mutant p53 completely abrogates these 
gain-of-function effects and fully restores wild type activity. Finally, using 
existing literature we classify patient data by the propensity of the mutant to 
form aggregates and find a significant difference in loss-of-heterozygosity 
and clinical outcome. Aggregating p53 mutants associate with poorer 
therapeutic response and long-term survival and tumor progression is also 
less dependent on loss-of-heterozygosity. The poorer clinical outcome of 
patients with aggregating mutations suggests that inhibition of p53 
aggregation might be a valuable therapeutic strategy. 
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The conformational changes throughout the Hsp90 ATPase cycle are 
controversial. We set out to obtain a dynamic picture of Hsp90 throughout 
its active cycle and upon binding of co-factors. NMR spectroscopy is the 
method of choice for studying protein dynamics, but we had to overcome 
the problem that Hsp90’s molecular weight is one order of magnitude above 
the traditional NMR size limit. 
 
We made human Hsp90beta accessible for an NMR approach by combining 
advanced NMR technology and an assignment strategy based on its isolated 
domains. We focussed on Isoleucine side chains, which are ubiquitously 
present all over Hsp90 and result in higher intensity than the usual amide 
spectra. This allowed us to annotate key elements in Hsp90 such as the ATP 
binding pocket, the ATP lid or the N-terminal dimerisation helix and to 
monitor their changes in the full-length protein by NMR. 
 
We mapped conformational changes in Hsp90 upon binding of nucleotide, 
drugs and co-factors. This resulted in a comprehensive picture of Hsp90 
throughout its active cycle. The results will be presented. 
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J proteins are obligate cochaperones of Hsp70s. Each contains a highly 
conserved J domain that plays a critical role in the stimulation of Hsp70's 
ATPase activity, thus stabilizing their interactions with client proteins. 
However, regions outside the J domain are structurally diverse. We have 
been using Saccharomyces cerevisiae as a model system to understand the 
evolution and specialization of J-protein function. The yeast cytosol/nucleus 
contains three J-proteins (Ydj1, Apj1 and Xdj1) having a domain structure 
very similar to that of DnaJ (often called Class I J-proteins). The absence of 
only one of these three, the very abundant Ydj1, causes an obvious growth 
defect. To understand J-protein specificity we have sought to identify the in 
vivo function of Apj1.  
Our data supports the hypothesis that Apj1 is involved in the SUMO (Small 
Ubiquitin Like Modifier) pathway, specifically in SUMO-targeted ubiquitin 
degradation, which has dedicated E3 ubiquitin ligases that recognize SUMO 
modified substrates and target them for ubiquitin mediated proteolysis. 
First, a deletion of APJ1 has a synthetic growth defect when combined with 
a deletion of either SLX5 or SLX8 (Synthetic Lethal of [X] unknown 
function), which encode known subunits of the Slx5-Slx8 SUMO-targeted 
ubiquitin ligase (STUbL) complex. Secondly, SUMO-conjugated proteins 
accumulate in apj1Δ slx5Δ cells. Thirdly, a known target of the Slx5:Slx8 
STUbL complex, Mot1 (Modifier of Transcription), is affected in apj1∆ 
cells, as in slx5∆ cells. Together, our preliminary results suggest that Apj1 
co-operates with the Slx5:Slx8 STUbL complex in recognition and/or 
degradation of proteins in yeast and thus has a role in protein quality 
control. Interestingly, no genetic interaction was observed between slx5∆ 
and a deletion of either YDJ1 or XDJ1, suggesting that Apj1 performs a 
specialized function in this pathway, not carried out by other Class I J 
proteins. Experiments are in progress to determine the basis of this 
specificity of Apj1 function. 
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The endoplasmic reticulum (ER) stress response is a defense system for 
dealing with the accumulation of unfolded proteins in the ER lumen. This 
system is termed the unfolded protein response (UPR). In mammalian cells, 
the three major ER stress transducers of the UPR are PERK, IRE1, and 
ATF6. These transducers sense unfolded proteins in the ER lumen and 
transduce signals to the nucleus. We identified Old Astrocyte Specifically 
Induced Substance (OASIS) as a novel ER stress transducer, which is 
especially expressed in astrocytes in central nervous system, and involved 
in the ER stress response. OASIS has the transmembrane domain that 
allows it to associate with the ER, and it also possess the transcription 
activation domain and the bZIP domain. However, the function of OASIS in 
astrocytes has remained unclear. We generated Oasis deficient mice to 
examine the roles of OASIS in astrocytes. Although the primary cultured 
astrocytes prepared from E18.5 Oasis deficient mice did not show the 
significant morphological differences, the BrdU corporation assay showed 
that the proliferation of Oasis deficient astrocytes were progressed 
compared with wild type astrocytes. We examined the expression levels of 
astrocyte differentiation markers using the neural precursor cells (NPCs) 
prepared from E14.5 mice. The expression levels of Gfap and S100β which 
are the markers of mature astrocytes, were decreased in Oasis deficient cells 
during astrocyte differentiation. In E18.5 mice cerebral cortex, the number 
of GFAP and S100β positive cells was decreased in Oasis deficient mice. In 
contrast, the number of Nestin and bLBP, which are the markers of 
immature astrocytes, positive cells was increased in Oasis deficient mice. 
Taken together, the maturation from NPCs to astrocytes was inhibited, and 
immature astrocytes, which are exhibited higher proliferation potential, 
were increased in Oasis deficient mice. 
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The chaperone and ubiquitin proteasome systems comprise the two major 
pathways to prevent the accumulation of misfolded proteins. The ubiquitin 
ligase (E3) CHIP sits at the interface of these pathways and is a critical 
component of the cellular response to proteotoxic stress. The mechanisms 
regulating the activity of CHIP, however, remain poorly understood. Here 
we describe a mechanism for the activation and inactivation of CHIP that 
relies on the addition and removal of ubiquitin to CHIP. We identify a novel 
ubiquitin conjugating enzyme (E2), Ube2w, that monoubiquitinates CHIP, a 
modification that is essential for CHIP function in cells. We also describe a 
novel mechanism that couples the completion of substrate ubiquitination 
with the inactivation of CHIP: We show that the deubiquitinating enzyme 
(DUB) ataxin-3, limits the length of polyubiquitin chains added to CHIP 
substrates and deubiquitinates CHIP in response to completion of substrate 
ubiquitination. Together these data describe a novel regulatory mechanism 
that regulate CHIP function and provide new insight into the functionality 
of DUB/E3 pairs. 
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Protein aggregation results in beta-sheet–like assemblies that adopt either a 
variety of amorphous morphologies or ordered amyloid-like structures. 
These differences in structure also reflect biological differences; amyloid 
and amorphous beta-aggregates have different chaperone affinities, 
accumulate in different cellular locations and are degraded by different 
mechanisms. Further, amyloid function depends entirely on a high intrinsic 
degree of order. Here we experimentally explored the sequence space of 
amyloid hexapeptides and used the derived data to build Waltz, a web-
based tool that uses a position-specific scoring matrix to determine 
amyloid-forming sequences. Waltz allows users to identify and better 
distinguish between amyloid sequences and amorphous beta-aggregates and 
allowed us to identify amyloid-forming regions in functional amyloids. 
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GRP94, the endoplasmic reticulum hsp90, participates in the 
conformational maturation of proteins destined for surface display or 
export, including all of the Toll-like receptors, IgGs, insulin-like growth 
factors, and some integrins. Despite having over 50% sequence identity 
with cytoplasmic Hsp90 and similar structures, the two paralogs have not 
been shown to complement each other in vivo, suggesting that mechanistic 
differences between the two exist. We have shown earlier that the N-
terminal regulatory domain of GRP94 contains a unique ligand-dependent 
switch that leads to an opening, rather than a closing, of the “lid” elements 
when nucleotides occupy the ATP binding pocket. This “extended open” 
conformation appears to be incompatible with both the “closed” lid and the 
formation of the N-terminal dimer interface that were observed upon ATP 
binding to Hsp90. To further probe the conformational states available to 
GRP94 and its mechanistically distinct lid, we have now determined the 
structure of the N-terminal domain of GRP94 in complex with PUH54, a 
novel inhibitor that binds with high affinity to GRP94 but only weakly to 
cytoplasmic Hsp90. The structure of the GRP94-PUH54 complex reveals a 
novel lid state for GRP94 that, for the first time, places it on a trajectory 
towards a conformation that closes over the ATP binding pocket. This 
conformation has implications both for the mechanistic cycle of GRP94 and 
also for the design of specific inhibitors for GRP94. 
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Endoplasmic reticulum (ER) stress has been reported to be present in liver 
and adipose tissue of obese mice and suggested to link obesity to insulin 
resistance and type 2 diabetes. To alleviate the stress in ER and maintain its 
homeostasis, the unfolded protein response (UPR) is considered to be 
activated. The haploinsufficiency of X-box binding protein 1 (XBP1), a key 
transcription factor of UPR, resulted in impaired insulin signaling. 
However, the tissue-specific function of XBP1 in obesity hasn’t been 
investigated. Here we will present the data for these studies. 
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Expression of Ribulose 1,5 bisphosphate carboxilase/oxygenase (Rubisco) 
is tightly regulated by light-induced redox changes. We describe a gene-
specific chaperone that is associated with nascent synthesis of the large 
subunit (LSU) polypeptide in a redox-sensitive manner. In land plants and 
green algae, Rubisco holoenzyme consists of eight large and eight small 
subunits (L8S8). We previously showed that oxidative stress leads to a 
dramatic arrest in the synthesis of its LSU, and a complete cessation of 
holoenzyme assembly. In the absence of assembly partners, the free small 
subunits (SSU) are therefore rapidly degraded. Interestingly, the N-terminus 
of Rubisco LSU is structured as a hidden RNA Recognition Motif (RRM), 
since it is buried and masked in the mature assembled protein. However, 
oxidizing conditions induce conformational changes that lead to exposure of 
this domain, promoting its RNA binding activity and causing ribosome 
stalling. The LSU-encoding rbcL transcript remains associated with the 
ribosomes, but shifts from heavy to light polysomes, as well as to 
monosomes, supporting that regulation occurs during translation elongation. 
We propose that during nascent synthesis of Rubisco LSU chains, the 
growing chain interacts with a dedicated chaperone that blocks the RNA 
binding activity of the N-terminal RRM domain, until assembly takes place. 
This novel regulatory mechanism is ancient and conserved throughout 
photosynthetic organisms, as it is also observed in land plants and in purple 
bacteria (Rhodospirillum rubrum), that express the primitive form II of 
Rubisco. This form consists of only two LSU chains and lacks the SSU. We 
propose that under oxidizing conditions the nascent LSU chains fail to 
interact with their dedicated chaperones, resulting in exposure of the RRM 
that binds any RNA in its vicinity. A novel DnaJ-like protein that is 
required for expression of Rubisco was identified in the chloroplasts of 
maize bundle sheath cells (BSD2). The partial similarity with DnaJ is by 
virtue of its four zinc finger domains. We identified the BSD2 homolog 
from the green alga Chlamydomonas reinhardtii and show that under 
normal conditions multimers of this protein are associated with rbcL loaded 
polysomes. Exposure to oxidizing conditions, or introducing a nonsense 
mutation in the rbcL coding region change its polysomal distribution, 
providing support to the association of BSD2 with nascent LSU chains. 
Altogether we describe a novel mechanism for chaperone-assisted control 
of Rubisco expression. 
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Protein synthesis is assisted and sustained in living cells by a number of 
factors including heat shock protein (HSP) and cyclophilin (CyP) 
chaperones. These molecular chaperones bind to nascent as well as mature 
proteins. The discovery of HSPs was realized through their identification as 
immediate responsive genes/proteins to heat stress, and later shown to bind 
denatured or unfolded proteins upon heat stress to protect structural 
conformation and prevent irreversible aggregation of specific proteins. The 
program of ripening (senescence) is the terminal stage of fruit development, 
which, in tomato, is associated with a ~10-fold reduction in de novo protein 
synthesis. However, during the initial stages of ripening the HSP and CyP 
transcripts persist, and are undetected thereafter. We are exploring the 
role(s) of these chaperones in fruit development and ripening, and during 
abiotic stresses. With this aim in mind, we have created novel transgenic 
tomato fruit that have longer life and are relatively better adept at 
withstanding heat shock stress. One of these transgenic plants overexpresses 
a yeast S-adenosylmethionine decarboxylase (SAMDC) gene in a ripening-
specific manner, and accumulates higher polyamines i.e. spermidine and 
spermine. The latter protect plants against abiotic stresses, and enable 
constitutive and sustained increase in transcripts of small HSPs and CyP 
during ripening. We are analyzing the tomato sHSP17.6 gene promoter and 
mRNA sequence for the presence of cis acting elements. Specific heat 
shock elements (HSEs) were found in the sHSP17.6 promoter region as 
well as downstream in mRNA coding sequence. Also apparent are DNA-
binding sites for transcription factors such as WRKY, MYB and CBF. We 
are experimentally testing direct and indirect interactions between HSEs, 
stress related transcription factors and polyamine-responsive elements 
(PREs). These studies should throw further light on our understanding of 
crosstalks among transcriptional factors regulating fruit development and 
ripening and, in particular, the role of chaperone genes.  
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Peroxiredoxins are ubiquitous antioxidants which protect cells against 
oxidative stress. We show that the yeast Tsa1 and Tsa2 peroxiredoxins co-
localize to ribosomes where they function to protect the Sup35 translation 
termination factor against oxidative stress-induced formation of its heritable 
[PSI+] prion conformation. In a tsa1 tsa2 [psi-] [PIN+] strain, the 
frequency with which the [PSI+] prion forms de novo is significantly 
elevated. The Tsa1 and Tsa2 peroxiredoxins, like other 2-Cys 
peroxiredoxins, have dual activities as peroxidases and chaperones, and we 
show that the peroxidase activity is required to suppress spontaneous de 
novo [PSI+] prion formation. Molecular oxygen is required for [PSI+] 
prion formation since growth under anaerobic conditions prevents prion 
formation in the tsa1 tsa2 mutant. Conversely, oxidative stress conditions 
induced by exposure to hydrogen peroxide elevates the rate of de novo 
[PSI+] prion formation leading to increased suppression of all three 
termination codons in the tsa1 tsa2 mutant. Altered translational fidelity in 
[PSI+] strains has been suggested to provide a mechanism which promotes 
genetic variation and phenotypic diversity. In agreement with this idea, we 
find that prion formation provides yeast cells with an adaptive advantage 
under oxidative stress conditions, since elimination of the [PSI+] prion 
from tsa1 tsa2 mutants renders the resulting [psi-] [pin-] cells 
hypersensitive to hydrogen peroxide. These data support a model where 
peroxiredoxins function to protect the ribosomal machinery against 
oxidative damage, but when these systems become overwhelmed, [PSI+] 
prion formation provides a mechanism for uncovering genetic traits which 
aid survival during oxidative stress conditions. We are currently 
investigating the mechanism of [PSI+] prion formation in the tsa1 tsa2 
mutant and will present our recent data describing the role of oxidative 
stress in prion formation. 
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The mechanisms for de novo protein folding differ significantly between 
bacteria and eukaryotes, as evidenced by the often observed poor yields of 
native eukaryotic proteins upon recombinant production in bacterial 
systems. Polypeptide synthesis rates are faster in bacteria than in 
eukaryotes, but the effects of general variations in translation rates on 
protein folding efficiency have remained largely unexplored. By employing 
E. coli cells with mutant ribosomes whose translation speed can be 
modulated, we have found that reducing polypeptide elongation rates leads 
to enhanced folding of diverse proteins of eukaryotic origin, including 
luciferase from the firefly P. pyralis, the green fluorescent protein from A. 
victoria and the telomere-binding protein Cdc13 from S. cerevisiae. These 
results suggest that in eukaryotes, protein folding necessitates slow 
translation rates. We have performed controls to rule out that the observed 
results are a consequence of increased protein degradation during slow 
translation or increased amino acid misincorporation during fast translation. 
In order to ascertain that a slow translation regime did not trigger the 
bacterial stress response, we analyzed steady-state levels of the main 
chaperones involved in protein folding in E. coli. We found no major 
differences in the chaperone levels between cultures grown under slow and 
fast regimes. We found that this generalized reduction in translation speed 
does not adversely impact the folding of the endogenous bacterial proteome, 
which confirmed our earlier observations that protein folding in bacteria 
appears to be largely uncoupled from protein synthesis. Utilization of this 
strategy has allowed the production of native eukaryotic multi-domain 
proteins previously unattainable in bacterial systems and may constitute a 
general alternative to the production of aggregation-prone recombinant 
proteins. 
 
 
This work was supported by a grant from the Welch Foundation (H-1648 to 
J.M.B.). 
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GroEL and GroES form a chaperonin nano-cage for single protein 
molecules to fold in isolation. Whether the isolation of folding-substrates is 
the sole determinant of efficient folding inside the cavity or the chaperonin 
nano-cage edits the folding-information encoded by the amino acid 
sequence is not understood. Here, we addressed this question using a 
double-mutant of the maltose binding protein, DM-MBP, as a substrate. We 
show that DM-MBP refolding is not limited by the formation of reversible 
aggregates and populates a kinetically-trapped state that is collapsed but 
structurally disordered. Introducing two long-range disulfide bonds into the 
DM-MBP sequence reduces the entropic barrier of folding and accelerates 
native state formation ~10-fold. Strikingly, steric confinement of the 
unfolded DM-MBP in the chaperonin cage closely mimics the effect of 
constraining disulfides on folding kinetics, in a manner mediated by 
negative charge clusters of the cage wall. These findings suggest that 
chaperonin dependence correlates with the tendency of proteins to populate 
entropically stabilized folding intermediates. The capacity to rescue proteins 
from such folding traps may explain the uniquely essential role of the 
chaperonin-cages within the chaperone network. 
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Protein degradation by the eukaryotic 26S proteasome or the homologous 
archaeal PAN-20S proteasome complex is a multistep process that requires 
ATP hydrolysis by the proteasome-associated AAA ATPase complex. 
However, the mechanisms by which these hexameric ATPases utilize ATP 
to promote protein breakdown and activate proteasomal function are poorly 
understood. Although PAN contains six identical ATPase subunits, we 
found that it exhibits three types of binding sites: 2 high affinity 
conformations (Kd=0.2uM), 2 with lower affinity (Kd=60uM), and 2 with 
conformations that fail to bind ATP. In fact, PAN never bound more than 
four of any type of nucleotide (ADP, ATP, or the nonhydroylyzable analog 
ATPγS), even at high concentrations. ATP binding to the high and lower 
affinity sites has distinct functional consequences on the proteasome. With 
two ATPγS molecules bound, PAN maximally stimulates opening of the 
gated channel for substrate entry into the 20S proteasome and has a high 
affinity for the 20S as well as for protein substrate. However, the binding of 
4 ATPγS reduces PAN’s ability to stimulate gate opening as well as its 
affinity for the 20S and substrates. These functional consequences of 
nucleotide binding are conserved in the mammalian 26S proteasome, since 
gate opening exhibited nearly identical multiphasic dependence on ATPγS 
concentration as found for the PAN-20S complex. Because ATP binding 
drives the association of the C-termini of the ATPase with the 20S and only 
two ATPase subunits bind ATP for maximal function it’s likely that only 
two ATPases’ C-termini dock into the 20S at any time and in a predictable 
pattern. This observation suggests how the hexameric ATPase ring 
associates with the heptameric 20S proteasome to regulate substrate 
degradation. 
 163 
AN EARLY ROLE FOR HSP70 IN THE FORMATION OF 
AGGRESOMES 
 
Matthew C Smith1, Gladis M Walter1, Susanne Wisén1, Martin 
Duennwald2, Jason E Gestwicki1  
 
1University of Michigan, Life Sciences Institute, 210 Washtenaw Ave, Ann 
Arbor, MI, 48109, 2Boston Biomedical, Research Institute, 64 Grove St, 
Watertown, MA, 02472 
 
During times of limited proteasomal function, aggresome formation is the 
active process by which cells sequester misfolded proteins towards the 
microtubule-organization center and away from the rest of the functioning 
proteome. Recent evidence has suggested that this aggregation process may 
be beneficial. However, very little is known about the molecular 
mechanisms that facilitate aggresome formation and only a few of the major 
mediators of aggregation are known. For example, genetic studies have 
suggested a role for heat shock protein 70 (Hsp70) in aggresome formation, 
but the details of this process remain uncertain. To specifically explore the 
roles of Hsp70 without changing its cellular concentration, we have 
developed membrane-permeable, chemical tools that stimulate or inhibit the 
ATPase activity of this chaperone. These probes are designed to explore the 
timing of Hsp70’s actions and to understand how nucleotide-dependent 
structural transitions impact aggresome formation. Using both yeast and 
mammalian cells expressing the polyQ expanded exon 1 fragment of 
Huntingtin protein (Htt), we pharmacologically manipulated the ATPase 
activity of Hsp70. Fluorescence microscopy experiments showed that this 
activity is only important during early stages of Htt aggregation. Moreover, 
stimulating this activity caused an accumulation of toxic structures, 
consistent with a role for soluble, oligomeric polyQ in proteotoxicity. To 
understand whether these toxic structures are associated with specific 
protein-protein interactions, we performed immunoprecipitations of Htt and 
identified compound-dependent interacting proteins by tandem mass 
spectrometry. These studies revealed a number of chaperones, including 
Hsp26, which differentially interact with Htt during aggregation. Together, 
these biochemical and chemical genetic studies are beginning to reveal the 
hierarchy of proteins downstream of Hsp70 that facilitate aggresome 
formation. 
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The ubiquitous family of Hsp70 molecular chaperones preserve core 
functional properties throughout phylogeny, such as the allosteric regulation 
of a substrate-binding domain (SBD) through dynamic coupling to an 
ATPase domain, and interaction with co-chaperone proteins that further 
modulate Hsp70 activity and provide links to specific functional roles. In 
eukaryotic Hsp70s, a C-terminal sequence motif mediates interaction with 
Chip, Hip and Hop proteins to coordinate Hsp70 function with other 
chaperone networks and degradation machinery. However, these proteins 
do not exist in bacteria, leading us to ask why many bacterial Hsp70s 
contain C-terminal sequence beyond the structured SBD β-domain and 
helical lid. Analysis of a multiple sequence alignment of 739 diverse 
Hsp70s reveals two sub-families based on patterns of C-terminal 
conservation: one group displays sequence resembling closely the 
eukaryotic protein-protein interaction motif, and surprisingly, a second 
group displays a previously undescribed conservational pattern distinct 
from eukaryotes. We explored the functional roles of these conserved sites 
within bacterial Hsp70s by mutation of the predominant E. coli Hsp70, 
DnaK. While all variants including C-terminal truncations are able to 
support lambda phage replication, in the context of a more stringent in vivo 
assay for DnaK function that we have developed, truncations and point 
mutations that alter the conserved C-terminal motif lead to loss of function. 
Purified DnaK constructs harboring the deleterious C-terminal mutations do 
not alter substrate binding, interdomain allostery or interaction with the co-
chaperones DnaJ and GrpE in vitro, suggesting that the C-terminus is 
involved in a previously uncharacterized functional role. 
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Yeast cells can be used to screen candidate drugs against mammalian prions 
since yeast prion exhibits clear mechanistic analogies but stringent species 
barrier with mammalian prion PrP. Although the coloration reporter system 
of [PSI+]/[psi-] yeast cells is a convenient tool to identify the ability of the 
tested molecules, there are a number of false positives including, in 
particular, compounds interfering with the white/red reporter system but not 
prion aggregation. In addition, SDS-PAGE analysis, which is used as a 
traditional quantification method in secondary screening by Bach et al., 
cannot detect the relative size of polymers which play an important role in 
the aggregation of Sup35p. In this study, an improved semi-denaturing 
detergent-agarose gel electrophoresis (SDD-AGE) technique, which could 
get more molecular weight information, were used to quantify the effects of 
tested compounds on Sup35p aggregation at protein level. Moreover, with 
the expression of Sup35p-GFP (NGMC) the fluorescent foci and 
fluorescence recovery after photobleaching (FRAP) were used to quantify 
the effects of tested compounds on Sup35p aggregation by confocal 
microscope realtimely in the living yeast cell. Using these two methods, 
effects of two known active antiprion compounds GuHCl and 
phenanthridine on Sup35p aggregation was precisely quantified at protein 
and cell levels. This result indicated that fluorescent assay and SDD-AGE 
analysis are of great feasibility to quantify the curing effects of candidate 
antiprion compounds in the yeast-based screening system. 
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Early researches on yeast prion have found that [PSI+] phenotype could 
transiently appear in an SUP35 repeat-expansion mutant [psi-] strain at 
stressful conditions, such as high salt concentrations. In this study, we 
investigated [PSI+] phenotype change with native Sup35p under different 
conditions of sodium chloride, magnesium chloride, sodium formate and 
sodium acetate. Moreover, the Sup35p status changes in vivo were further 
quantified with fluorescence recovery after photobleaching (FRAP) 
technique and semi-denaturing detergent-agarose gel electrophoresis (SDD-
AGE) analysis at cell and protein levels.  
Interestingly, although all tested salt stresses could result in different 
intensity of stress-dependent [PSI+] phenotype and present dose-dependent 
relationship in [psi-] yeast strains, the characters of Sup35p aggregation 
state in these stress induced cells were diversified. Fluorescent assay 
showed that fluorescent foci could appear only in sodium formate treated 
Sup35p-GFP (NGMC) [psi-] cells. FRAP results indicated all those four salt 
stresses induced Sup35p aggregate to a certain extent in [psi-] cells and the 
size of aggregates had increased with a time-dependent relationship. The 
aggregate sizes of Sup35p under 1M magnesium chloride and sodium 
formate conditions were bigger than those under 1M sodium chloride and 
sodium acetate conditions. SDD-AGE results indicated that SDS-insoluble 
Sup35p polymers, which might act as “seeds”, obviously presented only in 
magnesium chloride and sodium formate treated [psi–] cells. However, it 
seemed that those SDS-resistant Sup35p polymers are apparently different 
from that in [PSI+] cells. In addition, the influence of [PIN+] on Sup35p 
polymerization could not be readily excluded.  
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Folding proteins into their correct conformation is necessary for cellular 
vitality. Dysregulation of protein homeostasis can lead to protein 
aggregation and amyloid formation that is associated with numerous 
neurodegenerative disorders. In yeast, however, prions can “misfold” to 
form a self-propagating aggregate that is innocuous. The protein Sup35 is 
thought to convert to a prion form when changing conditions make its prion 
state, [PSI+], confer selective growth advantages. While a number of 
molecular chaperones affect the formation and propagation of the [PSI+] 
prion, another prion, [RNQ+], formed by Rnq1p, regulates the epigenetic 
switch of Sup35p. This is thought to occur by a direct physical interaction 
between the [RNQ+] prion and Sup35p, but the mechanism is unclear. 
Using a reporter for the [RNQ+] prion status, we previously identified a 
number of missense mutations in Rnq1p that greatly reduced the induction 
of [PSI+], but did not affect the propagation of [RNQ+]. With these Rnq1p 
mutants, we conducted a screen for second-site suppressors using a Sup35p 
chimera. We identified mutations in this construct that rescued the [PSI+] 
induction defect of the Rnq1p mutants. We hypothesize that the amino acid 
residues around these mutations define the interface between the [RNQ+] 
prion and Sup35p. We hope that further analysis will provide evidence that 
the [RNQ+] prion acts to cross-seed the formation of [PSI+]. This work will 
help elucidate how one aggregated protein can facilitate the conformational 
change of another protein. Strikingly, though, once the [PSI+] prion is 
propagating, the [RNQ+] prion has no effect. Instead, once prions are 
established, chaperones play a crucial role. 
One of the best-characterized chaperones in yeast is Hsp104p. The deletion 
of Hsp104p cures all known prions. While over-expression of Hsp104p also 
cures the [PSI+] prion, it has been shown to not affect [RNQ+]. Using the 
same reporter protein we developed, we can screen for chaperones that, 
when over-expressed, affect the propagation of [RNQ+]. Interestingly, it is 
suggested that chaperones have varied effects on different prion 
conformations, also called prion strains or variants. With this work, we 
hope to provide insight into how molecular chaperones recognize and affect 
prion variants differently. 
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In eukaryotes, proteasomes represent the main degradation route for cellular 
proteins, however, in bacteria, the occurrence of the 20S proteasome is 
limited to the group of actinobacteria, amongst them the highly pathogenic 
Mycobacterium tuberculosis (Mtb). Mtb uses a tagging system functionally 
analogous to eukaryotic ubiquitination, termed pupylation, to recruit 
substrates for proteasomal degradation. The pupylation-degradation 
pathway contributes to the virulence of Mtb supporting its persistance and 
proliferation inside the host macrophages. We have reconstituted and 
characterized the pupylation pathway that leads to conjugation of the 
prokaryotic ubiquitin-like protein (Pup) to proteasomal substrate proteins. 
We show that Pup is rendered coupling-competent by deamidation of its C-
terminal glutamine through the action of a previously uncharacterized 
protein Dop (deamidase of Pup). Then, PafA catalyzes formation of an 
isopeptide bond between the glutamate and a substrate lysine. The latter 
step turns over one ATP to ADP per coupled Pup, suggesting that Pup is 
activated for conjugation via phosphorylation of its C-terminal glutamte.  
We have also investigated the events downstream of the pupylation 
pathway, which lead to degradation of pupylated substrate proteins by the 
mycobacterial proteasome complex. We demonstrate that the proteasomal 
ATPase Mpa alone can recruit and unfold pupylated substrates, but that for 
degradation, physical interaction between Mpa and the proteasome is 
required. Initially, Pup is recognized by the coiled-coil domains of Mpa. 
Subsequently, the pupylated substrate is engaged into the Mpa-pore via the 
flexible N-terminal segment of Pup, suggesting that this segment functions 
as an unfolding initiation site. This assigns a dual role to Pup, serving to 
tether the substrate to the proteasome complex in analogy to ubiquitin, but 
unlike ubiquitin additionally serving also to initiate unfolding. As a result, 
unlike ubiquitin that is recycled at the regulatory particle, Pup is degraded 
along with the substrate protein.  
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Quality control processes maintain protein homeostasis by regulating 
polypeptide folding and degradation. Nascent and misfolded polypeptide 
folding is promoted by molecular chaperones, but rapid degradation ensues 
when they are inhibited. This degradation has clinical application such as 
when oncogenic kinases are degraded upon Hsp90 inhibition with 
geldanamycin. Mammalian CHIP is one ubiquitin ligase that promotes such 
degradation, but knocking out CHIP results only in limited breakdown of 
the quality control system indicating the presence of other ubiquitin ligases. 
Recent studies from our lab found that S. cerevisiae Ubr1 and Ubr2 
ubiquitin ligases are involved in the cytosolic protein quality control. We 
therefore wanted to test whether the same quality control pathway is 
conserved in a mammalian system.  
We used an in vivo geldanamycin-dependent degradation assay to see the 
effect of mouse UBR1 and UBR2 (homologs of yeast Ubr1) in the 
clearance of misfolded proteins. Using UBR1-/-, UBR2-/- and UBR1-/- 
UBR2-/- mouse embryonic fibroblasts we observed that there was reduced 
degradation of several Hsp90 client protein kinases, including Akt and 
Cdk4 compared to wild type cells. Strikingly there was an increase in the 
cellular levels of CHIP, a chaperone-associated ubiquitin ligase in the UBR 
knock out cells. In addition, we observed that UBR1 and UBR2 knockout 
cells were more resistant to geldanamycin with respect to cell viability. This 
phenotype was similar to that observed in yeast. These findings suggest that 
UBR1 and UBR2 promote cytosolic quality control in a conserved manner 
in a mammalian system.  
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The activator of Hsp90 ATPase, Aha1, is a putative Hsp90 co-chaperone 
that is so named, because it activates Hsp90 catalyzed ATP hydrolysis. 
Genetic studies have implicated Aha1 as being a general stimulator of 
Hsp90 function, and studies in vitro indicate that Hsp90 and Aha1 directly 
interact. Here we have examined the interactions of Aha1 with Hsp90 and 
its co-chaperone components under quasi-physiological conditions in 
reticulocyte lysate. Formation of stable complexes between Hsp90 and 
Aha1 required the addition of molybdate to reticulocyte lysate. The 
molybdate-stabilized interaction was labile in the presence of 0.5 M NaCl, a 
property common to complexes formed between Hsp90 and its co-
chaperones. Pull-down assays indicate that Aha1 is present in Hsp90 
complexes that also contain FKBP52 and p23. However, Aha1 was found to 
be absent from Hsp90 complexes containing p60/HOP, HIP, Hsp70 or 
Cdc37. Furthermore, while Aha1, like its smaller yeast homologue Hch1, 
restores v-Src activity in yeast strains deficient in Hsp90 function, no 
interaction of Aha1 and newly synthesized v-Src was detected and over-
expression of Aha1 in reticulocyte lysate did not stimulate the activity of v-
Src. In addition, no Aha1 was detected in Hsp90 complexes formed with 
newly synthesized progesterone hormone receptor and AKT, and over-
expression of Aha1 in reticulocyte lysate reduced Hsp90-dependent 
renaturation of thermally denatured firefly luciferase. However, an 
interaction between over-expressed Aha1 and AKT was detected in HeLa 
cells. Overexpression of Aha1 or suppression of Aha1 expression via 
shRNA in cultured cells had no effect on phosphotyrosine levels, suggesting 
that Aha1’s effect on v-Src activity in yeast is indirect. A concentration-
dependent increase in ANS fluorescence was observed upon its titration into 
a solution of recombinant Aha1p or its C-terminal START domain, but not 
its N-terminal domain, indicating the presence of a hydrophobic binding 
pocket. Aha1’s lipid binding specificity and interactions with novel client 
proteins will be discussed. (This work was supported by a grant from the 
OCAST: HR03-076). 
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Hsp90 is an evolutionary conserved molecular chaperone involved in 
cellular stress response and protein homeostasis. In addition, it has an 
important role in e.g. signal transduction, chromatin remodeling and cell 
cycle. In contrast to other cellular chaperones, Hsp90 does not appear to be 
a general chaperone for de novo folding. Rather, it stabilizes a wide variety 
of client proteins and keeps them poised for activation. Multiple high-
throughput studies in various organisms have uncovered many new Hsp90 
clients, but several aspects of the clients remain elusive. How does Hsp90 
recognize its client proteins? Are there sequence or structural features that 
characterize client proteins? How do various cochaperones contribute to 
Hsp90 specificity? 
 
We have utilized and further developed a luminescence and ELISA-based 
LUMIER assay to study protein-protein interactions (PPIs). The enhanced 
LUMIER assay facilitates quantitative measurement of PPIs in mammalian 
cells in high-throughput format. Its high sensitivity and linear range allows 
quantitative analysis of the effects of point mutations that cause subtle 
changes in protein interaction profiles. Furthermore, the assay is compatible 
with signaling-dependent events or small-molecule inhibitors. 
 
We have used the assay to study the association of Hsp90 with a large set of 
functionally important human proteins (kinases, transcription factors, 
cellular quality control proteins), and uncovered hundreds of new Hsp90 
client proteins. Our results also establish how alternative splicing, 
posttranslational modifications, single-nucleotide polymorphisms and 
clinically relevant disease mutations can influence Hsp90 clientele. 
Furthermore, interaction assays with known and novel Hsp90 cochaperones 
have allowed us to construct quantitative interaction maps that reveal how 
Hsp90 clientele is shaped by both general cochaperones and client-specific 
adaptor proteins. 
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Mutations in human p97, a type II AAA+ protein, have been implicated in 
IBMPFD (inclusion body myopathy associated with Paget’s disease of the 
bone and frontotemporal dementia). Previous crystallographic analyses 
showed that wild type p97 are invariably bound with ADP in the D1 
domain. Here, we show the crystal structures of ND1 fragment of the 
disease-related p97 mutants, for the first time, with ATPγS bound in the D1 
domain. In the present structure, the N domain undergoes rotational and 
translational movement. This conformational change has been confirmed to 
be driven by the bound nucleotide forms instead of caused by mutations, as 
the movement is reversible by ADP. Small angle X-ray scattering 
experiments further suggest that wild type p97 can undergo similar 
conformational change as that observed in the mutants. P97 is known to 
have pre-bound ADP in its D1 domain. We found that the amount of pre-
bound ADP in D1 domain is consistently lower in mutants. Nucleotide 
binding affinity of the D1 domain in mutants, as determined by ITC 
experiments, showed slightly lowered Kd values towards ADP than in wild 
type p97. Interestingly, titration with ATPγS displayed a unique biphasic 
exothermal profile which was only observed in the mutants, which could 
only be fitted by a two-site model suggesting that mutants allow the binding 
of ATPγS to both empty and ADP-prebound D1 sites. However, in the case 
of wild type p97, ATPγS can only get into the empty D1 sites and 
nucleotide exchange is prohibited in the sites with ADP-prebound.  
We proposed that IBMPFD mutations altered the nucleotide binding 
behavior of the D1 domain during the ATP cycle thus allowing a uniform 
and symmetrical binding of all D1 sites within the hexamer for ATPγS. As 
a result, all the N domains in a p97 hexamer could undergo a concerted 
conformational change as supported by the present crystal structures and the 
biphasic titration profile from ITC experiments for the mutants. In the wild 
type scenario, there is a tight control over the timing of nucleotide exchange 
among the D1 domains within the hexamer and the pre-bound ADP is not 
easily exchangeable. ATPγS is only allowed to get into the D1 empty sites 
suggesting an asymmetric hexamer in the presence of ATPγS. We believe 
that this asymmetric property in nucleotide states of D1 domains in various 
subunits of a p97 hexamer is essential for the function of p97. External 
stimulus such as ATP hydrolysis in D2 domain or interaction with adaptor 
proteins may be needed to trigger the nucleotide exchange at the ADP-
prebound sites. The present work also shed light into how the mutations 
might affect the function of p97 leading to the disease.  
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High mannose-type oligosaccharides, cotranslationally introduced to a 
nascent polypeptide by N-glycosylation, play a critical role in protein 
quality control (folding, transport and degradation). The fates of newly 
synthesized glycoproteins are thought to be determined through interactions 
with intracellular lectins such as EDEM (ER-degradation enhancing α-
mannosidase-like protein), ERGIC-53 and VIP36 that recognize high 
mannose-type glycans and are induced by ER stress. EDEM has been 
reported to recognize misfolded glycoproteins and facilitate the ERAD of 
misfolded glycoproteins. Cargo receptors (ERGIC-53 and VIP36) are 
known to recognize only a limited number of folded glycoproteins and 
transport their cargoes selectively through the secretory pathway. 
Antithrombin (AT) and α1-antitrypsin (α1-AT) are plasma glycoproteins 
that function as proteinase inhibitors. Three AT mutants (AT ΔE, AT ΔF, 
AT P-stop) and two α1-AT mutants (α1-AT NHK, α1-AT Z) are known to 
be degraded through the ERAD pathway. Here we examined if these lectins 
participate in the quality control of misfolded glycoproteins, using these 
three AT and two α1-AT mutants as model proteins. Co-
immunoprecipitations of EDEM with three AT mutants were observed, but 
not with AT Wt. Co-transfection of EDEM accelerated the degradation of 
AT P-stop. However, to our surprise, it delayed the degradation of AT ΔE 
and acclerated the secretion of AT ΔF without degradation. These results 
suggest that EDEM regulates the degrdation and secretion of AT mutants. 
Overexpression of ERGIC-53 induced a marked increase in the secretion of 
both α1-AT NHK and α1-AT Z, but not α1-AT Wt, three AT mutants or AT 
Wt. In contrast, overexpression of VIP36 resulted in an accelerated 
secretion of three AT mutants but not AT Wt, two α1-AT mutants or α1-AT 
Wt. Thus, both ERGIC-53 and VIP36 were shown to participate selectively 
in the quality control of specific glycoproteins regardless of their mutations. 
These results suggest that high mannose-binding lectins induced by ER 
stress are involved in the quality control of misfolded glycoproteins and 
regulate the ERAD and secretion of those mutants. 
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Molecular chaperones are typically either ATP-dependent or rely heavily on 
their ATP-dependent chaperone counterparts in order to promote protein 
folding. We describe a mechanism by which the tiny (9.7 kDa) acid stress 
chaperone HdeA is capable of independently facilitating the refolding of 
acid-denatured proteins in the bacterial periplasm, which lacks both ATP 
and ATP-dependent chaperone machines. Acid rapidly activates HdeA by 
partial unfolding and dimer dissociation. The partially unfolded HdeA 
monomer can then adaptively recognize a broad range of substrate proteins, 
in part using hydrophobic regions of the now exposed dimer interface. This 
allows HdeA to stably bind substrates at low pH and prevent their 
irreversible aggregation. pH neutralization subsequently triggers the slow 
release of substrate proteins from HdeA, keeping the free concentration of 
aggregation-sensitive intermediates below the threshold where they begin to 
aggregate. This provides a straightforward and ATP-independent 
mechanism that allows HdeA to facilitate protein refolding following 
extreme acid stress. Unlike previously characterized chaperones, HdeA 
appears to facilitate protein refolding by using a single substrate binding-
release cycle. Rather than relying on cellular ATP stores and co-chaperones, 
this cycle is entirely regulated by the external pH and is therefore energy-
neutral for the bacteria. 
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Protein folding is a prominent chaperone function of the Hsp70 system. We 
reported that the mammalian Hsc70 system with either type 1 DnaJ protein, 
DjA1 or DjA2, and a nucleotide exchange factor efficiently mediate the 
refolding of an unfolded protein. Many studies have examined chaperone 
interactions with peptide substrates or a few proteins that do not form 
aggregates, and various models were postulated to explain the folding by 
the Hsp70 system. However, the system plays a prominent role in the 
folding of aggregation-prone unfolded proteins. The direct measurement of 
the kinetics and stoichiometry of chaperone binding is obviously lacking. 
   To solve this issue, we developed a surface plasmon resonance (SPR) 
technique to monitor the initial processes of chaperone bindings to an 
unfolded protein. The substrate protein on a chip showed conformational 
transitions that slowly led to reduced chaperone binding. Some portion of 
the coupled protein was restored to the native conformation by the Hsc70 
system as revealed by the enzymatic activity. Surprisingly, the SPR 
measurement revealed that the multiple Hsc70 proteins and a dimer of DjA1 
initially bind independently to an unfolded protein. The SPR method 
delineated the essential features of chaperone binding; that multiple 
molecules of Hsc70 and a dimer of DjA1 independently bind to an unfolded 
protein at the initial step. The association rate of the Hsc70 was faster than 
that of DnaJ protein in a folding-compatible condition. The Hsp70 binding 
involved a conformational change that corresponds to the rate of ATP 
hydrolysis. The DjA1 binding occurred in a bivalent manner, and this 
coincides with the structural observations that the canonical DnaJ proteins 
are homodimers. Furthermore, an experiment with a peptide array scan 
revealed that the binding sites for Hsc70 and DjA1 are distinct and that 
there were 5 sites for Hsc70 and 2 sites for DjA1. All of these findings 
consistently incorporated the nature of individual chaperones that are 
known but not adequately considered in the folding models of unfolded 
proteins. 
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In the endoplasmic reticulum (ER), newly synthesized secretory and 
transmembrane proteins are correctly folded with the assistance of ER 
chaperones. If cells synthesize proteins in excess of the folding capacity of 
the ER, unfolded or misfolded proteins are accumulated in the ER, and 
cause cell death (ER stress). To cope with ER stress, cells activate the 
cytoprotective mechanism called the ER stress response or unfolded protein 
response (UPR). 
XBP1 is a transcription factor essential for mammalian ER stress response. 
In the absence of ER stress, XBP1 mRNA is expressed as pre-mRNA, from 
which a negative regulator pXBP1(U) is translated. Upon ER stress, XBP1 
pre-mRNA is converted to mature mRNA by the mechanism called 
cytoplasmic splicing, resulting in production of an active transcription 
factor, pXBP1(S). During the recovery phase from ER stress, pXBP1(U) 
enhances degradation of pXBP1(S). Thus, expression of XBP1 is regulated 
by two mechanisms – cytoplasmic splicing and degradation by the 
proteasome, though the underlying mechanism has remained to be clarified. 
Here, we identified UBC9 as a novel regulatory factor of XBP1 expression. 
UBC9 was found to bind to XBP1, and a leucine zipper motif of XBP1 is 
essential for binding. Overexpression of UBC9 in HeLa cells increased 
XBP1 expression and enhanced transcriptional induction in response to ER 
stress. From these results, we propose that UBC9 is a positive regulator of 
XBP1 expression. 
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Molecular chaperones are essential elements of the protein quality control 
machinery that governs translocation and folding of nascent polypeptides, 
refolding and degradation of misfolded proteins, and activation of a wide 
range of client proteins. The prokaryotic heat-shock protein DnaK is the E. 
coli representative of the ubiquitous Hsp70 family, which specializes in the 
binding of exposed hydrophobic regions in unfolded polypeptides. Accurate 
prediction of DnaK binding sites in E. coli proteins is an essential 
prerequisite to understand the precise function of this chaperone and the 
properties of 
its substrate proteins. In order to map DnaK binding sites in protein 
sequences, we have developed an algorithm that combines sequence 
information from peptide binding experiments and structural parameters 
from homology modelling.  We show that this combination significantly 
outperforms either single approach. The final predictor had a Matthews 
correlation coefficient (MCC) of 0.819 when assessed over the 144 tested 
peptide sequences to detect true positives and true negatives. To test the 
robustness of the learning set, we have conducted a simulated cross-
validation, where we omit 
sequences from the learning sets and calculate the rate of repredicting them. 
This resulted in a surprisingly good MCC of 0.703. The algorithm was also 
able to perform equally well on a blind test set of binders and non-binders, 
of which there was no prior knowledge in the learning sets. The algorithm is 
freely available at http://limbo.switchlab.org 
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Multiple cellular pathways influence the proteostasis network that maintains 
proper folding of the proteome. Dysregulation of expression of genes in 
these pathways may contribute to protein misfolding and aggregation. We 
propose that microRNAs provide a mode of regulation of genes influencing 
proteostasis. To determine whether microRNAs regulate these pathways, a 
deletion of Dicer, which is essential for the processing of all precursors of 
microRNAs, was crossed into a C. elegans strains expressing polyQ in the 
body wall muscle cells. Deletion of dcr-1 leads to an enhancement of polyQ 
aggregation suggesting that microRNAs play a significant role in 
proteostasis. Using a bioinformatics program called targetscan, we are 
surveying the 3’UTR of the genes that modify aggregation to identify 
binding sites for specific microRNAs. Mutations or deletions in mir-124, 
mir-355 or let-7 enhance polyQ aggregation. Our goal is to demonstrate that 
specific microRNAs provide a mode of regulation that can influence the 
level of target genes in cellular pathways that influence proteostasis. 
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From a screen for mutants which are physiologically linked to the unfolded 
protein response, we identified a novel allele of protein disulfide isomerase 
(PDI). This is the first time a mutant of PDI has been isolated from a 
forward genetic screen. Pdi1p is an essential protein in Saccharomyces 
cerevisiae involved in the formation of disulfide bonds in secretory and 
cell-surface proteins, but its in vivo role in oxidative protein folding is 
unclear. The PDI mutant contains a mutation in the a’ domain, and 
exhibited a defect in folding of various endogenous proteins. We sought to 
elucidate the role of Pdi1p in protein folding in the ER, and its involvement 
in other aspects of protein quality control. 
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The accumulation of intracellular protein aggregates is associated with 
aging, cell death and a number of degenerative diseases. To date, the 
properties of proteins that determine their aggregation propensity has 
mainly been studied in vitro, an environment devoid of the quality control 
machinery that allow cells to maintain proper proteostatsis. Here, we study 
the intracellular behavior of a panel of mutants of the Aβ peptide, which 
have previously been shown to have a broad range of intracellular 
aggregation propensities. We find that none of these peptides show 
evidence of aggregating when expressed under normal conditions, and than 
all are sequestered in an insoluble inclusion under conditions of proteasome 
inhibition that alter cellular proteostatsis. Our study illuminates how cells 
manage different kinds of aggregation-prone species under different 
conditions of protein folding stress. 
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Phosducin-like protein 1 (PhLP1) and the cytosolic chaperonin complex 
(CCT also called TRiC) have been shown to be essential chaperones in the 
assembly of the G protein βγ dimer. Gβ initially binds CCT and is folded 
into a quasi-native conformation, but requires PhLP1 to release from CCT. 
Once released, Gγ binds Gβ in the PhLP1-Gβ complex. The status of Gγ 
prior to association with Gβ, whether it is free in the cytosol or bound to a 
chaperone, is unknown. Recent work from our laboratory suggests that Gγ 
associates with the Gβ-CCT complex co-translationally through a coiled-
coil interaction between the N-termini of Gγ and Gβ. This interaction 
appears to stall Gγ translational until PhLP1 can associate with the complex 
and release Gβ from CCT. Evidence for such a co-translational mechanism 
of Gβγ assembly includes: i) inhibition of Gγ translation in the absence of 
PhLP1, ii) enhancement of Gγ translation is the absence of Gβ, iii) 
requirement of the Gγ N-terminal residues that form the coiled-coil with Gβ 
for PhLP1-dependence of Gγ translation, and iv) association of both PhLP1 
and CCT with translating ribosomes. Co-translational assembly allows 
hydrophobic residues on the small 71 amino acid Gγ to make immediate 
contacts with their hydrophobic partners on Gβ, thus avoiding problems of 
aggregation and degradation in the cytosol. These findings suggest an 
elegant mechanism by which these two proteins, which are unstable in their 
monomeric form, can associate into a stable complex as Gγ is being 
synthesized. 
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Endoplasmic reticulum (ER) is a cellular compartment where newly 
synthesized secretory and membrane proteins are folded and modified. 
Proteins that failed to be correctly folded are pulled out or retrotranslocated 
from the ER to the cytosol, and polyubiquitinated for degradation by the 
proteasome, which is known as ER-associated degradation (ERAD). 
Especially for membrane proteins, folding and ERAD are facilitated by 
cytosolic or ER luminal Hsp70 and Hsp40 family proteins. Mammalian 
cystic fibrosis transmembrane conductance regulator (CFTR) is one of the 
most widely used model proteins for exploration of quality control of 
membrane proteins. As for folding of CFTR, a cytosolic Hsp40 family 
protein Hdj2 is reported to play an important role. Recently, yeast Hlj1, 
which is an Hsp40 family protein anchored on the ER membrane, is 
involved in the degradation of CFTR artificially expressed in yeast cells. 
However, mammalian Hsp40 family protein contributing to the degradation 
of CFTR has not been identified so far. 
Here we show that DNAJB12 plays an important role in the degradation of 
a malfolded membrane protein in mammalian cells. DNAJB12 is an Hsp40 
family protein and is evolutionarily conserved from S. pombe to human. 
Our analysis of its expression revealed that the mRNA of DNAJB12 is 
ubiquitously expressed in mouse tissues. Further we show that DNAJB12 is 
a type-II transmembrane protein located on the ER with its J-domain facing 
the cytosolic side. This topology predicts that DNAJB12 may be able to 
corporate with cytosolic Hsc70 for the degradation of CFTR. Indeed, we 
have found that DNAJB12 is associated with Hsc70 via its J-domain in 
vivo. Remarkably, overexpression of DNAJB12 accelerated the degradation 
of CFTR, whereas knockdown of this protein resulted in the increased 
expression of CFTR. Furthermore, the DNAJB12-dependent degradation of 
CFTR was inhibited by a proteasome inhibitor. These findings suggest that 
DNAJB12 plays an important role in ERAD of mammalian ER membrane 
proteins. 
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On decoding genetic code of mRNA, ribosome forms mRNA-ribosome-
nascent chain (R-RNC) complex transiently, which should be, in principle, 
able to couple protein function with its own mRNA. However, almost all 
proteins acquire their function after released from ribosome and folded. 
Furthermore, duration of R-RNC complex is much shorter as compare with 
entire lifetime of each protein, which makes it difficult for nascent chain to 
affect its own mRNA. One exception is our previous finding that XBP1u 
protein recruits its own mRNA onto membrane as a state of nascent chain, 
which promotes cytoplasmic splicing of XBP1u mRNA by endoplasmic 
reticulum (ER) transmembrane protein IRE1α upon ER stress conditions. In 
our model, a highly hydrophobic region in XBP1u, HR2 is responsible for 
attaching the protein onto membrane and the C-terminal 53 residues 
downstream of HR2 is required for coupling the membrane localization of 
XBP1u with that of its own mRNA. Our model predicts XBP1u R-RNC 
complex needs to be targeted onto membrane before completion of the 
synthesis of XBP1u. However, XBP1u has only 53 amino acid residues 
after HR2. In addition, HR2 will probably need to be exposed out side of 
the ribosome tunnel for the interaction of HR2 with the membrane. Thus, it 
remained unclear how R-RNC is targeted to the membrane before the 
termination of the XBP1u synthesis. Here we propose novel mechanism to 
perform this process, metazoan cells have evolved. 
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Proteins in the cell are maintained in a dynamic balance of folding, 
degradation and localization. The human cytosolic chaperone Hsc70 is 
thought to have a central role in this balance. The Hsp40/DnaJ family of co-
chaperones are essential to stimulate the ATPase and substrate binding 
activities of Hsc70. Recent work has examined the biochemical properties 
of DnaJA1 (Hdj2) and DnaJA2, the main Type I Hsp40 proteins in humans. 
It was proposed that the DnaJAs have similar yet partially specialized 
characteristics which cooperate with Hsc70 in different situations. The 
function of the DnaJA co-chaperones in the cellular context was next 
addressed. Both DnaJA1 and DnaJA2 were active in HeLa cell models of 
polypeptide folding, with DnaJA1 generally showing the greatest activity. 
Mutants of the DnaJAs were used to explore their requirements for 
function, and their internal structures were found to be notably important. 
Intriguingly, in another model of chaperone-dependent HERG potassium 
channel folding at the endoplasmic reticulum of HEK293 cells, the DnaJAs 
were found to inhibit trafficking and maturation of the channel. Instead, the 
polypeptide was retained at the endoplasmic reticulum and degraded by 
proteasomes, most likely involving the Hsc70-dependent CHIP E3 ubiquitin 
ligase. Thus, the DnaJAs together with Hsc70 are key factors in the cellular 
regulation of protein destinies. 
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The highly conserved ClpP protease consists of two heptameric rings that 
interact by the interdigitation of an α-helix - β-strand handle domain motif 
to form a tetradecameric cylinder. We previously proposed that protease 
dynamics results in the temporary unstructuring of interacting pairs of 
handle domains, opening transient equatorial side pores that allow for 
peptide egress. Here, we report the structure of an Escherichia coli ClpP 
mutant in which each opposing pair of protomers is linked by a disulfide 
bond. This structure resembles the compact ClpP structure of Streptococcus 
pneumoniae, Mycobacterium tuberculosis, and Plasmodium falciparum 
ClpP, rather than the active, extended structure seen for all previously 
determined E. coli ClpP structures. The structural data, along with normal 
mode analysis, support a model whereby the ClpP cylinder switches 
dynamically between an active extended state required for substrate 
degradation and an inactive compact state required for peptide product 
release.  
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Small heat shock protein (sHsp) is a molecular chaperone with a conserved 
alpha-crystallin domain that normally forms large oligomers (9-50mer) in 
their native state. It has been shown that the oligomer dissociates to prevent 
protein aggregation under stressed conditions. Since sHsps have been found 
too be upregulated and co-localized with amyloid beta (Ab) in senile 
plaques of Alzheimer’s disease patients, sHsps are considered to be 
involved in the disease. Previous studies showed that sHsp prevent Ab 
aggregation in vitro. However, it remains to be demonstrated how the 
quaternary structure of sHsp influence on Ab aggregation. In this study, we 
have examined Ab aggregation in the presence of sHSP from fission yeast 
Schizosaccharomyces pombe (SpHsp16), which is homologous with other 
sHsps found in AD brain, and more importantly, shows clear temp-
dependent transition between oligomer and dimer (J. Biol. Chem. (2005) 
280, 32586). 
It has been shown that SpHsp16 dissociates into dimer under heat shock 
condition (50 deg) while it forms oligomer at a normal temperature (30 
deg). Ab fibrillation in the presence of with an equimolar (monomer conc.) 
amount of SpHsp16 at 30˚C or 50˚C for 24 hr was examined by 
transmission electron microscopy (TEM). When Ab was incubated with 
SpHsp16 at 30 deg, no mature amyloid fibrils were formed, indicating that 
Ab fibrillation was inhibited by oligomeric SpHsp16. In contrast, significant 
amount of amyloid fibrils were observed in samples incubated with 
SpHsp16 at 50˚C. Thioflavin T (ThT) fluorescence analysis suggests a 
difference in their inner structures. Interaction between Ab molecules and 
SpHsp16 of both oligomeric and dimeric structures was confirmed with co-
immunoprecipitation. 
Cell toxicity of Ab fibrils formed in the presence of dimeric SpHsp16 on rat 
PC12 cells was examined with MTT assay. Interestingly, its cell toxicity 
was much lower than that of “normal” Ab fibrils formed without SpHsp16. 
Immuno-histochemical study showed that this low toxicity could be 
explained by weak affinity of the fibril to the cell surface.  
In summary, our results showed that oligomeric SpHsp16 inhibits Ab 
fibrillation, and dimeric SpHsp16 induces formation of low toxic novel 
fibrillar amyloid which has different characteristics with well-known Ab 
amyloid fibrils formed without a molecular chaperone. 
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The endoplasmic reticulum (ER) is the cellular organelle responsible for 
protein folding and assembly, lipid biosynthesis, and calcium storage. The 
Unfolded Protein Response (UPR) is an adaptive intracellular stress 
response to the accumulation of unfolded or misfolded proteins in the ER. 
In this study, we demonstrated that the most conserved UPR sensor IRE1α, 
an ER transmembrane protein kinase/endoribonuclease, is required to 
maintain hepatic lipid homeostasis by preventing hepatic lipid accumulation 
and maintaining lipoprotein secretion. To elucidate the physiological role of 
IRE1α-mediated signaling in the liver, we generated hepatocyte-specific 
Ire1α null mice by utilizing albumin promoter-controlled Cre recombinase-
mediated deletion. Hepatocyte-specific deletion of Ire1α caused defective 
induction of genes encoding functions in ER-to-Golgi protein transport, 
oxidative protein folding, and ER-associated degradation of misfolded 
proteins. In response to ER stress, mice with hepatocyte-specific Ire1α 
deletion display profound hepatic steatosis. Further investigation revealed 
that IRE1α modulates expression of key metabolic transcription factors of 
the CCAAT/enhancer binding protein and peroxisome proliferator-activated 
receptor families and is required for efficient secretion of apolipoproteins 
upon disruption of ER homeostasis. The identification of IRE1α as a key 
regulator of hepatic steastosis may have important implications for human 
fatty liver diseases as well as metabolic syndrome.  
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GADD34 (product of a growth arrest and DNA damage-inducible gene) is 
expressed in response to a variety of cell stresses. Biochemical and cell 
biological showed that GADD34 protein was present in both membrane 
(primarily endoplasmic reticulum) and cytosol and proteasome inhibition 
preferentially enhanced the GADD34 levels protein associated with the 
endoplasmic reticulum (ER). Structure-function analyses identified an 
evolutionarily conserved ER-localization sequence near the N-terminus of 
GADD34 and highlighted key residues in an amphipathic helix as critical 
for membrane binding. Besides ER localization, yet other mutations on this 
region highlighted an unexpected ability of GADD34 to be localized at 
mitochondria. Both soluble and membrane-associated GADD34 effectively 
scaffolded the catalytic subunit of protein phosphatase-1 (PP1) and the 
eukaryotic translation initiation factor, eIF2α and promoted eIF2α 
dephosphorylation. The redistribution of GADD34 to cytosol was 
accompanied by significant reduction in its rate of degradation by the 
proteasome, resulting increased protein translation and misfolding. 
Together, the data hint a potential mechanism by which GADD34 
trafficking between distinct subcellular compartments may regulate the 
cellular levels of the protein and control protein translation. 
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Environmental or cellular insults constantly interfere with accurate folding 
and maturation of proteins. Since misfolded polypeptides tend to 
accumulate and may form toxic aggregates, protein quality control (PQC) 
mechanisms have evolved to ensure structural integrity of the cellular 
proteome. In the early secretory pathway, terminally misfolded or 
unassembled proteins are cleared from the endoplasmic reticulum (ER) in a 
process known as ER-associated protein degradation (ERAD). Aberrant 
proteins are first recognized and then retrotranslocated across the ER 
membrane into the cytosol for destruction by the ubiquitin-proteasome 
proteolytic system. In the yeast Saccharomyces cerevisiae glycoproteins 
with luminal lesions are removed by the HRD ligase, a large multiprotein 
complex embedded in the ER membrane that includes the E3 ubiquitin 
ligase Hrd1p. The ER luminal subcomplex contains the major substrate 
receptors Hrd3p and Yos9p. Hrd3p, a type I membrane protein, recruits 
potential substrates based on the presence of misfolded domains whereas 
Yos9p recognizes a mannose7-glycan structure specific for defective 
proteins. Only the recognition of this bipartite signal triggers the 
degradation of misfolded polypeptides. Here we will show data that Hrd3p 
and Yos9p might exhibit functions beyond substrate recognition. Our in 
vitro data suggest that Hrd3p and Yos9p prevent denatured proteins from 
aggregation and ensure their solubility as a prerequisite for efficient 
retrotranslocation into the cytosol. 
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Introduction and Objectives: Androgen withdrawal is the most effective 
form of systemic therapy for men with advanced prostate cancer. 
Unfortunately, androgen-independent progression is inevitable, and the 
development of hormone-refractory disease and death occurs within 2 to 3 
years in most men. The understanding of molecular mechanisms promoting 
the growth of androgen-independent prostate cancer cells is essential for the 
rational design of agents to treat advanced disease. We previously reported 
that Hsp27 level correlates with castrated resistant prostate cancer (CRPC). 
However, the mechanism by which Hsp27 mediates CRPC remains elusive.  
Material and methods: LNCaP and C4-2 cells were treated or not with IL-6 
and submitted to western blot, co-IP and immunofluorescence analysis. 
Cells were transfected with Hsp27 WT and Hsp27 siRNA and tested for 
their ability to modulate STAT3, Jak2, Erk expression and phosphorylation 
by western blot and STAT3 and PSA transactivation by luciferase assay.  
 complexes, STAT3 dimerization, nuclear translocation and tranactivation. 
Since, STAT3 phosphorylation was correlated with AR activation in ligand 
independent manner, Hsp27 knockdown abrogates IL-6 inducing PSA 
activation/expression in vitro and in vivo. Finally, Hsp27 knockdown using 
OGX-427 delayed time to CRPC in LNCaP xenograft model.Results: Here 
we report that Hsp27 is highly expressed and phosphorylated in androgen 
independent C4-2 cell line compared to androgen dependent cell line 
LNCaP. IL-6 induced Hsp27 phosphorylation via p38 kinase and triggers a 
rapid formation of Hsp27/STAT3 complexes in a time dependent manner. 
Hsp27 knockdown using siRNA or antisense (OGX-427 currently in phase I 
clinical trial in CRPC) abrogate IL-6 signalling pathway. Hsp27 knockdown 
inhibits the ability of IL-6 to induce STAT3 phosphorylation on tyrosine 
and serine and STAT3/Jak-2 and STAT3/PKC  
Conclusion: Taken together, these results support an important function of 
Hsp27 in CRPC and specifically in IL-6 signalling pathway and support 
further the rational of targeting Hsp27 in CRPC.  
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Our laboratory is working to develop a molecular level understanding of the 
pathways of secretory and membrane protein biosynthesis and metabolism. 
We are especially interested in the regulatory machinery controlling protein 
entry and insertion into the endoplasmic reticulum (ER), the site where 
nearly all secreted and membrane proteins are first made. Recently, we 
discovered a new pathway for membrane protein insertion into the ER used 
by a large class of 'tail-anchored' membrane proteins. In this pathway a 
cytosolic ATPase we named TRC40 selectively recognizes its membrane 
protein substrates, delivers them to the ER, and facilitates their insertion 
into the membrane. We have reconstituted these steps in vitro and are now 
using this system to identify novel machinery essential for regulating the 
efficient and proper biogenesis of tail-anchored proteins. Our ongoing 
studies reveal that substrate capture by TRC40 requires an additional 
protein complex that we have now purified and identified. Functional 
analysis reveals that this complex is acting as a 'pre-targeting' factor that 
directly binds tail-anchored substrates at the ribosome and transfers them to 
TRC40. Mechanistic and structural studies of the components of this 
membrane protein insertion pathway will be presented. 
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Accumulation of unfolded proteins in the endoplasmic reticulum (ER) by 
various ER stresses triggers the cytoplasmic splicing of XBP1u (unspliced) 
mRNA in metazoans or HAC1u mRNA in yeast by the transmembrane 
kinase/endoribonuclease IRE1, resulting in activation of the unfolded 
protein response, which maintains ER homeostasis. Under unstressed 
condition, whereas HAC1u mRNA in yeast is translationally repressed by 
stable base-pairing between 5’-untranslated region and its intron, XBP1u 
mRNA in mammals is translated and unstable XBP1u is produced. Since 
ER stress sensor IRE1 could be located in the ER membrane, 
HAC1u/XBP1u mRNAs should be recruited to the ER membrane in spite of 
nonsecretory proteins. Recently we reported that the nascent XBP1u 
polypeptide recruits its own mRNA to the membrane mediated through the 
HR2 hydrophobic region of XBP1u, which enhances the efficiency of 
cytoplasmic splicing of XBP1u mRNA under ER stress. Our data showed 
that the C-terminal 53-amino acid region of XBP1u protein, which locates 
to the downstream of HR2, is sufficient for tethering XBP1u mRNA to the 
membrane. However, if XBP1u mRNA-tethering to the membrane occurs 
during translation, 53-amino acid residues seem to be slightly short for the 
tethering because HR2 should be exposed outside of the ribosome tunnel. 
We hypothesize that decreasing the rate of polypeptide synthesis at the C-
terminus of XBP1u or polypeptide synthesis by polyribosome may 
contribute to the efficient tethering of mRNA to the membrane. Here we 
present and discuss a novel mechanism of membrane-association of XBP1u 
mRNA. 
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It has been firmly established that the information necessary for proteins to 
fold is contained within their amino acid sequence. However, since the 
process of translation is vectorial, nascent proteins emerge gradually from 
the ribosome as incomplete chains that are susceptible to misfolding. 
Ribosome movement along an mRNA is variable and may be influenced by 
tRNA availability and the physical-chemical properties of the anticodon-
codon interaction. Thus, the speed at which a polypeptide is synthesized is 
not uniform and depends, at least partially, on its coding sequence, which 
determines which specific isoacceptor tRNAs are utilized. Recent 
experiments from our laboratory suggest that translation speed and local 
folding events of the nascent protein are intimately coupled and require 
precise coordination. We wish to further understand how genetically 
encoded information may regulate translation speed and thus protein folding 
pathways. We have exploited differences in tRNA availability and protein 
folding efficiencies between bacteria and eukaryotes as tools to study these 
relationships. We have been capable of predictably accelerating and 
decelerating translation speed by engineering sequences that encode 
identical proteins, yet contain systematic variations along wobble positions 
of synonymous codons. Furthermore, we find that subtle manipulation of 
translation speeds along particular mRNA segments by these means can 
lead to significant increases in the folding efficiencies of these proteins 
upon recombinant production in bacteria. We believe our findings provide 
insight into how the genetic code, although nearly universal in its amino 
acid encoding properties, is utilized differently between bacteria and 
eukaryotes to regulate local protein folding events during protein 
biogenesis. Additionally, our results may provide further insight into how 
so-called “silent” polymorphisms may result in human disease and on how 
physiological and disease-related variations in tRNA concentrations impact 
cellular proteostasis, implicated in a wide variety of human diseases.  
 
This work was supported by an award from the Pew Scholars Program in 
the Biomedical Sciences to J.M.B.  
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An endoplasmic reticulum (ER) quality control system assists in efficient 
folding and disposal of misfolded proteins. N-linked glycans are critical in 
these events because their composition dictates interactions with molecular 
chaperones. UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) is a 
key quality control factor of the ER. It adds glucoses to N-linked glycans of 
non-glucosylated substrates that fail a quality control test, supporting 
additional rounds of chaperone binding and ER retention. How UGT1 
functions in its native environment is poorly understood. The role of UGT1 
in the maturation of glycoproteins at basal expression levels was analyzed. 
Prosaposin was identified as a prominent endogenous UGT1 substrate. A 
dramatic decrease in the secretion of prosaposin was observed in ugt1-/- 
cells with prosaposin localized to large juxtanuclear aggresome-like 
inclusions, indicative of its misfolding and the essential role that UGT1 
plays in its proper maturation. A model is proposed that explains how 
UGT1 may aid in the folding of sequential domain containing proteins such 
as prosaposin. 
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It is generally believed that formation/disassembly of intra- and inter-
molecular disulfide bonds and cis/trans isomerization of prolyl bonds in 
nascent polypeptides are rate-limiting steps for protein maturation in the 
endoplasmic reticulum (ER). Disulfide bonds reduction and prolyl bonds 
isomerization might also be crucial to insure the partial unfolding of 
terminally misfolded polypeptide chains that must be dislocated across the 
ER membrane for degradation operated by cytosolic proteasomes. The 
crucial intervention of several ER-resident oxidoreductases (PDIs) in 
polypeptide maturation is well documented and PDIs involvement in 
disposal of folding-defective proteins (ERAD) has also been established. In 
contrast, a role of peptidyl prolyl cis/trans isomerases (PPIs) in 
conformational maturation of nascent polypeptides or in protein quality 
control in the ER lumen of living cells is not yet supported by experimental 
data. Several tests aiming at understanding the role of PPIs by genetic 
manipulation or by pharmacologic inactivating their activity failed to reveal 
detectable phenotypes in vivo. This questions the involvement and the 
relevance of PPIs in protein quality control in the living cell. 
 
Here we show the potent inhibitory effect of Cyclosporine A (CsA) on 
disposal from the ER of soluble, misfolded polypeptides (ERAD-Ls 
substrates). CsA is a cyclic undecapeptide produced by the fungus 
Tolypocladium inflatum gams used in the clinics as an immunosuppressant 
to reduce the risk of graft rejection. CsA specifically inactivates 
immunophilin members of the PPIs family. We identify cyclophilin B as the 
ER-resident target of CsA that regulates disposal from the ER of a sub-class 
of ERAD-Ls substrates containing cis-prolines. 
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When increased production of secretory proteins overwhelms the capacity 
of the endoplasmic reticulum (ER) and the Golgi apparatus, eukaryotic cells 
expand their capacity to sustain secretory function. The capacity of the ER 
is enhanced by the mechanism called the ER stress response, but the 
mechanism regulating Golgi capacity (the Golgi stress response) has 
remained unclear. Here, we found that transcription of Golgi-related genes, 
including Golgi-specific glycosylation enzymes, was upregulated when 
mammalian cells were treated with a Golgi stress-inducing agent, monensin. 
This transcriptional induction is commonly regulated by a novel cis-acting 
element called the Golgi apparatus stress response element (GASE). We 
isolated a bHLH-ZIP protein, MLX, as a GASE binding protein, and found 
that overexpression of MLX suppressed transcriptional induction mediated 
through GASE, whereas another bHLH-ZIP protein, TFE3, is essential for 
GASE-mediated transcriptional induction. These findings suggested that the 
mammalian Golgi stress response is controlled by an elaborate network of 
bHLH-ZIP transcription factors. 
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Age-associated neurodegenerative diseases associated with protein 
misfolding, such as Huntington’s, Parkinson’s, and Alzheimer’s diseases, 
generate patterns of neuronal stress responses that allow a systems-based 
approach for the identification of novel drug targets, disease progression 
biomarkers, and the effect of putative therapeutics on normalizing network-
level alterations. We have developed a novel searchable protein-protein 
interaction database (PN-Explorer) utilizing data obtained across five 
species from yeast to human. By assembling an interactome network using 
physical interaction data and overlaying gene expression datasets, we have 
identified sub-networks that are co-expressed under various stress 
conditions. Furthermore, analyzing transcriptional data from a range of 
human post-mortem brain tissues, we have identified both positive and 
negative network responses associated with neurodegeneration. These data 
uncover similarities and differences in the proteostasis network in response 
to aging and age-onset diseases, distinct in qualitative and quantitative ways 
from network changes associated with the aging process. Such differences 
can be used to identify novel pathways and targets for therapeutic 
intervention, and should also provide insights into disease-progression 
biomarkers.  
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, west wing, lower level 
 PIN#:  Press 64345 (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
